tag:blogger.com,1999:blog-86819396179663394112024-03-05T22:51:15.384-08:00Seroquel Lawsuit BlogUnited States Attorney General Eric Holder stated referring to AstraZeneca's Seroquel Settlement with DOJ: "These were not victimless crimes" April 27th, 2010Seroquelhttp://www.blogger.com/profile/12012400050067849012noreply@blogger.comBlogger103125tag:blogger.com,1999:blog-8681939617966339411.post-75814726674538816742017-11-18T06:34:00.000-08:002017-11-18T06:34:31.477-08:00Too Little , Too Late - Texas Lawsuit Claims AstraZeneca Pushed Seroquel Antipsychotic to Kids<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj11LKmgwKmKmmAjFKRDRAaLNbRCJI3kZOdJ95MZyNgwO0MZpE15gHIyVkboiMD9hFSzkQY9otwR-tLYj4tfteVACHIPMNRGjz9XUmibN6kZimRoKI_0DdzoEnDqjarTDQEpXbPiLwAU76X/s1600/child-drugging.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="400" data-original-width="600" height="266" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj11LKmgwKmKmmAjFKRDRAaLNbRCJI3kZOdJ95MZyNgwO0MZpE15gHIyVkboiMD9hFSzkQY9otwR-tLYj4tfteVACHIPMNRGjz9XUmibN6kZimRoKI_0DdzoEnDqjarTDQEpXbPiLwAU76X/s400/child-drugging.jpg" width="400" /></a></div>
<h4>
<b>Too Little , Too Late - Texas Lawsuit Claims AstraZeneca Pushed Seroquel Antipsychotic to Kids</b></h4>
<h4>
<b> </b></h4>
Bloomberg News reports Texas and AstraZeneca are near a settlement in AZ's purposeful marketing of Anti-psychotic Seroquel to kids for profit as part of the state’s Medicaid program. Of course this is an example of AZ paying off another government entity with chump change and no admission of guilt; while the real child victims of these unconscionable crimes receive absolutely nothing for the damage done, the suffering endured, and their lives ruined.<br />
<br />
I call it "Political Theater" where a State Government portrays themselves as some kind of White Hat Wearing Cowboy Sheriff's lassoing up bad guy pharmaceutical bandits; when in fact the Town (child victims) has already been abandoned long ago. Who's fooling who here? Government isn't interested in the damage done to these kids...they just want to refill their own Medicaid money coffers.<br />
<br />
<h4>
Read the article for yourself. <a href="https://www.bloomberg.com/news/articles/2017-11-17/astrazeneca-in-talks-to-settle-texas-lawsuit-over-sales-tactics">astrazeneca-in-talks-to-settle-texas-lawsuit-over-sales-tactics</a> </h4>
Seroquelhttp://www.blogger.com/profile/12012400050067849012noreply@blogger.com0tag:blogger.com,1999:blog-8681939617966339411.post-39679721094329187102017-10-18T06:35:00.000-07:002017-10-18T06:35:42.402-07:00Lawsuit accuses AstraZeneca and Big Pharma of indirectly funding terrorists who killed US soldiers<div style="text-align: center;">
</div>
<div style="text-align: center;">
</div>
<div style="text-align: center;">
<img alt="https://www.wired.com/images_blogs/photos/uncategorized/2008/03/30/baghdadtopper.jpg" src="https://www.wired.com/images_blogs/photos/uncategorized/2008/03/30/baghdadtopper.jpg" /> </div>
<h3 style="text-align: center;">
<b> </b></h3>
<h3 style="text-align: center;">
<b>Lawsuit accuses AstraZeneca and others of indirectly funding terrorists who killed US soldiers</b></h3>
<div class="headline head1">
Fox News<a href="http://www.foxnews.com/us/2017/10/18/big-pharma-funded-anti-us-militia-in-iraq-us-veterans-allege-in-lawsuit.html"> big-pharma-funded-anti-us-militia-in-iraq</a> Financial Times <a href="https://www.ft.com/content/d5c1b734-b353-11e7-a398-73d59db9e399?mhq5j=e7">https://www.ft.com/content/d5c1b734-b353-11e7-a398-73d59db9e399?mhq5j=e7</a> and The New York Times <a href="https://www.nytimes.com/2017/10/17/us/johnson-ge-pfizer-terror-iraq.html">https://www.nytimes.com/2017/10/17/us/johnson-ge-pfizer-terror-iraq.html</a> report that Big Pharma funded anti-US militia in Iraq, US veterans allege in lawsuit</div>
<div style="text-align: left;">
<br /></div>
<br /><div class="speakable">
U.S. and European drug companies indirectly yet
knowingly funded Iran-backed Iraqi militias that carried out attacks
against U.S. troops, veterans of the Iraq War alleged in a lawsuit filed
Tuesday.</div>
<div class="speakable">
The lawsuit alleges that five drug
companies won contracts with the Iraqi government during the 2003 peak
of the war with knowledge that free drugs and medical devices would end
up in the hands of a Shiite militia.</div>
That militia would then sell the drugs and devices to the black market to fund its operations against the U.S., the <a href="https://www.nytimes.com/2017/10/17/us/johnson-ge-pfizer-terror-iraq.html" target="_blank">New York Times</a> reported.<br />
Named in the lawsuit are U.S. firms General Electric,
Johnson & Johnson and Pfizer and European drugmakers AstraZeneca and
Roche Holding A.G.<br />
The companies won contracts with the Iraqi Ministry of
Health that at the time was controlled by the leader of the Mahdi Army, a
group known for attacking U.S. troops and working closely with Lebanese
paramilitary group Hezbollah, which the U.S. has designated a terrorist
group, the Times reported.<br />
The group was known as the “Pill Army,” according to the <a href="https://www.ft.com/content/d5c1b734-b353-11e7-a398-73d59db9e399" target="_blank">Financial Times</a>, as some of the fighters were known to have been paid in drugs rather than cash.Seroquelhttp://www.blogger.com/profile/12012400050067849012noreply@blogger.com0tag:blogger.com,1999:blog-8681939617966339411.post-9331186292328541012014-11-09T18:27:00.000-08:002014-11-09T18:27:39.502-08:00Robin Williams - Early Signs Of Parkinsons's related Dementia At Death - Prescribed Black Box Warning Antipsychotic SeroquelRobin Williams - Showed Early Signs Of Parkinsons's related Dementia At Death - Prescribed Black Box Warning Anti-psychotic Seroquel<br />
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiasDirLJnG1XcaUw6599ROyDxnZHlwUzZ127P3W0fkgGfJiCV0vbULvA2ErHFcry92OMckDcUpC7-8xWe21THdNoq-OnQ8Id0ShJLerJedhq54DOQOYfpSQ9klbfMywzgZ234gOKN79wMQ/s1600/robin+williams.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiasDirLJnG1XcaUw6599ROyDxnZHlwUzZ127P3W0fkgGfJiCV0vbULvA2ErHFcry92OMckDcUpC7-8xWe21THdNoq-OnQ8Id0ShJLerJedhq54DOQOYfpSQ9klbfMywzgZ234gOKN79wMQ/s1600/robin+williams.jpg" height="223" width="400" /></a></div>
<h1 class="entry-title">
<span style="font-size: small;"> <a href="http://radaronline.com/exclusives/2014/11/robin-williams-coroners-report-death-suicide/">radaronline.com/exclusives/2014/11/robin-williams-coroners-report-death-suicide/</a></span></h1>
<br />
<br />
<!--[if gte mso 9]><xml>
<w:WordDocument>
<w:View>Normal</w:View>
<w:Zoom>0</w:Zoom>
<w:TrackMoves/>
<w:TrackFormatting/>
<w:PunctuationKerning/>
<w:ValidateAgainstSchemas/>
<w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
<w:IgnoreMixedContent>false</w:IgnoreMixedContent>
<w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
<w:DoNotPromoteQF/>
<w:LidThemeOther>EN-US</w:LidThemeOther>
<w:LidThemeAsian>X-NONE</w:LidThemeAsian>
<w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
<w:Compatibility>
<w:BreakWrappedTables/>
<w:SnapToGridInCell/>
<w:WrapTextWithPunct/>
<w:UseAsianBreakRules/>
<w:DontGrowAutofit/>
<w:SplitPgBreakAndParaMark/>
<w:EnableOpenTypeKerning/>
<w:DontFlipMirrorIndents/>
<w:OverrideTableStyleHps/>
</w:Compatibility>
<m:mathPr>
<m:mathFont m:val="Cambria Math"/>
<m:brkBin m:val="before"/>
<m:brkBinSub m:val="--"/>
<m:smallFrac m:val="off"/>
<m:dispDef/>
<m:lMargin m:val="0"/>
<m:rMargin m:val="0"/>
<m:defJc m:val="centerGroup"/>
<m:wrapIndent m:val="1440"/>
<m:intLim m:val="subSup"/>
<m:naryLim m:val="undOvr"/>
</m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
<w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true"
DefSemiHidden="true" DefQFormat="false" DefPriority="99"
LatentStyleCount="267">
<w:LsdException Locked="false" Priority="0" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Normal"/>
<w:LsdException Locked="false" Priority="9" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="heading 1"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9"/>
<w:LsdException Locked="false" Priority="39" Name="toc 1"/>
<w:LsdException Locked="false" Priority="39" Name="toc 2"/>
<w:LsdException Locked="false" Priority="39" Name="toc 3"/>
<w:LsdException Locked="false" Priority="39" Name="toc 4"/>
<w:LsdException Locked="false" Priority="39" Name="toc 5"/>
<w:LsdException Locked="false" Priority="39" Name="toc 6"/>
<w:LsdException Locked="false" Priority="39" Name="toc 7"/>
<w:LsdException Locked="false" Priority="39" Name="toc 8"/>
<w:LsdException Locked="false" Priority="39" Name="toc 9"/>
<w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption"/>
<w:LsdException Locked="false" Priority="10" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Title"/>
<w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font"/>
<w:LsdException Locked="false" Priority="11" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/>
<w:LsdException Locked="false" Priority="22" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Strong"/>
<w:LsdException Locked="false" Priority="20" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/>
<w:LsdException Locked="false" Priority="59" SemiHidden="false"
UnhideWhenUsed="false" Name="Table Grid"/>
<w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text"/>
<w:LsdException Locked="false" Priority="1" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 1"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 1"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 1"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/>
<w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision"/>
<w:LsdException Locked="false" Priority="34" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/>
<w:LsdException Locked="false" Priority="29" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Quote"/>
<w:LsdException Locked="false" Priority="30" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 1"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 1"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 2"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 2"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 2"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 2"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 2"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 3"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 3"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 3"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 3"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 3"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 4"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 4"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 4"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 4"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 4"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 5"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 5"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 5"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 5"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 5"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 6"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 6"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 6"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 6"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 6"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/>
<w:LsdException Locked="false" Priority="19" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/>
<w:LsdException Locked="false" Priority="21" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/>
<w:LsdException Locked="false" Priority="31" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/>
<w:LsdException Locked="false" Priority="32" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/>
<w:LsdException Locked="false" Priority="33" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Book Title"/>
<w:LsdException Locked="false" Priority="37" Name="Bibliography"/>
<w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading"/>
</w:LatentStyles>
</xml><![endif]--><!--[if gte mso 10]>
<style>
/* Style Definitions */
table.MsoNormalTable
{mso-style-name:"Table Normal";
mso-tstyle-rowband-size:0;
mso-tstyle-colband-size:0;
mso-style-noshow:yes;
mso-style-priority:99;
mso-style-parent:"";
mso-padding-alt:0in 5.4pt 0in 5.4pt;
mso-para-margin:0in;
mso-para-margin-bottom:.0001pt;
mso-pagination:widow-orphan;
font-size:10.0pt;
font-family:"Times New Roman","serif";}
</style>
<![endif]--><span style="font-size: 10.0pt;">information for SEROQUEL. </span>
<br />
<div class="MsoNormal">
<span style="font-family: "Arial","sans-serif"; font-size: 10.0pt;">SEROQUEL</span><span style="font-family: "Arial","sans-serif"; font-size: 6.0pt;">®</span><span style="font-family: "Arial","sans-serif"; font-size: 10.0pt;"></span></div>
<div class="MsoNormal">
<span style="font-family: "Arial","sans-serif"; font-size: 10.0pt;">(quetiapine
fumarate) Tablets </span></div>
<div class="MsoNormal">
<span style="font-size: 10.0pt;">Initial US Approval: 1997 </span></div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<span style="font-size: 10.0pt;">WARNING: INCREASED MORTALITY
IN ELDERLY PATIENTS </span></div>
<div class="MsoNormal">
<span style="font-size: 10.0pt;">WITH DEMENTIA-RELATED
PSYCHOSIS </span></div>
<div class="MsoNormal">
<span style="font-size: 10.0pt;"><span style="mso-spacerun: yes;"> </span></span><span style="font-family: "Arial","sans-serif"; font-size: 10.0pt;">•</span><span style="font-size: 10.0pt;">Antipsychotic
drugs are associated with an increased risk of death (5.1) </span></div>
<div class="MsoNormal">
<span style="font-family: "Arial","sans-serif"; font-size: 10.0pt;">•
</span><span style="font-size: 10.0pt;">Quetiapine is not approved for elderly
patients with Dementia-Related Psychosis (5.1)</span></div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<span style="font-size: 10.0pt;">WARNING: SUICIDALITY AND
ANTIDEPRESSANT DRUGS </span></div>
<div class="MsoNormal">
<span style="font-size: 10.0pt;">See Full Prescribing
Information for complete boxed warning. </span></div>
<div class="MsoNormal">
<span style="font-family: "Arial","sans-serif"; font-size: 10.0pt;">•
</span><span style="font-size: 10.0pt;">Increased risk of suicidal thinking and
behavior in children, adolescents and young adults taking antidepressants for
major depressive disorder and other psychiatric disorders</span><span style="font-family: "Arial","sans-serif"; font-size: 10.0pt;"></span></div>
<br />
<br />
<h1 class="head1_body">
<span style="font-weight: normal;">Alert for Healthcare Professionals: Quetiapine (marketed as Seroquel)</span></h1>
<div style="color: navy; font-size: 1.25em; text-align: center;">
9/2006: The issue described in this alert has been addressed in product labeling.</div>
<hr color="#000000" />
<div align="left">
FDA Alert [4/11/2005]: Increased Mortality in Patients with Dementia-Related Psychosis</div>
<div align="left">
FDA
has determined that patients with dementia-related psychosis treated
with atypical (second generation) antipsychotic medications are at an
increased risk of death compared to placebo. Based on currently
available data, FDA has requested that the package insert for Seoquel be
revised to include a black box warning describing this risk and noting
that this drug is not approved for this indication.</div>
<div align="left">
<br /></div>
<div align="left">
<strong> <a href="http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm152283.htm">fda/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders</a></strong></div>
<br />
<b> <a href="http://www.pdf.org/en/science_news/release/pr_1311105214">science_news/release/seroquel</a></b><br />
<br />
<b> <a href="http://www.drugs.com/news/parkinson-s-patients-still-antipsychotics-despite-warning-32439.html">parkinson-s-patients-still prescribed-antipsychotics-despite-warning-</a></b><br />
<br />
<b>--------------------------------------------------------------------------------------</b><br />
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhT57zHYE9-fu-gtbf1bviS0S6BQnTsZ5rcKuPz0NN1U8KJvmmBzIMcJCvRyg5rPzBRF3Rtc8U7i_OHRB9nremGBv9JzaMtiVMrxSSdnDNu-Hz5pstQZ15fKZpFQc5TvRnwsQGfekHx4fRH/s1600/Seroquel-Tablets.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhT57zHYE9-fu-gtbf1bviS0S6BQnTsZ5rcKuPz0NN1U8KJvmmBzIMcJCvRyg5rPzBRF3Rtc8U7i_OHRB9nremGBv9JzaMtiVMrxSSdnDNu-Hz5pstQZ15fKZpFQc5TvRnwsQGfekHx4fRH/s1600/Seroquel-Tablets.jpg" height="349" width="400" /></a></div>
<b> </b><br />
<br />
<br />
WebMD <a href="http://www.webmd.com/parkinsons-disease/news/20110711/antipsychotics-used-for-parkinsons-despite-warnings">parkinsons-disease/antipsychotics-used-for-parkinsons-despite-warnings</a><br />
<br />
Doctors continue to prescribe antipsychotic drugs to their patients with Parkinson's disease
and psychosis, despite "black box" warnings from the FDA linking them
to increased risk of death among patients with dementia, a study shows.<br />
<br />
<div class="node">
A black box warning is the strongest drug warning issued by the FDA.</div>
<div class="node">
<br /></div>
<div class="node">
"My sense is that the black box warnings don't
factor into decision making," says study researcher Daniel Weintraub,
MD, an associate professor of psychiatry at the University of
Pennsylvania.</div>
<div class="node">
The study is published in the <i>Archives of Neurology</i>.</div>
<div class="node">
<br /></div>
<div class="node">
The black box warning for antipsychotics says the
drugs are associated with an increased risk of death for those with
dementia, which is common among people diagnosed with Parkinson's. Some
commonly prescribed antipsychotics also worsen symptoms of Parkinson's<a href="https://www.blogger.com/null">.</a></div>
<div class="node">
<br /></div>
<div class="node" style="text-align: center;">
<u><span style="color: red;"><span style="font-size: large;">ENOUGH SAID! </span></span></u></div>
Seroquelhttp://www.blogger.com/profile/12012400050067849012noreply@blogger.com2tag:blogger.com,1999:blog-8681939617966339411.post-16094511411630813072014-10-10T14:58:00.000-07:002014-10-14T14:34:07.073-07:00Texas AG opens lawsuit against AstraZeneca for the illegal marketing of Seroquel Texas AG opens lawsuit against AstraZeneca for criminal fraud and the illegal marketing of Seroquel<br />
<br />
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhpQ0fb0wChZXU_fV_fVZ55pHWEhrXHrGqdd9G49hHXJVIfYBpcGhaYT18TqD3KwszKcPYDD7SMiQ8cccnB9efITIX3mpZdObjEJYdvHrkaMg5tDbI6NzsKAli4KlFQYi8lH41HK3E-bLkV/s1600/azshovel.jpg" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhpQ0fb0wChZXU_fV_fVZ55pHWEhrXHrGqdd9G49hHXJVIfYBpcGhaYT18TqD3KwszKcPYDD7SMiQ8cccnB9efITIX3mpZdObjEJYdvHrkaMg5tDbI6NzsKAli4KlFQYi8lH41HK3E-bLkV/s1600/azshovel.jpg" height="640" width="378" /></a><br />
<br />
Not that this news will have much of an effect on this politically connected corporate giant, or will it bring any solace to the countless thousands of lives lost, ruined, and cask aside by this criminal corporation.<br />
<br />
Those that have followed the Pharmaceutical corporate crime wave over the past couple of decades are asking the following question once again: <b>What "CIA" Corporate Integrity Agreement? </b><br />
<br />
This litigation has all the makings of just another chump change settlement where AstraZeneca pays a small fine and admits no wrong doing. It's just the way in works today in the United States of America. AZ is to big and connected to be held accountable...AstraZeneca is after all a member of the elite ruling class CLUB, and you the average Joe/Jane citizen are not invited to their club house party.<br />
<br />
The Wall Street Journal, veteran and well respected reporter Ed Silverman of Pharmalot fame are reporting: <br />
<br />
<h1 class="post-title h-main">
Texas AG Lawsuit Claims AstraZeneca Improperly Marketed Seroquel</h1>
The Texas Attorney General has filed a lawsuit this week against AstraZeneca <span data-change="90" data-changepercent="2.137767220902613" data-company-name="Astrazeneca PLC" data-country="UK" data-datetime="Oct. 10, 2014 4:39 PM" data-exchange-iso="XLON" data-iso="&pound;" data-offset="1" data-pc="4210.000" data-price="4300" data-ticker-name="AZN.LN" data-ticker="AZN" data-volume="5440163.00" data-widget="dj.ticker" id="0.5318947940503905"><a class="tkrQuote tkrPositive" data-ls-seen="1" href="http://blogs.wsj.com/public/quotes/main.html?type=djn&symbol=AZN.LN?mod=inlineTicker" target=""><span class="tkrName"></span><span class="tkrChange"></span></a></span>that alleges the drug maker illegally marketed its Seroquel
antipsychotic pill for unapproved uses, paid kickbacks to physician and
state health officials, and subsequently caused the state Medicaid
program to overpay for the medicine.<br />
<br />
The lawsuit,
which was filed in a state court in Texas, builds on claims in lawsuits
that were filed by two former AstraZeneca sales reps, who alleged the
drug maker used various tactics to induce physicians to prescribe
different versions of the Seroquel pill.<br />
As an example, the drug maker allegedly paid $465,000 to a pair of
unidentified state mental health officials “with the power to influence
formulary decisions within the state hospital system,” according to the
lawsuit. A formulary is listed of drugs for which an insurer offers
reimbursement.<br />
<br />
To read the complete article: <a href="http://blogs.wsj.com/pharmalot/2014/10/10/texas-ag-lawsuit-claims-astrazeneca-improperly-marketed-seroquel/">wsj.com/pharmalot/texas-ag-lawsuit-claims-astrazeneca-improperly-marketed-seroquel/</a><br />
<br />
Related Links:<br />
<a href="http://www.fiercepharma.com/story/texas-ag-astrazeneca-paid-465k-kickbacks-committed-fraud-seroquel-marketing/2014-10-13">fiercepharma.com/story/texas-ag-astrazeneca-paid-465k-kickbacks-committed-fraud-seroquel-marketing</a><br />
<br />
<a href="http://www.biopharmadive.com/news/az-faces-texas-lawsuit-over-bribery-improper-marketing-of-antipsychotic-dr/320278/">biopharmadive.com/news/az-faces-texas-lawsuit-over-bribery-improper-marketing-of-antipsychotic</a>Seroquelhttp://www.blogger.com/profile/12012400050067849012noreply@blogger.com0tag:blogger.com,1999:blog-8681939617966339411.post-6864010859968399662013-11-01T08:56:00.000-07:002013-11-01T09:03:58.723-07:00AstraZeneca Seroquel - The criminal cover-up that is still killing decades later - a walk down tragedy's memory lane<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjBvshyphenhyphenn1lDPGP_fd-F4PNYXzRsirIZ5dP-FqvLHvyx18iJgF-QD6QAgLZrAxII2POax7f32LH0QC-qe5h7I6xg-6ZauVxT_VYtwT69ZLyNu9aCNFHxd5BTNpE1o0kylyX7kyASbbjIa3zh/s1600/astraZeneca.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="435" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjBvshyphenhyphenn1lDPGP_fd-F4PNYXzRsirIZ5dP-FqvLHvyx18iJgF-QD6QAgLZrAxII2POax7f32LH0QC-qe5h7I6xg-6ZauVxT_VYtwT69ZLyNu9aCNFHxd5BTNpE1o0kylyX7kyASbbjIa3zh/s640/astraZeneca.jpg" width="640" /></a></div>
<br />
After all the propaganda and empty promises...From the White House, The Senate, The Congress, The Federal Courts, The DOJ, The FDA, A Billion Dollar AstraZeneca Legal Dream Team, and finally all those seedy plaintiff law firms who sold out their own clients for huge profits; No one has been held accountable for these unconscionable crimes that have either killed or severely injured many many thousands of innocent victims.<br />
<br />
This blog has chronicled this dead-end journey from the injured parties' perspective, attempting to tell the story that is seldom reported by the news media, in the faint hope that some day justice will be served, and that these kinds of corporate criminal tragedies are not repeated in the future.<br />
<br />
Unfortunately, that is just not reality...the entrenched greed and corruption continues to prevail at every turn and all levels of the regulatory and judicial process. These pages have been read by all of the aforementioned parties highlighted above to no avail. This blog has been attacked, faced numerous threats/acts of intimidation for exposing and reporting the truth. Unfortunately, the only success that has been accomplished is public awareness and a living archive of what everyday citizens face when confronting institutionalized corruption.<br />
<br />
Today, I would like to share once more an excellent program produced by BBC News years ago...nothing has really changed since this report; yet I believe it encapsulates this criminal story as well as any report to date. I ask you to take a walk down this tragic memory lane and never forget...it was very real people just like yourself that had their lives and health destroyed simply in the name of unquenchable corporate greed. I believe you will find the time spent listening to this broadcast well worth the time invested.<br />
<br />
<h1 class="episode-title">
Drug danger distraction?</h1>
<div id="episode-summary">
<dl class="episode-summary--list-item">
<dt class="episode-summary--list-item-key">Duration: 40 minutes</dt>
</dl>
<dl class="episode-summary--list-item">
<dt class="episode-summary--list-item-key">First broadcast: Tuesday 26 January 2010</dt>
</dl>
</div>
<div class="full_synopsis" id="synopsis">
<div class="copy" content="A British drug company is being sued by more than 15,000 people in the United States who claim its bestselling antipsychotic drug caused severe weight gain, diabetes and other serious medical conditions. Ann Alexander investigates concerns about the way it was marketed and asks how much the public should be told about the drugs they take.">
A
British drug company is being sued by more than 15,000 people in the
United States who claim its bestselling antipsychotic drug caused severe
weight gain, diabetes and other serious medical conditions. Ann
Alexander investigates concerns about the way it was marketed and asks
how much the public should be told about the drugs they take.</div>
</div>
<br />
<a href="http://www.bbc.co.uk/programmes/b00q3gjj">http://www.bbc.co.uk/programmes/b00q3gjj</a>Seroquelhttp://www.blogger.com/profile/12012400050067849012noreply@blogger.com4tag:blogger.com,1999:blog-8681939617966339411.post-85047031300558517642013-07-27T18:02:00.000-07:002013-07-27T22:26:35.881-07:00AstraZeneca, GSK, and The Pharmaceutical Industry Crime Syndicate - Criminal Bribery, Sex, Drugs, & Fun Times in China...<div class="separator" style="clear: both; text-align: center;">
</div>
<div style="text-align: justify;">
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEin2k9l3AOjG22y1hxt-NS-AS3u7Q4VjzVnnYykJjjo0Lw2aE7dHgzauEeLTG8wcHO0dQ0Fv30UoSG9C7UFiEC2rLQWgk5JaBhamZsNmJsaZTGgR53nIrsVuqap2onIIusmgJdooKyd5KMi/s1600/suziewang.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="640" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEin2k9l3AOjG22y1hxt-NS-AS3u7Q4VjzVnnYykJjjo0Lw2aE7dHgzauEeLTG8wcHO0dQ0Fv30UoSG9C7UFiEC2rLQWgk5JaBhamZsNmJsaZTGgR53nIrsVuqap2onIIusmgJdooKyd5KMi/s640/suziewang.jpg" width="432" /></a></div>
<span style="font-size: large;"><b> </b></span><span style="font-size: xx-small;"><span style="font-size: xx-small;">Hat Tip to <a href="http://pharmagossip.blogspot.com/">pharmagossip</a> for (edited) imag</span>e</span><br />
<span style="font-size: large;"><b> </b></span><span style="font-size: large;"><b> </b></span><br />
<span style="font-size: large;"><b>AstraZeneca, GSK, and The Pharmaceutical Industry Crime Syndicate - Criminal Bribery, Sex, Drugs, & Fun Times in China...</b></span></div>
<br />
As if the latest information and news comes as any surprise to anyone with these TOO BIG TO FAIL, TOO BIG TO BE HELD ACCOUNTABLE pharmaceutical corporate giants...remember all those CIA's (corporate integrity agreements), the meaningless token fines, the ghost writing, the hidden information, crimes, and lawsuits...the shallow apologies...When it comes to money & profits it all means absolutely nothing...read & weep as you peruse the following articles... <br />
<br />
<div style="text-align: left;">
<b><span style="font-size: x-small;"><i>From the </i></span><span style="font-size: x-small;"><i><a href="http://www.guardian.co.uk/" itemprop="publisher">guardian.co.uk</a>,: </i></span><span style="font-size: x-small;"><i><a href="http://www.guardian.co.uk/business/2013/jul/23/american-held-chinese-bribery-investigation">chinese-bribery-investigation</a> </i></span></b></div>
<div style="text-align: left;">
<b><br /></b></div>
<div style="text-align: left;">
<b><span style="font-size: x-small;"><i>"Police also detained two members of AstraZeneca's Chinese staff for
questioning on Tuesday. The employees in Astra's main Shanghai sales
centre are line managers of an Astra sales representative detained on
Friday.</i></span></b></div>
<div style="text-align: left;">
<b><span style="font-size: x-small;"><i>An Astra spokeswoman said one of the managers was
"continuing to assist the [Shanghai public security] bureau with their
inquiries". She said there was "no reason to believe [the arrest] is
related to other investigations".</i></span></b></div>
<div style="text-align: left;">
<b><span style="font-size: x-small;"><i>Meanwhile, four more western
drug companies – Sanofi, Novartis, Merck and Roche – said they had used
the same travel agency that GSK allegedly used to funnel bribes to
doctors. All four companies said they had stopped using the Shanghai
Linjiang agency."</i></span></b></div>
<div style="text-align: left;">
<b><br /></b></div>
<div style="text-align: left;">
<b><span style="font-size: x-small;"><i>from the </i></span><span style="font-size: x-small;"><i><a href="http://www.guardian.co.uk/" itemprop="publisher">guardian.co.uk</a>, <a href="http://www.telegraph.co.uk/finance/newsbysector/pharmaceuticalsandchemicals/10204304/Chinese-police-allege-Glaxo-sales-reps-trained-to-offer-sexual-bribes.html">sales-reps-trained-to-offer-sexual-bribes</a></i></span></b></div>
<div style="text-align: left;">
<b><br /></b></div>
<div style="text-align: left;">
<b><span style="font-size: x-small;"><i> </i></span><span style="font-size: x-small;"><i>"The woman, named as Ms Wang, said “some executives gave clear directives to
the sales department to offer bribes to doctors with money or opportunities
to attend academic conferences.”
</i></span></b></div>
<div class="fourthPar">
<b><span style="font-size: x-small;"><i>
Ms Wang said she would even go so far as fulfilling some doctors’ “sexual
desires” in order to “meet their needs” and persuade them to prescribe more
drugs.
</i></span></b></div>
<div class="fifthPar">
<b><span style="font-size: x-small;"><i>
A doctor from a “reputable hospital” whose real name was not given, claimed
that one GSK representative had “blatantly offered kickbacks to doctors”. </i></span></b><br />
<b><br /></b>
<b><span style="font-size: x-small;"><i>And at The 1 Boring Old Man Blog the conversation is already getting hot hot hot with new post <a href="http://1boringoldman.com/index.php/2013/07/23/an-irreducible-conflict/">an-irreducible-conflict</a> and <a href="http://1boringoldman.com/index.php/2013/07/27/more-glaxo-china/">more-china</a></i></span></b><br />
<b><span style="font-size: x-small;"><i><br /></i></span></b>
<b><span style="font-size: x-small;"><i>"The industry thrives by relying on irrational exuberance, well designed
illusion, and a dash or two of crime. And they can’t seem to stop…"</i></span></b><br />
<br />
<b><span style="font-size: x-small;"><i>Also, over at Pharmalot <a href="http://www.pharmalive.com/bribes-sex-fraud-did-glaxo-violate-its-corporate-integrity-agreement">bribes-sex-fraud-did-glaxo-violate-its-corporate-integrity-agreement</a></i></span></b><br />
<br />
<b><span style="font-size: x-small;"><i> </i></span></b><span style="font-size: x-small;"><b><i>"A violation could lead the US Department of Health and Human Services
Office of Inspector General to seek to exclude the drugmaker from
contracts with federal healthcare programs, such as Medicare and
Medicaid. This is big business, of course, and so any whiff of trouble
that could impact the CIA has investors on alert.</i></b></span><br />
<br />
<span style="font-size: x-small;"><b><i>
</i></b></span><span style="font-size: x-small;"><b><i>On a conference call this morning to discuss the latest earnings,
Glaxo ceo Andrew Witty was asked whether Glaxo staff believe the
scandals in China would have an effect on the CIA, since it is known
that US authorities are probing the drugmaker for violations of the
Foreign Corrupt Practices Act (<a href="http://www.justice.gov/criminal/fraud/fcpa/">this is the law</a>)
and the UK's Serious Fraud Office is also conducting a probe. Witty,
however, breezed past the question without offering a response."</i></b></span><br />
<br />
<b><span style="font-size: x-small;"><i> Some back story here --> <a href="http://seroquellawsuitblog.blogspot.com/2011/09/astrazeneca-seroquel-marketing-of.html">astrazeneca-seroquel-marketing </a></i></span></b><br />
<br />
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiOOI_QvvK63uoQ_SCNkSG4eVHgePw_vSjZAcJvkKD29mM9Rq1Pj6ht_HcUNkArmzvtuDU8aa5V4vb7l6GNYCOM2omHJQccPNKMtzbDQWs1kW6wRCvlQioxcafPtLGzfBZmPcpWRh4Kgr4M/s1600/pills4pussy.jpg" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="316" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiOOI_QvvK63uoQ_SCNkSG4eVHgePw_vSjZAcJvkKD29mM9Rq1Pj6ht_HcUNkArmzvtuDU8aa5V4vb7l6GNYCOM2omHJQccPNKMtzbDQWs1kW6wRCvlQioxcafPtLGzfBZmPcpWRh4Kgr4M/s400/pills4pussy.jpg" width="400" /></a></div>
<span style="font-size: xx-small;"><i>Image via the world renowned PharmaGiles</i></span></div>
<br />
<br />Seroquelhttp://www.blogger.com/profile/12012400050067849012noreply@blogger.com0tag:blogger.com,1999:blog-8681939617966339411.post-62896387671433719132012-08-24T07:37:00.000-07:002012-08-24T07:37:46.007-07:00South Carolina Attorney General reaches $26M settlement against AstraZeneca for "willfully misleading consumers on the potentially serious side effects of the anti-psychotic drug Seroquel" <br />
<div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjmPUGU9QiV2sL917DaLnmQJJpeSwnopHBCZUbp-xzNe4dRDqkQ0etK4mgbAI24bt1lMTeqc4m86bLiI0-HrAQqW7mJ49z81DkY4yYyLjjc491QKLeqnVShYh6v2cmjn1NcIC0EH8F0gwQW/s1600/seroquel.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjmPUGU9QiV2sL917DaLnmQJJpeSwnopHBCZUbp-xzNe4dRDqkQ0etK4mgbAI24bt1lMTeqc4m86bLiI0-HrAQqW7mJ49z81DkY4yYyLjjc491QKLeqnVShYh6v2cmjn1NcIC0EH8F0gwQW/s1600/seroquel.jpg" /></a></div><h1 class="art_head" style="background-color: white; border: 0px; font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 21px; margin: 0px 0px 15px; outline: 0px; padding: 0px;"><span style="font-family: inherit; font-style: inherit; font-weight: inherit;">SC Attorney General reaches $26M settlement against AstraZeneca</span></h1><div class="art_byline" style="background-color: white; border-top-color: rgb(204, 204, 204); border-top-style: solid; border-width: 1px 0px 0px; font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 12px; font-weight: bold; margin: 10px 0px 5px; outline: 0px; padding: 10px 0px 0px;">By <a href="http://www.goupstate.com/personalia/10082" rel="author" style="border: 0px; color: #004776; font-family: inherit; font-style: inherit; font-weight: inherit; margin: 0px; outline: 0px; padding: 0px; text-decoration: none;">Lynne P. Shackleford</a><br />
<a href="mailto:lynne.shackleford@shj.com" style="border: 0px; color: #004776; font-family: inherit; font-style: inherit; font-weight: inherit; margin: 0px; outline: 0px; padding: 0px; text-decoration: none;">lynne.shackleford@shj.com</a></div><div class="art_pubdate" data-date="08/23/2012" style="background-color: white; border-bottom-color: rgb(204, 204, 204); border-bottom-style: solid; border-width: 0px 0px 1px; font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 10px; margin: 0px 0px 10px; outline: 0px; padding: 0px 0px 10px;"><h5 style="border: 0px; color: #666666; font-family: inherit; font-size: 11px; font-style: italic; line-height: 1.5; margin: 0px; outline: 0px; padding: 0px;">Published: Thursday, August 23, 2012 at 5:46 p.m.</h5><h5 style="border: 0px; color: #666666; font-family: inherit; font-size: 11px; font-style: italic; line-height: 1.5; margin: 0px; outline: 0px; padding: 0px;">Last Modified: Thursday, August 23, 2012 at 5:46 p.m.</h5></div><div class="article_text article_paragraph0" style="background-color: white; border: 0px; font-family: georgia, serif; font-size: 14px; line-height: 23px; margin: 0px; outline: 0px; padding: 0px; word-spacing: 2px;"><div style="border: 0px; font-family: inherit; font-style: inherit; line-height: 25px; margin-bottom: 1em; outline: 0px; padding: 0px;">The S.C. Attorney General's Office has secured a $26 million settlement against the multi-billion pharmaceutical company AstraZeneca for violating the state Unfair Trade Practices Act by willfully misleading consumers on the potentially serious side effects of the anti-psychotic drug Seroquel.</div></div><div class="pagholder" style="border: 0px; font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 10px; margin: 0px; outline: 0px; padding: 0px;"><div class="article_text article_paragraph1 google_elide" style="border: 0px; font-family: georgia, serif; font-size: 14px; font-style: inherit; line-height: 23px; margin: 0px; outline: 0px; padding: 0px; word-spacing: 2px;"><div class="pagpag1" style="background-color: white; border: 0px; font-family: inherit; font-style: inherit; line-height: 25px; margin-bottom: 1em; outline: 0px; padding: 0px;">The settlement order was filed Aug. 22 and is the third award, and final case against anti-psychotic drug manufacturers in South Carolina, that the Attorney General's Office has prosecuted since 2009. The cases began under former Attorney General Henry McMaster, who contracted with the Spartanburg law firm of Harrison, White, Smith and Coggins to prosecute the case on behalf of the state. The Spartanburg firm then contracted with two other firms in Columbia and Houston to assist with the litigation, which continued under Attorney General Alan Wilson.</div><div class="pagpag1" style="background-color: white; border: 0px; font-family: inherit; font-style: inherit; line-height: 25px; margin-bottom: 1em; outline: 0px; padding: 0px;">In the lawsuit order, the company agreed to pay $26 million, which includes $20 million in damages and restitution to the state, $5 million in penalties and $1 million in trial costs. In 2010, AstraZeneca had $5.3 billion in worldwide sales including $3.75 billion in the U.S.</div><div class="pagpag1" style="background-color: white; border: 0px; font-family: inherit; font-style: inherit; line-height: 25px; margin-bottom: 1em; outline: 0px; padding: 0px;">Bryan Stirling, deputy attorney general, sai<span style="font-style: inherit;">d the settlement is fair to the state. A portion of the funds will go into the general fund, some will go to Medicaid and other funds to insurance companies.</span></div><div class="pagpag1" style="background-color: white; border: 0px; line-height: 25px; margin-bottom: 1em; outline: 0px; padding: 0px;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEig0xOliaJktIJ8tmkloG35m6VgJn3d0N46mRPQUbY7wTU_9u-klUA0Hi8t19G4p62OgUcU_bzunhvwC4bUzX9XQZznguix9fNAk46iWBJ49A4-4vR9I2vvP450iAb3vvFAmPsRH4s2jJOf/s1600/Law-Legal-Court-Guilty-Verdict-Web-Graphic_20100616142336_320_240.JPG" imageanchor="1" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEig0xOliaJktIJ8tmkloG35m6VgJn3d0N46mRPQUbY7wTU_9u-klUA0Hi8t19G4p62OgUcU_bzunhvwC4bUzX9XQZznguix9fNAk46iWBJ49A4-4vR9I2vvP450iAb3vvFAmPsRH4s2jJOf/s1600/Law-Legal-Court-Guilty-Verdict-Web-Graphic_20100616142336_320_240.JPG" /></a>Stirling said the Attorney General's Office sued on behalf of the state and the state agencies that paid additional funds because of the medication side effects.</div><div class="pagpag1" style="background-color: white; border: 0px; line-height: 25px; margin-bottom: 1em; outline: 0px; padding: 0px;">AstraZeneca did not admit any wrongdoing or violation, but agreed to pay the sum to resolve the state action, according to the order signed by Circuit Court Judge Roger Couch."</div><div class="pagpag1" style="background-color: white; border: 0px; line-height: 25px; margin-bottom: 1em; outline: 0px; padding: 0px;"><br />
</div><div class="pagpag1" style="border: 0px; line-height: 25px; margin-bottom: 1em; outline: 0px; padding: 0px;"><span style="background-color: blue;"><a href="http://www.goupstate.com/article/20120823/ARTICLES/120829820/1083/ARTICLES?p=1&tc=pg"><span style="color: white;">Read the article </span></a></span></div><div class="pagpag1" style="background-color: white; border: 0px; line-height: 25px; margin-bottom: 1em; outline: 0px; padding: 0px;"><br />
</div></div></div>Seroquelhttp://www.blogger.com/profile/12012400050067849012noreply@blogger.com0tag:blogger.com,1999:blog-8681939617966339411.post-85299344328511301422012-06-14T14:03:00.002-07:002012-06-15T08:25:38.370-07:00AstraZeneca - Seroquel - Army Apologizes for Seroquel Death<div class="logo"></div><div class="tag"></div><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg4CdCctn5BVtUeN30vqsVg3sMULXrKDLphTrKCi6OmlUzCdwt9IFVLUhb9pepd_ToyTX4gyLdTIarrlBPZeHcrXhczShgan03jmfkzKFHoeYP9GBbz3SLbwsaw4GKJJ0Xwuws7N26IBgko/s1600/poison_pills.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="400" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg4CdCctn5BVtUeN30vqsVg3sMULXrKDLphTrKCi6OmlUzCdwt9IFVLUhb9pepd_ToyTX4gyLdTIarrlBPZeHcrXhczShgan03jmfkzKFHoeYP9GBbz3SLbwsaw4GKJJ0Xwuws7N26IBgko/s400/poison_pills.jpg" width="348" /></a></div><h2><a href="http://www.armytimes.com/news/2012/06/military-dod-cracks-down-on-off-label-seroquel-use-061412w/">From the ArmyTimes</a></h2><h2>DoD cracks down on off-label drug use</h2><br />
<div class="subtitle"></div>By <a href="mailto:pkime@militarytimes.com?subject=Question%20from%20ArmyTimes.com%20reader">Patricia Kime</a> - Staff writer<br />
<div class="info">Posted : Thursday Jun 14, 2012 10:01:04 EDT</div><form id="hidden"></form>A letter landed in Stan White’s mailbox in Cross Lanes, W.Va., in April.<br />
It began: “On behalf of the men and women of the U.S. Armed Forces … I extend my sincerest and deepest sympathy for the loss of your sons.”<br />
<br />
But the note wasn’t simply a condolence. The message from Air Force Lt. Gen. Brooks Bash informed White that U.S. Central Command had decided in March to remove the powerful antipsychotic drug Seroquel from its approved formulary list.<br />
<br />
Under the new rules, CENTCOM doctors now must request a waiver if they write a prescription for Seroquel, also known as quetiapine.<br />
<br />
The change is a small victory for White, who had already lost one son to combat and has sought restrictions on the drug he believes contributed to the death of a younger son.<br />
<br />
Marine Cpl. Andrew White died Feb. 12, 2008, at age 23 from a lethal combination of medications prescribed for post-traumatic stress disorder, mainly clonazepam, quetiapine and paroxetine — the latter two known to sometimes affect the heart’s regular rhythm.<br />
<br />
“I have never been one to say I’m opposed to medication — I’m just opposed to these medications, which have a side effect of causing cardiac arrest,” White said June 6.<br />
<div class="storyFeature"><h3>Off-label use soars</h3>Prescriptions for Seroquel have exploded in the past decade, especially in the armed forces, where it often is prescribed off-label as a sleep aid.<br />
<br />
In 2003, service members were diagnosed with insomnia at a rate of 30 per 10,000; by 2009, the rate had risen to 226 per 10,000. Prescriptions for Seroquel, or quetiapine, have subsequently soared, multiplying 27-fold in the same time period.<br />
<br />
The drug is known to cause drowsiness and chase away nightmares associated with post-traumatic stress disorder.<br />
<br />
Navy Capt. Mike Colston of the Office of the Assistant Secretary of Defense for Health Affairs said medications become popular as providers learn about them and as they receive new approvals for use by the Food and Drug Administration — in the case of quetiapine, as an add-on therapy for antidepressants.<br />
Yet questions have been raised over whether its off-label use for insomnia was more than a grass-roots movement by physicians. In April 2010, manufacturer Astra-Zeneca agreed to pay $520 million to the federal government to settle a civil suit alleging that it illegally marketed Seroquel for a host of off-label uses such as Alzheimer’s disease, anxiety, PTSD and sleeplessness.<br />
<br />
According to The Associated Press, in 2009, the Pentagon spent $8.6 million on the drug, while the Veterans Affairs Department spent $125.4 million.<br />
<br />
Recent moves by the Pentagon to restrict prescriptions for atypical antipsychotic drugs were the result of a search for safe, proven therapies for troops, Colston said.<br />
<br />
“We aim to … discourage the use of off-label medication treatments with antipsychotic medications before established evidence-based strategies have been implemented,” he said.<br />
<br />
</div>Earlier this year, Assistant Secretary of Defense for Health Affairs Dr. Jonathan Woodson asked the military services to monitor prescriptions for atypical antipsychotic medications, a class of drugs that includes quetiapine.<br />
The medications are approved by the Food and Drug Administration for treating schizophrenia and bipolar disorder. But in the past decade, their popularity has soared for off-label use, including for treating PTSD and insomnia.<br />
<br />
A 2011 study of 692 patients prescribed quetiapine at Madigan Army Medical Center, Wash., showed just 9.4 percent received it for an FDA-approved use, while 57 percent received it for insomnia.<br />
In 2011, the services issued 54,581 prescriptions for Seroquel alone, the most for any antipsychotic medication — more than 2.5 times the number of prescriptions for the second-most prescribed atypical antipsychotic, Abilify, and nearly four times the number for risperidone, according to information obtained by a Military Times under a Freedom of Information Act request.<br />
<h3>A growing alarm</h3>Quetiapine has the strongest somnolent effect of all atypical antipsychotics, and is commonly prescribed troops for relieving nightmares.<br />
<br />
But as its popularity has grown, evidence has mounted pointing to links between atypical antipsychotics and irregular heartbeat and even death — prompting critics and physicians, including Woodson, to sound the alarm on frequent prescriptions.<br />
<br />
“Providers should use caution when these agents are used as sleep aids in service members struggling with substance use disorders, especially given the risk of such side effects as glucose dysregulation and cardiac effects,” Woodson wrote Feb. 22.<br />
<br />
A study in the January 2009 New England Journal of Medicine found the rate of sudden cardiac death doubled for those taking atypical antipsychotic drugs, and there were three such deaths per year for every 1,000 patients taking the medication.<br />
<br />
The risk of a fatal heart event also increased with dosage, and study author and Vanderbilt University researcher Wayne Ray said mixing these medications with others that cause irregular heartbeat, known medically as QT prolongation, could worsen the issue and possibly cause death.<br />
<br />
“We saw this strong relationship between the antipsychotics and sudden death … and all the information we had pointed to the drugs as the cause,” Ray said after the study was published. “Our findings … would suggest avoiding other medications that prolong QT whenever possible because when you give two together, you’re … increasing the patient’s risk.”<br />
<br />
The Madigan study, conducted by Army Lt. Col. Vincent Mysliwiec and presented last June at a meeting of the American Academy of Sleep Medicine, showed that of 692 patients who took quetiapine, 126 were monitored for heart arrhythmia within six months of starting on the drug, and of those, 11 showed an abnormal heart rhythm.<br />
<br />
Ten of those cases were directly attributed to quetiapine; when the medication was stopped, their heart rhythm returned to normal, according to Psychiatric News.<br />
<br />
Through an Army spokesman, Mysliwiec declined to release the study but said it was available to Defense Department physicians on request.<br />
<br />
A 2008 Dutch study also showed patients taking more than one QT-interval-prolonging drug had 4.8 times the risk of cardiac arrest.<br />
<h3>‘He just died’</h3>White attributes his son’s death, and those of at least three others from West Virginia — Army Pfc. Derick Johnson, 22; Army National Guard Sgt. Eric Layne, 29; and Marine Cpl. Nicholas Endicott, 24 — to at least two heart-rhythm-altering drugs, quetiapine and paroxetine.<br />
<br />
Since their cases were publicized, others have stepped forward, including Alicia McElroy, whose husband, Army National Guard Staff Sgt. James McElroy, 30, was found dead in his barracks while receiving treatment for PTSD at Fort Benning, Ga.<br />
<br />
She said that among his many medications were Paxil, Seroquel and Klonopin.<br />
“This wasn’t a long, slow death. It wasn’t an overdose. He wasn’t found unconscious. He just died,” said Alicia McElroy, who is still awaiting autopsy results. Her husband died June 6, 2011.<br />
<br />
Seroquel maker AstraZeneca stands behind the safety record of its medication, which it made exclusively until March 2012, when the patent expired.<br />
<br />
“Patient safety is a priority for AstraZeneca, and we think Seroquel is safe and effective when it’s used as recommended,” Stephanie Andrzejewski said.<br />
<br />
She added the company does not condone prescribing Seroquel for off-label uses.<br />
“We trust doctors to use medical judgment in … determining when it is appropriate to prescribe medications,” she said.<br />
<br />
In July 2011, the FDA required AstraZeneca to add a warning to the drug’s label regarding its potential cardiac risk.<br />
<h3>The services take action</h3>The service surgeons general have responded to Woodson’s request for their policy guidance on atypical antipsychotics, Defense Department spokesman Navy Capt. Michael Colston said June 4. According to documents released by Colston:<br />
<br />
• The Army decided risperidone should not be prescribed because its risks outweigh its benefits, and providers who prescribe other such drugs, including quetiapine, “must clearly document their rationale” and receive informed consent from the patient.<br />
<br />
• The Navy Department agreed to monitor providers and flag those who prescribe the most atypical antipsychotics off-label for additional review.<br />
<br />
• The Air Force, which prescribes atypical antipsychotics to “fewer than 0.15 percent of airmen,” will review provider prescribing practices and counsel those who show a pattern.<br />
<br />
• The Washington, D.C., area medical command will conduct periodic evaluations of drugs prescribed to patients with PTSD and follow-up evaluations to see whether further monitoring is needed.<br />
<br />
White, who had another son, Army Sgt. Robert White, killed in combat, said he is glad the military is moving away from medications for PTSD.<br />
<br />
“I know people who have died from medication,” he said. “I don’t know anyone who’s ever been killed by counseling.”<br />
<br />
<i>Staff writer <a href="mailto:atilghman@militarytimes.com?subject=Question%20from%20ArmyTimes.com%20reader">Andrew Tilghman</a> contributed to this report.</i><br />
<br />
<i>---------------------------------------------</i><br />
<br />
<i>for further reading on this topic <a href="http://www.pharmalot.com/2012/06/the-us-military-and-off-label-antipsychotic-use/">Pharmalot has written a related article </a></i><br />
<br />
<a href="http://www.pharmalot.com/2012/06/the-us-military-and-off-label-antipsychotic-use/" rel="bookmark" title="Permanent Link to The US Military And Off-Label Antipsychotic Use"><span style="font-size: small;">The US Military And Off-Label Antipsychotic</span> <span style="font-size: small;">Use</span></a><br />
<br />
By Ed Silverman // <a href="http://www.pharmalot.com/2012/06/14/"> June 14th, 2012</a><span style="font-size: small;"> </span><br />
<span style="font-size: small;"> </span><br />
But growing concern over links between antipsychotics – especially Seroquel, which is the most widely prescribed antipscyhotic by the US military – and irregular heartbeats is prompting moves to restrict usage. For instance, a retrospective review of 692 patients who were prescribed Seroquel at the Madigan Army Medical Center in 2007 and 2008 found that only 3.4 percent received the drug for an approved use, which would also include adjunct treatment for depression.<br />
<br />
However, 60 percent received the drug for insomnia, 19 percent for anxiety, 12 percent for mood disorders and 8 percent for post-traumatic stress disorder. Yet, only 18 percent were screened for irregular heartbeats and 126 underwent an EKG, with 11 percent showing abnormal heart rhythms, according to a presentation at the American Academy of Sleep Medicine annual meeting (<a href="http://www.sleepmeeting.org/pdf/2011abstractsupplement.pdf">here is the presentation – see page A179</a>).<br />
<br />
Such findings underscore the concerns. Last year, the armed services issued 54,581 prescriptions for Seroquel alone, the most for any antipsychotic — and more than 2.5 times the number of prescriptions for the second-most prescribed atypical antipsychotic, Abilify, and nearly four times the number for Risperdal, according to information obtained by <a href="http://www.airforcetimes.com/news/2012/06/military-dod-cracks-down-on-off-label-seroquel-use-061412w/">Military Times</a> under a Freedom of Information Act request.<br />
<br />
In 2003, Military Times reports, service members were diagnosed with insomnia at a rate of 30 per 10,000. By 2009, the rate had jumped to 226 per 10,000. Prescriptions for Seroquel rose 27-fold in the same time period. And according to The Associated Press, in 2009, the Pentagon spent $8.6 million on the drug, while the Veterans Affairs Department spent $125.4 million. That same year, results of a proof-of-concept study showed Seroquel benefited patients with post-traumatic stress disorder (see <a href="http://www.docguide.com/quetiapine-monotherapy-provides-benefit-patients-chronic-post-traumatic-stress-disorder">this</a> and <a href="http://clinicaltrials.gov/ct2/show/NCT00237393?term=quetiapine+and+hamner&rank=1">this</a>).<br />
<br />
Meanwhile, a 2008 study in the British Journal of Clinical Pharmacology showed patients taking more than one drug that can cause irregular heartbeats had 4.8 times the risk of cardiac arrest (<a href="http://www.ncbi.nlm.nih.gov/pubmed/19523015">look here</a>). A study the following year in The New England Journal of Medicine found the rate of sudden cardiac death doubled for those taking atypical antipsychotics, and there were three such deaths each year for every 1,000 patients taking such a drug (<a href="http://www.nejm.org/doi/full/10.1056/NEJMoa0806994">here is the abstract</a>). The risk of a fatal heart event also increased with dosage, the Military Times notes.<br />
<br />
Moreover, mixing antipsychotics with others that cause irregular heartbeat, known medically as QT prolongation, could cause more harm and, possibly, death.<br />
<br />
<i>**read full article at the link provided above</i>**Seroquelhttp://www.blogger.com/profile/12012400050067849012noreply@blogger.com2tag:blogger.com,1999:blog-8681939617966339411.post-61993920612654610812012-04-28T09:08:00.000-07:002012-04-28T09:08:09.283-07:00Seroquel, sexual favors and unretracted research papers: Martha Rosenberg asks "Why Are These Fraudulent Papers Unretracted?"<b><span style="font-size: large;">From CounterPunch <a href="http://www.counterpunch.org/2012/04/27/why-are-these-fraudulent-papers-unretracted/"><span style="color: blue;">Why Are These Fraudulent Papers Unretracted?</span></a> by Martha Rosenberg</span></b><br />
<div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjmPUGU9QiV2sL917DaLnmQJJpeSwnopHBCZUbp-xzNe4dRDqkQ0etK4mgbAI24bt1lMTeqc4m86bLiI0-HrAQqW7mJ49z81DkY4yYyLjjc491QKLeqnVShYh6v2cmjn1NcIC0EH8F0gwQW/s1600/seroquel.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="300" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjmPUGU9QiV2sL917DaLnmQJJpeSwnopHBCZUbp-xzNe4dRDqkQ0etK4mgbAI24bt1lMTeqc4m86bLiI0-HrAQqW7mJ49z81DkY4yYyLjjc491QKLeqnVShYh6v2cmjn1NcIC0EH8F0gwQW/s400/seroquel.jpg" width="400" /></a></div><b><span style="font-size: large;"><br />
</span></b><br />
<br />
<h1 class="article-title" style="font-family: Helvetica; font-size: 36px; line-height: 36px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 3px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px;">Why Are These Fraudulent Papers Unretracted?</h1><div class="mainauthorstyle" style="font-family: Helvetica; font-size: 12px; letter-spacing: 1px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; margin-top: 9px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px;">by MARTHA ROSENBERG</div><div class="main-text" style="font-family: Georgia; line-height: 21px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; position: relative;"><div style="font-size: 16px; margin-bottom: 1em; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px;">"According to <a href="http://www.nytimes.com/2012/04/17/science/rise-in-scientific-journal-retractions-prompts-calls-for-reform.html?pagewanted=all" style="color: #cf1028; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-decoration: none;">Science Times[1],</a> the Tuesday science section in the <em style="margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px;">New York Times</em>, scientific retractions are on the rise because of a “dysfunctional scientific climate” that has created a “winner-take-all game with perverse incentives that lead scientists to cut corners and, in some cases, commit acts of misconduct.”</div><div style="font-size: 16px; margin-bottom: 1em; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px;">But elsewhere, audacious, falsified research stands unretracted–including the work of authors who actually went to prison for fraud!</div><div style="font-size: 16px; margin-bottom: 1em; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px;">Richard Borison, MD, former psychiatry chief at the Augusta Veterans Affairs medical center and Medical College of Georgia, was sentenced to 15 years in prison for a $10 million clinical trial fraud<a href="http://www.counterpunch.org/2012/04/27/why-are-these-fraudulent-papers-unretracted/#_ftn2" style="color: #cf1028; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-decoration: none;" title="">[2]</a> but his 1996 US Seroquel® Study Group research is unretracted.<a href="http://www.counterpunch.org/2012/04/27/why-are-these-fraudulent-papers-unretracted/#_ftn3" style="color: #cf1028; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-decoration: none;" title="">[3]</a> In fact, it is cited in 173 works and medical textbooks, misleading future medical professionals.<a href="http://www.counterpunch.org/2012/04/27/why-are-these-fraudulent-papers-unretracted/#_ftn4" style="color: #cf1028; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-decoration: none;" title="">[4]</a></div><div style="font-size: 16px; margin-bottom: 1em; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px;">Scott Reuben, MD, the “Bernie Madoff” of medicine who published research on clinical trials that never existed, was sentenced to six months in prison in 2010.<a href="http://www.counterpunch.org/2012/04/27/why-are-these-fraudulent-papers-unretracted/#_ftn5" style="color: #cf1028; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-decoration: none;" title="">[5]</a> But his <a href="http://www.amazon.com/exec/obidos/ASIN/1616145935/counterpunchmaga" style="color: #cf1028; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-decoration: none;"><img alt="" class="alignright" height="274" src="http://www.counterpunch.org/wp-content/uploads/2012/03/rosenbergjunk.jpeg" style="border-bottom-style: none; border-color: initial; border-image: initial; border-left-style: none; border-right-style: none; border-top-style: none; border-width: initial; float: right; margin-bottom: 15px; margin-left: 0px; margin-right: 0px; margin-top: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px;" title="rosenbergjunk" width="175" /></a>“research” on popular pain killers like Celebrex and Lyrica is unretracted.<a href="http://www.counterpunch.org/2012/04/27/why-are-these-fraudulent-papers-unretracted/#_ftn6" style="color: #cf1028; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-decoration: none;" title="">[6]</a> If going to prison for research fraud is not enough reason for retraction, what is?</div><div style="font-size: 16px; margin-bottom: 1em; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px;">Wayne MacFadden, MD, resigned as US medical director for Seroquel in 2006, after sexual affairs with two coworker women researchers surfaced<a href="http://www.counterpunch.org/2012/04/27/why-are-these-fraudulent-papers-unretracted/#_ftn7" style="color: #cf1028; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-decoration: none;" title="">[7]</a>, but the related work is unretracted and was even part of Seroquel’s FDA approval package for bipolar disorder.<a href="http://www.counterpunch.org/2012/04/27/why-are-these-fraudulent-papers-unretracted/#_ftn8" style="color: #cf1028; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-decoration: none;" title="">[8]</a>"</div><div style="font-size: 16px; margin-bottom: 1em; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px;"><span style="background-color: white; color: magenta;">Read the article</span><span style="background-color: white; color: magenta;"> </span><span style="background-color: white; color: black;"><a href="http://www.counterpunch.org/2012/04/27/why-are-these-fraudulent-papers-unretracted/" style="background-color: white;">in its entirety here</a></span></div><div style="font-size: 16px; margin-bottom: 1em; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px;"><br />
</div><div style="margin-bottom: 1em; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: center;"><span style="font-size: x-large;">MORE ASTRAZENECA NEWS</span></div><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEid-Haq0emeiAnqBvVZrlGMWBv1gua0h2SpXN-I3IkcGwURk91WqyZgO4LbsSGslTt2jEpvHzmRmUA9XgUeCnkfM-Rx18lMt47DToPJLrwn6fl_hKWTe4VjG5w5G8t7luMtexDCVwbQrCOu/s1600/brennan_buckets.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="232" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEid-Haq0emeiAnqBvVZrlGMWBv1gua0h2SpXN-I3IkcGwURk91WqyZgO4LbsSGslTt2jEpvHzmRmUA9XgUeCnkfM-Rx18lMt47DToPJLrwn6fl_hKWTe4VjG5w5G8t7luMtexDCVwbQrCOu/s320/brennan_buckets.jpg" width="320" /></a></div><div style="margin-bottom: 1em; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: left;"><span style="font-size: x-large;">CEO David Brennan Quits Under Pressure From Investors </span></div><div style="margin-bottom: 1em; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: left;"><span style="font-size: x-large;"><a href="http://www.guardian.co.uk/business/2012/apr/26/astrazeneca-boss-quits-boardroom-coup?newsfeed=true">Brennan Quits</a> </span></div><div style="margin-bottom: 1em; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: left;"><span style="font-size: x-large;">"</span><span style="background-color: white; color: #333333; font-family: arial, sans-serif; font-size: 14px; line-height: 18px;">While the company would not comment about his retirement package, which is still being finalised, Brennan could walk away with about £5m – after receiving more than £9m in pay, perks and shares last year.</span></div><div style="background-color: white; background-repeat: no-repeat no-repeat; border-collapse: collapse; color: #333333; font-family: arial, sans-serif; font-size: 14px; line-height: 18px; margin-bottom: 13px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px;">Shares in the group, which also announced a 38% drop in three-month profits to £1.34bn and a reduction in its 2012 earnings target, were the biggest fallers in the FTSE 100, down 6.1% at £26.66, wiping £2.2bn from the company's market value.</div><div style="background-color: white; background-repeat: no-repeat no-repeat; border-collapse: collapse; color: #333333; font-family: arial, sans-serif; font-size: 14px; line-height: 18px; margin-bottom: 13px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px;">Brennan will be replaced temporarily by finance director Simon Lowth from 1 June. Former Volvo boss Leif Johansson will take over as chairman from Louis Schweitzer, 69, on the same day – three months earlier than planned. Johansson will then lead the hunt for a permanent successor to Brennan. Headhunters Spencer Stuart have been hired to scout out internal and external candidates.</div><div style="background-color: white; background-repeat: no-repeat no-repeat; border-collapse: collapse; color: #333333; font-family: arial, sans-serif; font-size: 14px; line-height: 18px; margin-bottom: 13px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px;">Brennan, 58, said he had been contemplating his departure for some time and told the board formally of his intention to quit on Wednesday, following private conversations with the chairman. The board then decided to accelerate the process by appointing Lowth as interim CEO, a move backed by Brennan.</div><div style="background-color: white; background-repeat: no-repeat no-repeat; border-collapse: collapse; color: #333333; font-family: arial, sans-serif; font-size: 14px; line-height: 18px; margin-bottom: 13px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjHiXrItQ8oMfIi1e9niCahEiBM745s2xsEEOk5I51k959S5hKuMT9Mvpn7hWkRmfgQz8w4XbuvSkJxJuD1zC2TTPuT6d_xubRY6ira33ol1rRiaaAsjvPf8Lg7BNLtPWXQbcqfB5FNz4sk/s1600/big-pharma-ii.jpg" imageanchor="1" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" height="320" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjHiXrItQ8oMfIi1e9niCahEiBM745s2xsEEOk5I51k959S5hKuMT9Mvpn7hWkRmfgQz8w4XbuvSkJxJuD1zC2TTPuT6d_xubRY6ira33ol1rRiaaAsjvPf8Lg7BNLtPWXQbcqfB5FNz4sk/s320/big-pharma-ii.jpg" width="208" /></a>Both Brennan and Schweitzer were reportedly encouraged to retire earlier than planned by non-executive directors on the board. However, Brennan insisted: "The decision to retire was entirely my decision. I've been contemplating it for a while. It was time to give someone else the chance to take the company to the next level."</div><div style="background-color: white; background-repeat: no-repeat no-repeat; border-collapse: collapse; color: #333333; font-family: arial, sans-serif; line-height: 18px; margin-bottom: 13px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px;"><span style="font-size: 14px;">He said he wanted to spend more time with his family (he is married with four grown-up children and has six grandchildren) and to "figure out ways to influence healthcare from a different position"</span><span style="font-size: x-large;">."</span></div></div>Seroquelhttp://www.blogger.com/profile/12012400050067849012noreply@blogger.com1tag:blogger.com,1999:blog-8681939617966339411.post-14539157952435281452012-03-27T08:37:00.000-07:002012-03-27T08:37:35.636-07:00AstraZeneca (Seroquel) CEO David Brennan sees huge pay jump - HOW CRIME PAYS QUITE HANDSOMELY<div class="storyHead"> <div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhFTbtl3ThoY4pmd1s2S6qdXKKVhPytQnoOpEpP71LbClwrNBwgE02H-53p8KbwUjKbu5jqwNm4KFnzRWcOs83kfeMEkvihmTp_1tk4MDW3hVy4teMBRsOpJ_A0saQb4PLDfbfu_PUoWUky/s1600/headroom.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="640" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhFTbtl3ThoY4pmd1s2S6qdXKKVhPytQnoOpEpP71LbClwrNBwgE02H-53p8KbwUjKbu5jqwNm4KFnzRWcOs83kfeMEkvihmTp_1tk4MDW3hVy4teMBRsOpJ_A0saQb4PLDfbfu_PUoWUky/s640/headroom.jpg" width="542" /></a></div><h3 style="text-align: center;"><b>AstraZeneca (Seroquel) CEO David Brennan sees pay jump to £9.1m - HOW CORPORATE CRIME PAYS QUITE HANDSOMELY </b></h3><br />
As countless injured Seroquel litigants are now being pushing & dumped into the streets by unscrupulous ambulance chaser law firms <i>(many of those will cont. to suffer on in abject poverty without ever seeing the slightest shred of justice unto their death)</i>; And even after those DOJ <i>(Department of Justice)</i> fines, the massive health damage inflicted upon the general public, the ever growing volumes of documented corp crimes: AstraZeneca Chief David Brennan sees pay jump to £9.1m.<br />
<br />
That's right folks, in that other select members only <i>(TO BIG TO HOLD ACCOUNTABLE)</i> world of corporate crime, pay offs, political wrangling, billion dollar legal teams, and the untold billions in ill gotten profits... CRIME PAYS....& it PAYS OFF BIG TIME<br />
<br />
-----------------------------------------------------------------------------------------<br />
<h1><a href="http://www.telegraph.co.uk/finance/newsbysector/pharmaceuticalsandchemicals/9168852/AstraZeneca-chief-David-Brennan-sees-pay-jump-to-9.1m.html">From The Telegraph UK</a> </h1><h1>AstraZeneca chief David Brennan sees pay jump to £9.1m</h1><h2> AstraZeneca chief executive David Brennan saw his total pay climb to more than £9.1m in 2011, after an increased payout from a share award which vested last year. </h2></div><div id="storyEmbSlide"> <div class="slideshow ssMain"> <div class="nextPrevLayer"> <div class="ssImg" style="display: block;"> <div style="text-align: center;"><img alt="AstraZeneca chief David Brennan sees pay jump to £9.1m" height="287" src="http://i.telegraph.co.uk/multimedia/archive/01844/astra_1844509c.jpg" width="460" /></div><div class="artImageExtras"> <div class="ingCaptionCredit"> <span style="font-size: x-small;"><i><span class="caption">Mr Brennan's 2008 share award also vested last year, with a value of £5.8m, the annual report shows.</span> <span class="credit">Photo: PA</span></i></span></div><div class="ingCaptionCredit"><span class="credit"> </span></div></div></div></div></div></div><div class="cl"> </div><div class="bylineComments"> <div> <div class="bylineBody">Telegraph staff</div></div><div class="publishedDate">10:20AM BST 27 Mar 2012</div><div class="publishedDate"><br />
</div><div class="cl"> </div></div><div class="firstPar"> The pay hike happened despite concern about Astra's pipeline of new drugs, as it faces a looming "patent cliff", with several of its best-selling medicines losing exclusivity and facing competition from cheaper generic versions in the next few years.<br />
<br />
</div><div class="secondPar"> Last week, the company had to pull the plug on an anti-depressant it was developing, incurring a $50m (£31.3m) charge, and in February announced 7,000 job cuts to save money.<br />
<br />
</div><div class="thirdPar"> Mr Brennan's base pay rose 2.5pc to £997,223 in 2011, and including a bonus and other payments, was up 11pc to £3.37m, according to the pharma company's <a href="http://www.astrazeneca-annualreports.com/2011/">annual report</a>.<br />
<br />
</div><div class="fourthPar"> His 2008 share award also vested last year, with a value of £5.8m, the annual report shows. </div><div class="fifthPar"> The size of the share award was increased by 25pc by the board, after Astra came top of its peer group between 2008 and 2010. <br />
<br />
<br />
Mr Brennan turned down any increase in his base pay for 2012, the report shows. </div>Seroquelhttp://www.blogger.com/profile/12012400050067849012noreply@blogger.com2tag:blogger.com,1999:blog-8681939617966339411.post-24818772250484739902012-03-21T15:48:00.001-07:002012-03-21T15:55:05.890-07:00THE CLIENT DUMP - AstraZeneca Seroquel - The Miller Firm LLC - Saiontz & Kirk, PA "YouHaveALawyer", Ennis&Ennis PA - Pharmaceutical Tort Mills, Sleazy Liars, and Greedy Scoundrels<table align="center" cellpadding="0" cellspacing="0" class="tr-caption-container" style="margin-left: auto; margin-right: auto; text-align: center;"><tbody>
<tr><td style="text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg5ywqVsROrBfnRNP4P8-wiRVtX3q1BS6-zlM6XYqQt9FJdIdshqZRul6ebF0_rXE0w8EvkoiMA8Orcl9ps5IvYNTRp9yu-9hiO9rUCCkDkCP9YsZvjUdCpOkNP6JuSPjPLZa1wbg7ZIqWf/s1600/mike_miller.jpg" style="margin-left: auto; margin-right: auto;"><img border="0" height="400" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg5ywqVsROrBfnRNP4P8-wiRVtX3q1BS6-zlM6XYqQt9FJdIdshqZRul6ebF0_rXE0w8EvkoiMA8Orcl9ps5IvYNTRp9yu-9hiO9rUCCkDkCP9YsZvjUdCpOkNP6JuSPjPLZa1wbg7ZIqWf/s400/mike_miller.jpg" width="247" /></a></td></tr>
<tr><td class="tr-caption" style="text-align: center;"><span style="color: #cc0000;">Micheal J. Miller - Chief Liar @ The Miller Firm LLC</span> </td></tr>
</tbody></table><br />
<table align="center" cellpadding="0" cellspacing="0" class="tr-caption-container" style="margin-left: auto; margin-right: auto; text-align: center;"><tbody>
<tr><td style="text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh72rXHyvuJnJPxYsA2ppnZMV9LGjwJ-_Z8BCmL9DPorsgNDH_lo9lSVzHumGKvbUa-aCA_zN7_gbdzPkXiRzS-MGVDa8a3rUDQI01w0F02qm62rFXTo-8pwlomonzeIFSsXVRT5S9A9j7F/s1600/youhavealawyer.jpg" imageanchor="1" style="margin-left: auto; margin-right: auto;"><img border="0" height="340" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh72rXHyvuJnJPxYsA2ppnZMV9LGjwJ-_Z8BCmL9DPorsgNDH_lo9lSVzHumGKvbUa-aCA_zN7_gbdzPkXiRzS-MGVDa8a3rUDQI01w0F02qm62rFXTo-8pwlomonzeIFSsXVRT5S9A9j7F/s400/youhavealawyer.jpg" width="400" /></a></td></tr>
<tr style="color: #cc0000;"><td class="tr-caption" style="text-align: center;">Saiontz & Kirk, PA - Non-Participant Co-counsel & Tort Legal Mill case gatherers & sellers </td></tr>
</tbody></table><div style="text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg5ywqVsROrBfnRNP4P8-wiRVtX3q1BS6-zlM6XYqQt9FJdIdshqZRul6ebF0_rXE0w8EvkoiMA8Orcl9ps5IvYNTRp9yu-9hiO9rUCCkDkCP9YsZvjUdCpOkNP6JuSPjPLZa1wbg7ZIqWf/s1600/mike_miller.jpg" style="margin-left: 1em; margin-right: 1em;"></a><span style="font-size: large;"><b>THE CLIENT DUMP - AstraZeneca Seroquel - The Miller Firm LLC - Saiontz & Kirk, PA "YouHaveALawyer", Ennis&Ennis PA - Pharmaceutical Tort Mills, Sleazy Liars, & Greedy Scoundrels</b></span></div><br />
Well, we all knew this was coming....we just didn't know exactly how The Miller Firm LLC was going to try justifying their constant lies and magical settlement approval % manipulation. Today I received a copy of this letter below along with some enlightening correspondence from a long time trusted source.<br />
<br />
My source stated that this "DUMP" letter is packed with misrepresentation & outright lies that have been conjured up by The Miller Firm LLC to avoid the appearance and undeniable reality that they have or are in the active process of a targeted and purposeful client dump in an unethical scheme to force a rejected settlement through solely for self gain.<br />
<br />
My source went on to pin point inaccuracies in this DUMP letter starting with deceiving legal speak in the opening sentence stating:<br />
<br />
<div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjBDTMR6hOCNigL0iQsapfbeB2jcDCSHCwImsdtBHY2gCme2BhUnFtHaFPuY_iIepIOWeb8diMobD37CNXxH5_cb6P9Iy576XOFTBj47Ip-32DvomMpqHObHu-qUUMzyn0Q1DO-unVFsDT7/s1600/liars.PNG" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="92" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjBDTMR6hOCNigL0iQsapfbeB2jcDCSHCwImsdtBHY2gCme2BhUnFtHaFPuY_iIepIOWeb8diMobD37CNXxH5_cb6P9Iy576XOFTBj47Ip-32DvomMpqHObHu-qUUMzyn0Q1DO-unVFsDT7/s640/liars.PNG" width="640" /></a></div><br />
My "source" unequivocally states that Saiontz & Kirk P.A. was not hired to investigate a claim, but to represent the "source" in a valid, evidenced, and documented case against AstraZeneca.<br />
<br />
The "source" stated that they did not hire The Miller Firm LLC to represent them in any way, shape, or form. In fact, Saiontz & Kirk P.A. sold the "sources" case to The Miller Firm LLC, while having no active involvement or participation as Co-counsel in the Seroquel Litigation from that time on. In fact all client questions & inquires were automatically forwarded to The Miller Firm LLC without their response once the sale had occurred.<br />
<br />
Now, onto the most important point and evidential lie in this "DUMP" letter. My source stated that they "NEVER" "EVER" requested that their case be closed. In fact they sent in a valid appeal letter outlining their concerns within the 7 day time limit constraints The Miller Firm LLC & the Garretson Resolution Group placed on appeals, and for signing onto or not signing onto the <a href="http://seroquellawsuitblog.blogspot.com/2011/08/miller-firm-llc-you-have-lawyer-saiontz.html">settlement</a> process.<br />
<br />
That <a href="http://seroquellawsuitblog.blogspot.com/2011/10/miller-firm-llc-garretson-and.html">appeal</a> letter was completely ignored by The Miller Firm LLC. In fact on numerous occasions in direct correspondence with The Miller Firm LLC; The Miller Firm Representatives stated that they were not going to take a single case to court, none were worthy of trial, and there would be absolutely no renegotiation of the settlement terms with AstraZeneca.<br />
<br />
The Miller Firm LLC is acting today & as were they then; they are the sole cause or catalyst behind any and all separation of legal representation. For The Miller Firm LLC to even imply that the "Source" requested that their case be closed constitutes a totally fraudulent statement and most egregious blatant lie.<br />
<br />
Who shall you the reader believe? Let's just match & compare the signatures on the "DUMP" letter below, to the THREAT letter Mr. Miller denied he wrote to <a href="http://newsandinsight.thomsonreuters.com/Legal/News/2011/09_-_September/Law_firms_blast_disclosure_of_Seroquel_settlement_documents/">Reuters News and Insight</a>. In fact Miller & his firm, (including co-counsel) all appear to have some serious problems related to telling the truth and subsequent honesty.<br />
<br />
<i><span style="font-size: small;"><b>So why might you think a request for being relieved of contractual obligation or being DUMPED directly by the Miller Firm LLC makes such a huge difference in this settlement going forward?</b></span></i><br />
<br />
<i><span style="font-size: small;"><b> </b> </span></i>Because <span style="font-size: large;"><i>The Miller Firm appears to using this misinformation/lies to drop clients from equations which directly skews the settlement acceptance percentages for this pay out proposal</i></span>.<br />
<br />
So instead of having a 40% rejection rate or 249 client rejections. The Miller Firm appears to have jettisoned most of those clients, and then went about the nasty business of recalculating the approval percentage numbers with the approximately 374 remaining approval clients to reach that magical 93% approval threshold to submit to AstraZeneca to cash in on their pay day.<br />
<br />
The only problem here is that the clients didn't ask for their cases to be closed...they simply wanted to be properly represented or sent a notice of being released because they rejected the settlement by their original counsel. The Miller Firm is playing unethical slight of hand here...and are clearly attempting to erase the voices & rights of those injured parties that rejected this insulting settlement by closing their cases and then acting like they never existed to the calculations, the courts and to AstraZeneca... That is about as sleazy, disingenuous, and underhanded as it gets folks...<br />
<br />
<span style="font-size: large;"><b>This is the 7.4 million dollar question that must be answered? Has The Miller Firm LLC & Co-counsel conspired against one segment of clients they have a sworn legal & ethical obligation too represent; to unequally represent another segment of clients they represent, solely for their own self gain & personal business interest?</b></span><br />
<br />
This is the heart felt message I am sending out to the DOJ "Department Of Justice" & Federal Courts; are you listening to the actual injured parties and clients yet.....please do! <br />
<br />
<br />
<br />
<br />
<br />
<div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj3ZP1DC3iZH4QnFzYaX3N_UAnIkCvCr7O5QkqdMp95NNjBa3zUTUIsz9a7iBUdbBD1XRtFcaR0R_RsuRJwlwf8lO5UlRcFS18ZWRyKtXOd3C6HbRzfQBfj5CdhfK49PxcFmjs3HrZA-gXx/s1600/img071.jpg" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="640" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj3ZP1DC3iZH4QnFzYaX3N_UAnIkCvCr7O5QkqdMp95NNjBa3zUTUIsz9a7iBUdbBD1XRtFcaR0R_RsuRJwlwf8lO5UlRcFS18ZWRyKtXOd3C6HbRzfQBfj5CdhfK49PxcFmjs3HrZA-gXx/s640/img071.jpg" width="494" /></a></div><div style="text-align: center;"></div>Seroquelhttp://www.blogger.com/profile/12012400050067849012noreply@blogger.com1tag:blogger.com,1999:blog-8681939617966339411.post-7939537554105380972012-03-19T12:57:00.002-07:002012-03-19T14:12:04.875-07:00THE FIX IS IN - The Miller Firm LLC says they have magically reached settlement threshold & are presenting results to AstraZeneca in an attempt to cash in on the Seroquel Litigation<table align="center" cellpadding="0" cellspacing="0" class="tr-caption-container" style="margin-left: auto; margin-right: auto; text-align: center;"><tbody>
<tr><td style="text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiFDIrFcmc-uylD23qd5d4VKZvWe-FkwCcCM48MC933Jk-9UzUnE-ZyOH3Gipngj7wlqFDsIg2zR0oPoN4l8eNp658EHENU2GBOBicMD7IwqG3UrycHZ1UoNVgg7W5h9oCS6C8ziwRJqYXN/s1600/a_fat_evil_greedy_money_loving_man__xlarge.jpg" imageanchor="1" style="margin-left: auto; margin-right: auto;"><img border="0" height="393" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiFDIrFcmc-uylD23qd5d4VKZvWe-FkwCcCM48MC933Jk-9UzUnE-ZyOH3Gipngj7wlqFDsIg2zR0oPoN4l8eNp658EHENU2GBOBicMD7IwqG3UrycHZ1UoNVgg7W5h9oCS6C8ziwRJqYXN/s400/a_fat_evil_greedy_money_loving_man__xlarge.jpg" width="400" /></a></td></tr>
<tr><td class="tr-caption" style="text-align: center;">Hear Ye! Hear Ye! for all those injured or killed by Seroquel! it's settled Suckers</td></tr>
</tbody></table><br />
<div style="text-align: center;"><span style="font-size: large;"><b> THE FIX IS IN - The Miller Firm LLC says they have magically reached settlement threshold, & are presenting results to AstraZeneca in an attempt to cash in on the Seroquel Litigation</b></span></div><div style="text-align: center;"><br />
</div><div style="text-align: left;"><i>In the continuing saga of "How the Seroquel Settlement World Turns" The Miller Firm Seroquel Update Recording</i><i> today (*800* 882 -2525) announced they have reached the required number of settlement packets to move forward with asking AstraZeneca to release funds. </i></div><div style="text-align: left;"><br />
</div><div style="text-align: left;"><i>Of course The Miller Firm does not say <span style="font-size: large;"><b>how many</b></span> settlement approval packets they have actually received, or <span style="font-size: large;"><b>how many</b></span> clients they have dumped to the streets in pursuing this magical threshold mark of 93% approval.</i></div><div style="text-align: left;"><br />
</div><div style="text-align: left;"><i> This is all very secretive stuff that The Miller isn't sharing with their Clients or anyone else except AZ (you know the clients, injured parties, those people they are supposedly working for). Though one must seriously & reasonably wonder out loud what's really going on here; especially when a firm has been sitting at a 40% rejection rate for a year, and then in three weeks time somehow pulls a settlement agreement rabbit out of thier hat so to speak. </i></div><div style="text-align: left;"><br />
</div><div style="text-align: left;"><i>This is why interested parties and clients <b>are asking & calling for an investigation by Federal authorities @ the Department of Justice and the Court. </b>Not only does the documented actions of The Miller Firm not passing the ethical & professional smell test....shall we start throwing around nasty words like "Fraud"? "Racketeering"? "Conspiracy"? or other related pleasantries to garner attention to the Injured Parties plight....The time has now come to have this secretive & unsavory curtain pulled back for all to see...</i></div><div style="text-align: left;"><br />
</div><div style="text-align: left;"><i>We know that The Miller Firm LLC and non-participant co-counsel have been tooting the settlement horn with their cheerleader buddies at the Garretson Resolution Group & AstraZeneca for over a year now. From the clients I've had correspondence with...The Miller Firm has quashed any & all conversation, inquiry, or mention of further negotiations or any chance of preparing their cases further for trial. </i></div><div style="text-align: left;"><br />
</div><div style="text-align: left;"><i>There are so many questions, yet The Miller Firm & co-counsel refuse to answer any and all questions that don't directly refer to getting this settlement approved, or getting that settlement cash in their pockets. </i></div><div style="text-align: left;"><br />
</div><div style="text-align: left;"><i>This blog has chronicled this secretive, often threatening, and closed door process for almost a year now....Injured parties that are refusing this insulting & unfair offer are no closer to receiving legitimate counsel, a court hearing before a jury of their peers, or finding even the most remote form of justice now, anymore than they were then. </i></div><div style="text-align: left;"><br />
</div><div style="text-align: left;"><i>This is a testament to how truly perverted and corrupted our legal system, the law profession, and the courts have become. It seems or appears that only the wealthy, elite, politically connected, corrupted, and those recognized into the small members only club receive the treasured promise of the courts and justice in America...The rest receive what has been written on the pages of this blog....it's simply insult added to injury....</i></div><div style="text-align: left;"><br />
</div><div style="text-align: left;"><i>I invite you the reader to go back & read through this blog's journey over the past many mouths & ask yourself this question; Have injured parties in the Seroquel litigation received anything that can be taken as, would be construed as, or closely resembling justice from the courts, media, their own legal representation, and most of all....from the AstraZeneca corporation that with forethought and malice caused them grave injury or death with the drug Seroquel? </i></div><div style="text-align: left;"><br />
</div><div style="text-align: left;"><i>as they say....this ain't over until the last Seroquel induced fat lady sings.... </i><br />
<br />
<i>But then again...will injured parties even be dealing with AstraZeneca six months or a year down the road...or some other huge corporate entity?</i><br />
<i>----------------------------------------- </i><br />
<i><br />
</i><br />
<i><a href="http://www.mmm-online.com/astrazenecas-patent-plight-points-toward-takeover-analyst/article/231696/?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed:+MMMHome+%28MMM+Home%29">from MM&M - medical, marketing & media</a></i><br />
<br />
<b>AstraZeneca's patent plight points toward takeover: analyst</b><br />
<br />
<div id="byline"><div class="articleAuthor" id="articleAuthor"><a href="http://www.mmm-online.com/deborah-weinstein/author/1215/" rel="author" title="More Articles by Deborah Weinstein">Deborah Weinstein</a></div><div class="articleDate" id="articleDate">March 13, 2012</div><div class="articleDate" id="articleDate"> Despite a brimming pipeline touted by execs earlier this year, storm clouds are gathering for AstraZeneca, and the best way to weather them is through a takeover, says one analyst.<br />
If it wants to deliver results, the UK drugmaker's dwindling set of options really boils down to one: take over a company with a pipeline that will keep it afloat, wrote Tim Anderson of Sanford Bernstein.<br />
<br />
In a note titled, "Something's Gotta Give. But When & Why?" Anderson writes of a "left for dead" attitude by many investors towards the company. “AZN faces a prolonged, multi-year patent cliff that gives it among the steepest revenue and EPS declines of the different US and European companies we cover,” Anderson noted, referring to a slew of patent expirations that start in 2012 and run through the next the next four years. Among those aging out this year are anti-psychotic Seroquel and blood pressure drug Atacand. Seroquel IR and XR brought in over $6 billion in sales for the company last year, and Atacand brought in almost $2 billion. Blockbuster Crestor ($6.6 billion in sales last year), already generic in some European markets and facing a threat from off-patent Lipitor in the US, is scheduled to lose US exclusivity in 2016.<br />
<br />
click on the link above to read the rest of the article.... </div><div class="articleDate" id="articleDate"></div></div><br />
<i><br />
</i><br />
<i><br />
</i></div><div style="text-align: left;"><br />
</div><br />
<div style="text-align: left;"><br />
</div><div style="text-align: left;"><br />
</div><div style="text-align: left;"><br />
</div>Seroquelhttp://www.blogger.com/profile/12012400050067849012noreply@blogger.com1tag:blogger.com,1999:blog-8681939617966339411.post-22877015343861555712012-03-17T14:22:00.002-07:002012-03-17T14:39:02.262-07:00AstraZeneca Sues the FDA to extend Seroquel patent & profits - The outrageous hypocrisy of it all<div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhlOJH_ycVnwLm5lzRHxDUP0zkMtO92axBab-HjCcv_A_1iOaqtllhm73n23ogW8a3BxX9JCxljSa5ckA-2cldLxknrza22_-rj_l4XxiSr_KwOj0mhU2k9OLvJ-1LYYYijlhpC3XJz7JXe/s1600/Greedy2.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="328" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhlOJH_ycVnwLm5lzRHxDUP0zkMtO92axBab-HjCcv_A_1iOaqtllhm73n23ogW8a3BxX9JCxljSa5ckA-2cldLxknrza22_-rj_l4XxiSr_KwOj0mhU2k9OLvJ-1LYYYijlhpC3XJz7JXe/s400/Greedy2.jpg" width="400" /></a></div><br />
<div style="text-align: center;"><span style="font-size: large;"><b>AstraZeneca Sues the FDA to extend Seroquel patent & profits - The outrageous hypocrisy of it all</b></span></div><div style="text-align: center;"><br />
</div><div style="text-align: left;"><span style="font-size: small;">Yes, it's beyond ludicrous I know....but those very same greed mongering corporate thugs @ AstraZeneca who have stolen literally mountains of money by their blatant acts of illegal marketing, political pandering & deceit, and by hiding the dangerous & deadly side effects of the drug Seroquel while making it a multi-billion dollar a year block buster; are now suing the FDA because the soon to be released generic version of Seroquel doesn't have the exact same label warning incert as the AstraZeneca patented version. </span></div><div style="text-align: left;"><br />
</div><div style="text-align: left;"><span style="font-size: small;">Now, very few rational people are going to argue that full, safe, and complete product labeling isn't a good thing. But let's get real here....AstraZeneca has never been concerned about safety or patient health when it comes to Seroquel...they sure as hell didn't want consumers (or anyone else for that matter) knowing all the dirty secrets and dangerous details of this drug when marketing Seroquel into a mega billion </span><span style="font-size: small;">dollar</span><span style="font-size: small;"> per year profit maker. Now they want to hold on to their deadly cash cow patent even longer...please give us all a break...this is yet another case of the special & privileged corporate elite abusing the legal system, the citizens of America, & others from around the world purely for greed's sake.</span></div><div style="text-align: left;"><br />
</div><div style="text-align: left;"><span style="font-size: small;">------------------------------------------------------------------------------------------- </span></div><div style="text-align: left;"><span style="font-size: small;"><br />
</span></div><div style="text-align: left;"><span style="font-size: small;"><a href="http://blog.pharmexec.com/2012/03/14/az-sues-fda-over-seroquel/">From the Pharma Exec Blog</a> </span></div><h1 class="entry-title">AZ's Seroquel Battle with FDA: A Mark of Desperation?</h1><div class="entry-meta"><span class="meta-prep meta-prep-author">By </span><span class="author vcard"><a class="url fn n" href="http://blog.pharmexec.com/author/guest-blogger/" title="View all posts by Guest Blogger">Guest Blogger</a></span><span class="meta-sep meta-sep-entry-date"> | </span><span class="meta-prep meta-prep-entry-date">Published: </span><span class="entry-date"><abbr class="published" title="2012-03-14T08:13:52-0400">March 14, 2012</abbr></span></div><div class="entry-meta"></div><i>By Ana Nicholls, Healthcare Analyst at the <a href="http://www.eiu.com/Default.aspx">Economist Intelligence Unit</a>.</i><br />
<br />
Is it a mark of desperation? UK-based pharma company AstraZeneca has resorted to suing the US Food and Drug Administration in a bid to stop it from approving generic competition to Seroquel, the company’s blockbuster anti-depressant, before December 2012. The core patent for Seroquel IR expired in September last year, and its paediatric patent runs out this month, although Seroquel XR (the later version) still has protection till 2017.<br />
<br />
<span id="more-3701"></span><br />
The FDA has yet to approve a generic version, and AstraZeneca is arguing that it should not do so. The company claims that important decisions have still not been made over warning labels on the generic versions of Seroquel IR, which need to mimic those on the original, while it still has data exclusivity rights stemming from the clinical trials it has conducted.<br />
<br />
<br />
AstraZeneca tried a Citizens’ Petition against the FDA earlier this month, with no joy, so it is now trying a lawsuit. The case is a long shot, but the costs will certainly be far lower than the losses the company will incur when Seroquel’s patent expires. The drug generated sales of US$4.3bn worldwide last year, of which US$3.3bn was in the US. Moreover, if AstraZeneca wins, then it (and other companies) may also have developed another way of extending protection for many of the drugs that are coming off-patent.<br />
<br />
<br />
If so, that would be very welcome news in this, the steepest year of the patent cliff. This year, around US$27bn-worth of blockbuster sales will be exposed to generic competition in the US, according to Fitch Ratings. AZ, along with Pfizer and Forest Laboratories of the US, is one of the companies hardest hit. AZ calculates that it lost almost US$2bn in revenue during 2011 as a result of generic competition. Other companies have tried different tactics to protect their patents – Pfizer, for example, struck exclusivity deals with pharmacy benefits managers to protect sales of Lipitor after its US patent expired late last year.<br />
<br />
Yet the mood in the US is firmly against pharma companies who are seen as blocking competition, making the likelihood of AZ winning its case appear remote. Though attempts to legislate have foundered, the current US government has campaigned against what it dubs “pay-for-delay” tactics, which mainly involve deals between pharma companies and their potential generic competitors. The chairman of the Federal Trade Council Jon Leibowitz claimed last year that such arrangements cost consumer US$3.5bn a year in higher drug prices.<br />
<br />
---------------------------------------------<br />
<br />
Once again in this article above, Seroquel is being referred to as an antidepressant drug - so let's make it absolutely clear, and correct once again this often used blatant mistake reported by the main stream media & others.<br />
<br />
<span style="font-size: large;"><i><b>Seroquel is not an antidepressant drug</b></i><i><b>...it is a powerful neuroleptic drug (anti-psychotic)</b></i></span>.<br />
<br />
<div style="background-color: white; border: medium none; color: black; overflow: hidden; text-align: left; text-decoration: none;"><b>neuroleptic drug</b> - tranquilizer used to treat psychotic conditions when a calming effect is desired<br />
<div class="Syn"><a href="http://www.thefreedictionary.com/antipsychotic">antipsychotic</a>, <a href="http://www.thefreedictionary.com/antipsychotic+agent">antipsychotic agent</a>, <a href="http://www.thefreedictionary.com/antipsychotic+drug">antipsychotic drug</a>, <a href="http://www.thefreedictionary.com/major+tranquilizer">major tranquilizer</a>, <a href="http://www.thefreedictionary.com/major+tranquilliser">major tranquilliser</a>, <a href="http://www.thefreedictionary.com/major+tranquillizer">major tranquillizer</a>, <a href="http://www.thefreedictionary.com/neuroleptic">neuroleptic</a>, <a href="http://www.thefreedictionary.com/neuroleptic+agent">neuroleptic agent</a></div></div><div style="text-align: left;"><span style="font-size: large;"><b><br />
</b></span></div>Seroquelhttp://www.blogger.com/profile/12012400050067849012noreply@blogger.com0tag:blogger.com,1999:blog-8681939617966339411.post-78599444973865527222012-03-17T13:13:00.002-07:002012-03-17T13:50:32.624-07:00Busted in Louisiana: For attempting to sell AstraZeneca's Seroquel,and possession of Seroquel and marijuana<div style="text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhxGrnS7uB8q5uJ266dgRgM6Hk3CR_p7AwR-WeaWq-dLk92tlYajpLRmkDg0RxsvD7DMSLtmSnkgBDktqvMQGoM7fyuN8_glQM63RbZdYpez5EmxFbO__2luszaTBu5Z0zQJxljusmjLpvt/s1600/Seroquel+image.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhxGrnS7uB8q5uJ266dgRgM6Hk3CR_p7AwR-WeaWq-dLk92tlYajpLRmkDg0RxsvD7DMSLtmSnkgBDktqvMQGoM7fyuN8_glQM63RbZdYpez5EmxFbO__2luszaTBu5Z0zQJxljusmjLpvt/s1600/Seroquel+image.jpg" /></a><span style="font-size: x-large;">Prescription drug street sales attempt of antipsychotic Seroquel</span></div><div style="color: #2c2c2c; font-family: Helvetica, Arial, sans-serif; font-size: 16px; line-height: 24px; margin-bottom: 18px; padding-bottom: 0px; padding-left: 160px; padding-right: 0px; padding-top: 0px; text-align: left;"><b><br />
</b></div><div style="color: #2c2c2c; font-family: Helvetica, Arial, sans-serif; font-size: 16px; line-height: 24px; margin-bottom: 18px; padding-bottom: 0px; padding-left: 160px; padding-right: 0px; padding-top: 0px; text-align: left;"><b>NEWS: Monroe, Louisiana </b></div><div style="color: #2c2c2c; font-family: Helvetica, Arial, sans-serif; font-size: 16px; line-height: 24px; margin-bottom: 18px; padding-bottom: 0px; padding-left: 160px; padding-right: 0px; padding-top: 0px; text-align: left;"><b>Monroe police arrested a man Monday evening accused of drug possession near a child.</b></div><div style="color: #2c2c2c; font-family: Helvetica, Arial, sans-serif; font-size: 16px; line-height: 24px; margin-bottom: 18px; padding-bottom: 0px; padding-left: 160px; padding-right: 0px; padding-top: 0px; text-align: left;"><span class="pp"></span>Glenn Armstrong, 19, of 1702 Railroad Ave., Monroe, was booked into Ouachita Correctional Center on charges of possession of Seroquel, possession of marijuana, possession of controlled and dangerous substances in the presence of juveniles, stop sign violation, no driver's license and no insurance.<span class="aa"></span></div><div style="color: #2c2c2c; font-family: Helvetica, Arial, sans-serif; font-size: 16px; line-height: 24px; margin-bottom: 18px; padding-bottom: 0px; padding-left: 160px; padding-right: 0px; padding-top: 0px; text-align: left;"><span class="pp"></span>An arrest affidavit stated an officer was traveling westbound on Texas Avenue when he saw the driver of a Mazda vehicle run a red traffic light at the intersection with South Second Street. Police said the driver, later identified as Armstrong, stopped in the 500 block of South First Street.During the traffic stop, police said Armstrong could not show them a proper driver's license or proof of insurance. Police said Armstrong appeared to be nervous.</div><div style="color: #2c2c2c; font-family: Helvetica, Arial, sans-serif; font-size: 16px; line-height: 24px; margin-bottom: 18px; padding-bottom: 0px; padding-left: 160px; padding-right: 0px; padding-top: 0px; text-align: left;">The report stated police saw two 16-year-old juveniles in Armstrong's vehicle. <b>A search of the vehicle revealed a bottle of suspected Seroquel pills and a small bag of suspected marijuana</b>. The unnamed juveniles told police Armstrong had been trying to sell the suspected pills before he was stopped.</div><div style="color: #2c2c2c; font-family: Helvetica, Arial, sans-serif; font-size: 16px; line-height: 24px; margin-bottom: 18px; padding-bottom: 0px; padding-left: 160px; padding-right: 0px; padding-top: 0px; text-align: left;">Bond was $16,050.</div><br />
<br />
<a href="http://www.thenewsstar.com/article/20120314/NEWS01/203140333">MPD accuses suspect of having drugs near child</a><br />
<br />
---------------------------------------------------------------------------------- <br />
<br />
And also in the news....an article that can be placed in the category of doing much too little, far too late....<br />
<br />
<span style="font-size: large;"><b>State puts lid on overprescribing doctors</b></span><br />
<br />
<div class="byline">By <a class="headlinelink3" href="mailto:andrewconte@tribweb.com">Andrew Conte</a>, <a href="http://www.pittsburghlive.com/x/pittsburghtrib/news/regional/s_786956.html">PITTSBURGH TRIBUNE-REVIEW</a><br />
Saturday, March 17, 2012 </div><div style="background-color: white; border: medium none; color: black; overflow: hidden; text-align: left; text-decoration: none;"><br />
</div>Pennsylvania has investigated and removed some doctors who were among the top prescribers of painkillers and mental health drugs for Medicaid patients, officials said in a letter made public on Friday.<br />
<br />
Five doctors were disqualified from participating in the program; four had their licenses suspended; two were referred to prosecutors for review; and one is under investigation, the state Department of Public Welfare told U.S. Senate investigators.<br />
<br />
The state reported its actions in a Feb. 27 letter to Sen. Charles Grassley, R-Iowa, who has been investigating abuses nationwide of medicines such as the anti-depressant Xanax. Pennsylvania initially provided information about the top 10 prescribers of eight antipsychotic, painkiller or anti-anxiety drugs to Grassley in 2010.<br />
<br />
"We are seeing that certain states, including Pennsylvania, are reporting that they or the state medical board has taken action against medical providers, and that's good news," said Jill Gerber, Grassley's spokeswoman.<br />
<br />
The state welfare department said it sent intervention letters to 51 other doctors, showing their patients' drug histories. The state said its program encourages doctors to discontinue unnecessary prescriptions, reduce drug quantities or switch to other treatments.<br />
<i><b>State officials declined to identify any doctors.</b></i><br />
<br />
"Our administration is dedicated to rooting out all waste, abuse and fraud in our programs and services," spokeswoman Donna Kirker Morgan said in a statement.<br />
<br />
"Although the senator's questions are an interesting snapshot of antipsychotic drug utilization in the Medicaid system, the questions do not delve into important facts and backgrounds about patients and their current needs for such drugs and the circumstances for such prescriptions."<br />
<br />
Top prescribers continue to dispense many of the drugs at a high cost for taxpayers, the state's response shows. Along with its letter, public welfare reported the top 10 prescribers for eight drugs, showing the number of prescriptions each doctor wrote and the dollar value of them.<br />
One doctor last year gave out 6,950 prescriptions for Xanax — or more than 19 every day — at a cost of nearly $70,500. The year before,<span style="font-size: large;"><i><b> another doctor wrote 1,864 prescriptions for Seroquel, an antidepression and schizophrenia drug that can cost up to $12 per tablet. The Seroquel prescriptions cost taxpayers more than $1 million.</b></i></span><br />
<br />
The state attorney general's office could not immediately provide details about whether any of the public welfare referrals resulted in prosecution. "We aggressively pursue provider fraud, which diverts limited taxpayer resources from Medicaid recipients with legitimate needs," spokesman Nils Hagen-Frederiksen said.<br />
<br />
The state's response to Grassley was made public yesterday when the agency responded to a Right-to-Know Request filed by Ken Kramer, an investigator for Citizens Commission on Human Rights International, a group that investigates and exposes psychiatric abuse.<br />
<br />
"It's very good to see Pennsylvania taking action," Kramer, 55, of Clearwater, Fla., said in an email to the Tribune-Review. <i><b>"There is no debate on this: Patients are overdrugged, Medicaid is overbilled and taxpayers are overburdened -- all caused by the bogus prescribing of psychiatrists."</b></i><br />
<div style="background-color: white; border: medium none; color: black; overflow: hidden; text-align: left; text-decoration: none;"><br />
Read more: <a href="http://www.pittsburghlive.com/x/pittsburghtrib/news/regional/s_786956.html#ixzz1pPLOahMo" style="color: #003399;">State puts lid on overprescribing doctors - Pittsburgh Tribune-Review</a> <a href="http://www.pittsburghlive.com/x/pittsburghtrib/news/regional/s_786956.html#ixzz1pPLOahMo" style="color: #003399;">http://www.pittsburghlive.com/x/pittsburghtrib/news/regional/s_786956.html#ixzz1pPLOahMo</a></div><div style="background-color: white; border: medium none; color: black; overflow: hidden; text-align: left; text-decoration: none;"><br />
</div><div style="background-color: white; border: medium none; color: black; overflow: hidden; text-align: left; text-decoration: none;">--------------------------------------------------------------------</div><div style="background-color: white; border: medium none; color: black; overflow: hidden; text-align: left; text-decoration: none;"><br />
</div><div style="background-color: white; border: medium none; color: black; overflow: hidden; text-align: left; text-decoration: none;">So everyone is absolutely clear and to correct a blatant mistake often reported by media. Seroquel is not an anti-depressant drug...it is a powerful neuroleptic drug (anti-psychotic). </div><div style="background-color: white; border: medium none; color: black; overflow: hidden; text-align: left; text-decoration: none;"></div><div style="background-color: white; border: medium none; color: black; overflow: hidden; text-align: left; text-decoration: none;"><b>neuroleptic drug</b> - tranquilizer used to treat psychotic conditions when a calming effect is desired<br />
<div class="Syn"><a href="http://www.thefreedictionary.com/antipsychotic">antipsychotic</a>, <a href="http://www.thefreedictionary.com/antipsychotic+agent">antipsychotic agent</a>, <a href="http://www.thefreedictionary.com/antipsychotic+drug">antipsychotic drug</a>, <a href="http://www.thefreedictionary.com/major+tranquilizer">major tranquilizer</a>, <a href="http://www.thefreedictionary.com/major+tranquilliser">major tranquilliser</a>, <a href="http://www.thefreedictionary.com/major+tranquillizer">major tranquillizer</a>, <a href="http://www.thefreedictionary.com/neuroleptic">neuroleptic</a>, <a href="http://www.thefreedictionary.com/neuroleptic+agent">neuroleptic agent</a></div></div><div style="background-color: white; border: medium none; color: black; overflow: hidden; text-align: left; text-decoration: none;"><br />
</div>Seroquelhttp://www.blogger.com/profile/12012400050067849012noreply@blogger.com0tag:blogger.com,1999:blog-8681939617966339411.post-60542132684328328912012-03-15T14:14:00.001-07:002012-03-15T21:37:50.329-07:00AstraZeneca Seroquel Litigation Update - The Miller Firm LLC, Ennis & Ennis, P.A., and Saiontz & Kirk, P.A. "You Had A Lawyer" - Are Law Firms Using Legal Sleight of Hand to Force Through a Rejected Settlement Offer?<div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiwFlRuPckQ-cXAyd8PZdQo-owYdAzFxsIJFKYrtc0ZTKYBL1-WBpR7gO5JML0iQqbe7NkIaX1hyphenhyphen2AA3ggJpqi_kuE1t8pO7L_2xyu7FXJQK7FehUxkXIP0EdFMEd9cGncRafFYKB48Qkcq/s1600/legal+slieght+of+hnad.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="281" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiwFlRuPckQ-cXAyd8PZdQo-owYdAzFxsIJFKYrtc0ZTKYBL1-WBpR7gO5JML0iQqbe7NkIaX1hyphenhyphen2AA3ggJpqi_kuE1t8pO7L_2xyu7FXJQK7FehUxkXIP0EdFMEd9cGncRafFYKB48Qkcq/s400/legal+slieght+of+hnad.jpg" width="400" /></a></div><div style="text-align: center;"><b>AstraZeneca Seroquel Litigation Update - The Miller Firm LLC, Ennis & Ennis, P.A., and Saiontz & Kirk, P.A. "You Had A Lawyer" - Are Law Firms Using Legal Sleight of Hand to Force Through a Rejected Settlement Offer?</b></div><div style="text-align: center;"><br />
</div><div style="text-align: left;">Where we left off in the last Post <a href="http://seroquellawsuitblog.blogspot.com/2012/03/astrazeneca-seroquel-litigation-update.html">HERE</a> , The Miller Firm LLC was reporting they had magically reached 78% acceptance figure for the Seroquel settlement offer; even though for many months there has been a 40% rejection of the same settlement offer. This week on The Miller Firm Seroquel Update Recording<i> (*800* 882 -2525)</i> states that they have now reached an 85% approval; while going further to boast & state that they will meet their goal this week <i>( 93% approval is needed for the settlement to go forward)</i> . </div><div style="text-align: left;"><br />
</div><div style="text-align: left;">WOW!! How does something like this happen? Shall we start wondering how one goes <i>(in a couple of weeks)</i> from a settlement that was dead and buried to a miraculous acceptance of 93%? </div><div style="text-align: left;"><br />
</div><div style="text-align: left;">1. We know these firms have been marketing the heck out of this lousy settlement for almost a year now..</div><div style="text-align: left;"><br />
</div><div style="text-align: left;">2. We also know The Miller Firm had/has made in quite clear to anyone appealing the process or who has not signed onto this settlement would be dropped from representation <i>(evidenced by The Miller Firms numerous statements that there would be absolutely no re-negotiations, that client appeals would & have been ignored, & there would zero trials going forward).</i></div><div style="text-align: left;"><br />
</div><div style="text-align: left;"><i>3. </i>We also know the stated settlement deadlines have come & gone....then out of thin air are being extended only to suite the law firms whimsical insistence that this settlement be accepted for their own selfish gain...<i>(not acting in the clients best interest) </i></div><div style="text-align: left;"><br />
</div><div style="text-align: left;">OK, we know that the above statements has been the sleazy case & hard to stomach reality for some time now....so what else has magically changed in the past couple of weeks?</div><div style="text-align: left;"><br />
</div><div style="text-align: left;">4. <span style="font-size: large;"><b>How about the dumping of clients!</b></span> it sure appears that The Miller Firm has conspired against & jettisoned clients that did not accept the settlement, & are holding back that information/notification until they get the settlement money in their grubby and greedy legal mitts; and are recalculating <i>(or are now in the process of recalculating)</i> the new numbers to meet the 93% acceptance threshold criteria for AstraZeneca to release settlement funds. It's not like it's any hidden secret at this juncture that The Miller Firm & their Sleazy "gather & sell clients" co-counsel are in this for the money & very little else.....</div><div style="text-align: left;"><br />
</div><div style="text-align: left;">Now if that is what has actually happened; then not only is it not kosher or ethical; It also flies in the face of any reasonable or rational comprehension of the original settlement offer which was supposedly sent out to all the 623 clients The Miller Firm were supposedly representing. </div><div style="text-align: left;"><br />
</div><div style="text-align: left;">Radical changes in events and the status of tort settlements don't just change like this overnight....There must be explanations, extenuating factors or justifiable reasons behind such changes....I believe clients have a right to know....after all....who is The Miller Firm & their co-counsel legally and ethically bound to represent in their best interest....the clients or just themselves?</div><div style="text-align: left;"><br />
</div><div style="text-align: left;">Of course The Miller Firm as usual is being very secretive, tight lipped, and closed mouth about what they are doing...They will only make references or comments related to pushing this offer through at all cost & nothing else.</div><div style="text-align: left;"><br />
</div><div style="text-align: left;"> In fact, anyone questioning the process or this settlement approval push is ostracized from not only the entire process, but from all pertinent information & inquiry <i>(including receiving mailings and letters that were supposedly sent out to all represented clients!!)</i>. </div><div style="text-align: left;"><br />
</div><div style="text-align: left;">Considering The Miller Firms track record and history of supplying <strike>misleading/misinformation/bullshit</strike> <i>(lies)</i> throughout this whole ordeal; <i><span style="font-size: large;"><b>I & others are calling for the court and federal authorities to investigation the practices and actions that have been used and employed by The Miller Firm and related co-counsel throughout this litigation</b></span></i>. Something smells completely rotten here; injured clients & the public have a right to know what's really going on!</div>Seroquelhttp://www.blogger.com/profile/12012400050067849012noreply@blogger.com0tag:blogger.com,1999:blog-8681939617966339411.post-9133299706668274112012-03-12T10:55:00.003-07:002012-03-12T12:23:03.818-07:00AstraZeneca Seroquel Litigation Update - The Miller Firm LLC, Ennis and Ennis, P.A., & Saiontz & Kirk, P.A. "You Had a Lawyer" - Legalized Snake Oil Salesman - The selling of a bad settlement for profit<div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgdKBXs9OKhykbCc89ylHhsYK3Q2_uNCqEDMp-myOk1dsGeHvis6qDkNm-O0pI3FOHB7VkaUZ7v9ZF2j5dKFBTHnFujrE4hyphenhyphenTXqajoOvz08MWizwQd-l1EaNI1_bAlxOROviN0SX7KT0vSL/s1600/snake-oil-2.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="400" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgdKBXs9OKhykbCc89ylHhsYK3Q2_uNCqEDMp-myOk1dsGeHvis6qDkNm-O0pI3FOHB7VkaUZ7v9ZF2j5dKFBTHnFujrE4hyphenhyphenTXqajoOvz08MWizwQd-l1EaNI1_bAlxOROviN0SX7KT0vSL/s400/snake-oil-2.jpg" width="337" /></a></div><div class="separator" style="clear: both; text-align: center;"><br />
</div><div class="separator" style="clear: both; text-align: center;"> <span style="font-size: medium;"><b>AstraZeneca Seroquel </b></span><span style="font-size: medium;"><b>Litigation Update</b></span><span style="font-size: medium;"><b> - The Miller Firm LLC, Ennis and Ennis, P.A., & Saiontz & Kirk, P.A. "You Had a Lawyer" - Legalized Snake Oil Salesman - The selling of a bad settlement for profit </b></span></div><div class="separator" style="clear: both; text-align: center;"><br />
</div><div class="separator" style="clear: both; text-align: center;"><br />
</div><div class="separator" style="clear: both; text-align: left;"></div><div class="MsoNormal">It’s appears The Miller Firm (including client gathering and case selling non-participant co-counsel <span class="st">Saiontz & Kirk, P.A , </span>Ennis&Ennis, P.A. ) are in a desperate “sell the failed settlement” at all cost mode presently. Just three weeks ago The Miller Firm had stated in their update phone recording that they only had somewhere around 60% of the 93% settlement acceptance needed for the Seroquel settlement to fly. This past week after a concerted “Sell the Settlement” campaign they are now claiming a 78% acceptance figure; while also claiming that they have mailed out a “letter” to all their Seroquel Clients. </div><div class="MsoNormal"><br />
</div><div class="MsoNormal">The Miller Firm seems to say a lot of things…yet how much of it is truth, and how much of it is just meaningless bravado & blatant lies? </div><div class="MsoNormal"><br />
</div><div class="MsoNormal">Let's look at this example from The Miller Firm web site: </div><div class="MsoNormal" style="text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhnSo76XozlYcRPzjId59qJRe_eTR2MUHUTEafRB-AyiujWk7U-UKehhDWoRQ21KUlcYBr0l1ZoK9Yujf8qI_gsAwltvSkKGrWsIU6uDgUSqz29yf_3EuWaooDDBkteOHTUnhA4vy6tJRZQ/s1600/Miller+firm+bullshit.PNG" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="281" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhnSo76XozlYcRPzjId59qJRe_eTR2MUHUTEafRB-AyiujWk7U-UKehhDWoRQ21KUlcYBr0l1ZoK9Yujf8qI_gsAwltvSkKGrWsIU6uDgUSqz29yf_3EuWaooDDBkteOHTUnhA4vy6tJRZQ/s320/Miller+firm+bullshit.PNG" width="320" /></a></div><div class="MsoNormal">I & others can attest that this statement & claim is complete bullshit, & one utter laughable falsehood. </div><div class="MsoNormal"><br />
</div><div class="MsoNormal">I happen to personally stay in contact with some of The Miller Firm clients. One of sources stated The Miller Firm had told them three weeks ago that they were being dropped as a client for not accepting the settlement offer & would receive a letter stating that fact within seven days; <i style="color: #cc0000;"><b>That letter has never arrived!</b></i> This same client also has not received this latest “sell the settlement” propaganda letter The Miller Firm has claimed to have sent out to <i style="color: #cc0000;"><b>“all”</b></i> of their clients. </div><div class="MsoNormal"><br />
</div><div class="MsoNormal">It is truly a nasty & underhanded business for ambulance chaser firms like “Miller” who are attempting to sell a horrible & unfair settlement offer for AstraZeneca & themselves, while throwing actual injured parties under the bus.</div><div class="MsoNormal"><br />
</div><div class="MsoNormal"> In fact, it’s actually quite difficult to differentiate who is worse or more evil in this litigation: AstraZeneca whose product Seroquel has purposely harmed & killed so many to make Money, or the plaintiff law firms that are using their Seroquel clients simply as cash cows to collect large windfall paydays for themselves.</div><div class="MsoNormal"><br />
</div><div class="MsoNormal">There’s only one thing we know for sure & as absolute truth: Seroquel injured parties are not receiving proper representation or anything that can be construed as being within the realm of actual justice. This whole litigation amounts to nothing more than shady backrooms and a very secretive member’s only club of greedy & self serving individuals/law firms that are shaking down those forever injured Seroquel clients for their own personal profit & gain.</div><div class="MsoNormal"><br />
</div><div class="MsoNormal"><b>The numbers don't lie:</b></div><div class="MsoNormal"><br />
</div><div class="MsoNormal">So how does The Miller Firm offer stack up against other settlement offers in this litigation?: SAME COURT, SAME DRUG, SAME INJURIES - </div><div class="MsoNormal"><br />
</div><div style="color: #990000; text-align: center;"><span style="font-size: small;"><b>Weitz & Luxenberg P.C.</b></span></div><div style="color: #990000; text-align: center;"><span style="font-size: small;"><b>92.5 million dollar distribution pot</b></span></div><div style="color: #990000; text-align: center;"><span style="font-size: small;"><b>2351 clients</b></span></div><div style="color: #990000; text-align: center;"><span style="font-size: small;"><b>(before deductions) average claim = 39 thousand & change (an embarrassing pittance)</b></span></div><div style="color: #990000; text-align: center;"><span style="font-size: small;"><b><br />
</b></span> </div><div style="color: #990000; text-align: center;"><span style="font-size: small;"><b>The Miller Firm LLC</b></span></div><div style="color: #990000; text-align: center;"><span style="font-size: small;"><b>6.9 million dollar distribution pot</b></span></div><div style="color: #990000; text-align: center;"><span style="font-size: small;"><b>623 clients</b></span></div><div style="color: #990000; text-align: center;"><span style="font-size: small;"><b>(before deductions) average claim = 11 thousand & change (a complete insult)</b></span><br />
<br />
</div><div style="color: #990000; text-align: center;"></div><div style="color: #990000; text-align: left;"><i>(Please note this settlement is not & has never been about injuries suffered by claimants, or holding AstraZeneca accountable for their despicable actions : it is only about the cost of continuing to litigate claims. The Plaintiff law firms have created out of thin air a false & misleading perception that this settlement offer is about receiving compensation for injuries incurred! IT IS NOT! That is a disingenuous ploy & misrepresentation of reality being used to sell this settlement and for nothing else)</i><span style="font-size: small;"><b> </b></span></div><div style="color: #990000; text-align: center;"><span style="font-size: small;"><b><br />
</b></span></div><div class="MsoNormal"><br />
</div><div class="MsoNormal"><b>Now let us look at the numbers in The Miller Firm settlement offer that they are so desperately selling their clients at present: <i>(ask yourself who is winning and who is losing here?)</i></b></div><div class="MsoNormal"><br />
</div><div class="MsoNormal"><i><b>The Miller Firm Settlement offer for an estimated 623 Seroquel Clients: </b></i></div><div class="MsoNormal"><br />
</div><div class="MsoNormal"><i><b>Total Settlement Offer is roughly<span style="font-size: large;"><span style="color: #38761d;"> </span></span></b><b><span style="font-size: large;"><span style="color: #38761d;">7.4 million dollars <span style="font-size: small;">(including hold back funds)</span></span></span></b></i><span style="font-size: large;"><span style="color: #38761d;">.</span></span> </div><div class="MsoNormal"><br />
</div><div class="MsoNormal"><br />
</div><div class="MsoNormal">The Miller Firm & their Co-counsel are taking 40% plus fees & expenses right off the top: a ballpark figure of a <span style="color: #38761d; font-size: large;"><b>2.7 million dollar pay day</b></span> <i>(not bad for not preparing or having cases ready for trial.....just sitting around in some backroom swinging a sweet deal for themselves)</i></div><div class="MsoNormal"><br />
</div><div class="MsoNormal">Then the Garretson Resolution Group is calculated into the racket for their piece of the action: <i>(they do the paper work, create the "sell the settlement" packets, and barter lean resolution for a nice slice of pie somewhere in the neighborhood of </i><span style="font-size: large;"><b><span style="color: #38761d;">$260,000 dollars</span></b></span></div><div class="MsoNormal"><br />
</div><div class="MsoNormal">Then Uncle Sam steps in & takes their <span style="font-size: large;"><b><span style="color: #38761d;">% cut</span></b></span> for Medicare/Medicaid reimbursement; plus there are other potential private leans or outstanding debts that can be deducted...this amount will vary for each client/state/&situation. </div><div class="MsoNormal"><br />
</div><div class="MsoNormal">Then at the very tail end of the settlement feast; the injured party receives their actual paltry offer; which averages in the neighborhood of <span style="font-size: large;"><b><span style="color: #38761d;">4 to 5 thousand dollars.</span></b></span></div><div class="separator" style="clear: both; text-align: center;"><br />
</div><div class="separator" style="clear: both; text-align: left;">So as you can see: everyone has their hands in the settlement cookie jar, except the actual injured parties. The lawyers get rich and move on to their next drug or device litigation for another backroom golden deal. All the tag a longs like Garretson grab their share. </div><div class="separator" style="clear: both; text-align: left;"><br />
</div><div class="separator" style="clear: both; text-align: left;">And probably the greatest injustice of all is that AstraZeneca clears the slate; paying out virtually nothing to forever cover their criminal actions and the damage Seroquel has directly caused (& will continue to cause) to many thousands of innocent citizens; while AZ has made & will continue making <span style="font-size: large;"><b style="color: #38761d;">untold billions of dollars</b></span> in pure profit.</div><div class="separator" style="clear: both; text-align: left;"><br />
</div><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEid-Haq0emeiAnqBvVZrlGMWBv1gua0h2SpXN-I3IkcGwURk91WqyZgO4LbsSGslTt2jEpvHzmRmUA9XgUeCnkfM-Rx18lMt47DToPJLrwn6fl_hKWTe4VjG5w5G8t7luMtexDCVwbQrCOu/s1600/brennan_buckets.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="232" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEid-Haq0emeiAnqBvVZrlGMWBv1gua0h2SpXN-I3IkcGwURk91WqyZgO4LbsSGslTt2jEpvHzmRmUA9XgUeCnkfM-Rx18lMt47DToPJLrwn6fl_hKWTe4VjG5w5G8t7luMtexDCVwbQrCOu/s320/brennan_buckets.jpg" width="320" /></a></div><div class="separator" style="clear: both; text-align: left;"><br />
</div><div class="separator" style="clear: both; text-align: left;"><br />
</div><div class="separator" style="clear: both; text-align: left;"><br />
</div><div class="separator" style="clear: both; text-align: left;"><br />
</div><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgQ3sKtjBk1uP_NB10GRkAmID0w9LMo772RK0qcr_K9_gwhyphenhyphen7c8ZhrlbkH3sldPouIurUVnBfZFsrCbC6TvCAcclgk96JPlj3AS9FfB6_Oudoe6p3a6TTHyQMJmC_TmVfmof4_gpBfKa_am/s1600/smell+test+chart.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="512" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgQ3sKtjBk1uP_NB10GRkAmID0w9LMo772RK0qcr_K9_gwhyphenhyphen7c8ZhrlbkH3sldPouIurUVnBfZFsrCbC6TvCAcclgk96JPlj3AS9FfB6_Oudoe6p3a6TTHyQMJmC_TmVfmof4_gpBfKa_am/s640/smell+test+chart.jpg" width="640" /></a></div><div class="separator" style="clear: both; text-align: left;"><br />
</div><div class="separator" style="clear: both; text-align: center;"><br />
</div><div class="separator" style="clear: both; text-align: center;"><br />
</div><div class="separator" style="clear: both; text-align: center;"><br />
</div><div class="separator" style="clear: both; text-align: center;"><br />
</div><div class="separator" style="clear: both; text-align: center;"><br />
</div><div class="separator" style="clear: both; text-align: center;"><br />
</div><div class="separator" style="clear: both; text-align: center;"><br />
</div><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhnSo76XozlYcRPzjId59qJRe_eTR2MUHUTEafRB-AyiujWk7U-UKehhDWoRQ21KUlcYBr0l1ZoK9Yujf8qI_gsAwltvSkKGrWsIU6uDgUSqz29yf_3EuWaooDDBkteOHTUnhA4vy6tJRZQ/s1600/Miller+firm+bullshit.PNG" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><br />
</a></div><span style="font-size: medium;"><b><br />
</b></span>Seroquelhttp://www.blogger.com/profile/12012400050067849012noreply@blogger.com0tag:blogger.com,1999:blog-8681939617966339411.post-89646197331491630022012-03-09T08:09:00.000-08:002012-03-09T08:09:14.195-08:00FDA acts with reckless abandon denying AstraZeneca's Citizen Petition regarding generic Seroquel labeling<h1 style="background-color: white; border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #4b306a; font-family: Arial, Helvetica, sans-serif; font-size: 2.6em; margin-bottom: 30px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; vertical-align: baseline;">FDA responds to AstraZeneca Citizen Petitions on quetiapine product labelling</h1><div style="background-color: white; border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: Arial, Helvetica, sans-serif; font-size: 12px; line-height: 1.6em; margin-bottom: 18px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; vertical-align: baseline;">Friday, 9 March 2012</div><div class="rte-content" style="background-color: white; border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; vertical-align: baseline;"><div style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: Arial, Helvetica, sans-serif; font-size: 12px; line-height: 1.6em; margin-bottom: 18px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; vertical-align: baseline;"><b>AstraZeneca </b>today announced that on 7 March 2012, the FDA denied Citizen Petitions requesting that the FDA withhold finally approving any generic quetiapine product with labelling that omits certain hyperglycaemia warning language that the FDA required AstraZeneca to include in the labelling for SEROQUEL® (quetiapine fumarate) and SEROQUEL XR® (quetiapine fumarate).</div><div style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: Arial, Helvetica, sans-serif; font-size: 12px; line-height: 1.6em; margin-bottom: 18px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; vertical-align: baseline;"><a href="http://www.astrazeneca.com/Media/Press-releases/Article/FDA-responds-AstraZeneca-Citizen-Petitions-quetiapine-product-labelling"><span style="color: blue;">AstraZeneca is evaluating the FDA’s decision and reasoning</span></a>.</div><div style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: Arial, Helvetica, sans-serif; font-size: 12px; line-height: 1.6em; margin-bottom: 18px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; vertical-align: baseline;"><br />
</div><div style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: Arial, Helvetica, sans-serif; line-height: 1.6em; margin-bottom: 18px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; vertical-align: baseline;"><i>The U.S. FDA acts with reckless endangerment when it omits ANY drug side effect warnings from the label of the antipsychotic Seroquel (quetiapine). The antipsychotic is being prescribed for off-label use for insomnia, anxiety, for PTSD, to war veterans, to children--and the FDA which could act as a gatekeeper for drug safety---continues to promote the use of this dangerous product by actions like this. The fact that the drug made its way to the market place with a background of buried data and internal documents that show AstraZeneca's intent to market the drug anyway should be enough to pull this drug from sales. Instead it receives numerous and seemingly endless indications and now is on its way to generic version. The off-label prescribing will only increase with that version available! </i></div><div style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; margin-bottom: 18px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; vertical-align: baseline;"><i><span style="font-family: Arial, Helvetica, sans-serif;"><span style="line-height: 1.6em;">AstraZeneca's Citizen Petition appears to be one of serving the public, but make no mistake that was a move to keep this drug non-generic as long as possible for $$$ The major drug company with over 26,000 lawsuits for diabetes (which still is being ironed out, as the plaintiffs have not received settlements yet) suddenly wants to display all </span><span style="line-height: 25px;">hyperglycemia related</span><span style="line-height: 1.6em;"> labeling on generics? </span></span></i></div><div style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: Arial, Helvetica, sans-serif; line-height: 1.6em; margin-bottom: 18px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; vertical-align: baseline;"><span style="line-height: 1.6em;"><i><span style="font-size: x-large;">Why didn't AstraZeneca display that on the product label from the beginning? </span>The company buried Study 15, skewed data and KNEW the drug could cause weight gain and diabetes! NOW they want to be treated equally? If the generic drug doesn't have all the warning labels we were required to have then let's complain to the FDA? I smell $$$$$$$! </i></span></div><div style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: Arial, Helvetica, sans-serif; line-height: 1.6em; margin-bottom: 18px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; vertical-align: baseline;"><span style="line-height: 1.6em;"><i><br />
</i></span></div><div style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: Arial, Helvetica, sans-serif; line-height: 1.6em; margin-bottom: 18px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; vertical-align: baseline;">This news on the heels of a commentary published in the<a href="http://anp.sagepub.com/content/46/3/279.2.full"> <span style="color: magenta;">Australian & New Zealand Journal of Psychiatry</span></a></div><div style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: Arial, Helvetica, sans-serif; line-height: 1.6em; margin-bottom: 18px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; vertical-align: baseline;"><br />
</div><div style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: Arial, Helvetica, sans-serif; font-size: 12px; line-height: 1.6em; margin-bottom: 18px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; vertical-align: baseline;"></div><h1 id="article-title-1" style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #403838; font-size: 1.8em; line-height: inherit; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 10px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: left; vertical-align: baseline;">Quetiapine-related harms are on the rise</h1><div class="contributors intlv" style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #403838; font-size: 13px; line-height: 16px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: left; vertical-align: baseline;"><ol class="contributor-list" id="contrib-group-1" style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-size: inherit; font-style: inherit; font-weight: bold; line-height: inherit; list-style-image: initial; list-style-position: initial; list-style-type: none; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 15px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; vertical-align: baseline;"><li class="contributor" id="contrib-1" style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; display: block; font-size: inherit; font-style: inherit; font-weight: inherit; line-height: 1.7; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: left; vertical-align: baseline;"><span class="name" style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-size: inherit; font-style: inherit; font-weight: inherit; line-height: inherit; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: inherit; vertical-align: baseline;"><a class="name-search" href="http://anp.sagepub.com/search?author1=Cherie+E+Heilbronn&sortspec=date&submit=Submit" style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #333333; font-size: inherit; font-style: inherit; line-height: inherit; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: inherit; text-decoration: none; vertical-align: 0px; white-space: nowrap;">Cherie E Heilbronn</a></span><a class="xref-aff" href="http://anp.sagepub.com/content/46/3/279.2.full#aff-1" id="xref-aff-1-1" style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #305484; font-size: inherit; font-style: inherit; font-weight: normal; line-height: inherit; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: inherit; vertical-align: 0px;">1</a></li>
<li class="contributor" id="contrib-2" style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; display: block; font-size: inherit; font-style: inherit; font-weight: inherit; line-height: 1.7; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: left; vertical-align: baseline;"><span class="name" style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-size: inherit; font-style: inherit; font-weight: inherit; line-height: inherit; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: inherit; vertical-align: baseline;"><a class="name-search" href="http://anp.sagepub.com/search?author1=Belinda+Lloyd&sortspec=date&submit=Submit" style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #333333; font-size: inherit; font-style: inherit; line-height: inherit; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: inherit; text-decoration: none; vertical-align: 0px; white-space: nowrap;">Belinda Lloyd</a></span><a class="xref-aff" href="http://anp.sagepub.com/content/46/3/279.2.full#aff-1" id="xref-aff-1-2" style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #305484; font-size: inherit; font-style: inherit; font-weight: normal; line-height: inherit; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: inherit; vertical-align: 0px;">1</a></li>
<li class="contributor" id="contrib-3" style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; display: block; font-size: inherit; font-style: inherit; font-weight: inherit; line-height: 1.7; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: left; vertical-align: baseline;"><span class="name" style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-size: inherit; font-style: inherit; font-weight: inherit; line-height: inherit; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: inherit; vertical-align: baseline;"><a class="name-search" href="http://anp.sagepub.com/search?author1=Paul+McElwee&sortspec=date&submit=Submit" style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #333333; font-size: inherit; font-style: inherit; line-height: inherit; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: inherit; text-decoration: none; vertical-align: 0px; white-space: nowrap;">Paul McElwee</a></span><a class="xref-aff" href="http://anp.sagepub.com/content/46/3/279.2.full#aff-1" id="xref-aff-1-3" style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #305484; font-size: inherit; font-style: inherit; font-weight: normal; line-height: inherit; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: inherit; vertical-align: 0px;">1</a></li>
<li class="contributor" id="contrib-4" style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; display: block; font-size: inherit; font-style: inherit; font-weight: inherit; line-height: 1.7; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: left; vertical-align: baseline;"><span class="name" style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-size: inherit; font-style: inherit; font-weight: inherit; line-height: inherit; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: inherit; vertical-align: baseline;"><a class="name-search" href="http://anp.sagepub.com/search?author1=Alan+Eade&sortspec=date&submit=Submit" style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #333333; font-size: inherit; font-style: inherit; line-height: inherit; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: inherit; text-decoration: none; vertical-align: 0px; white-space: nowrap;">Alan Eade</a></span><a class="xref-aff" href="http://anp.sagepub.com/content/46/3/279.2.full#aff-2" id="xref-aff-2-1" style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #305484; font-size: inherit; font-style: inherit; font-weight: normal; line-height: inherit; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: inherit; vertical-align: 0px;">2</a></li>
<li class="last" id="contrib-5" style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; display: block; font-size: inherit; font-style: inherit; font-weight: inherit; line-height: 1.7; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: left; vertical-align: baseline;"><span class="name" style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-size: inherit; font-style: inherit; font-weight: inherit; line-height: inherit; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: inherit; vertical-align: baseline;"><a class="name-search" href="http://anp.sagepub.com/search?author1=Dan+I+Lubman&sortspec=date&submit=Submit" style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #333333; font-size: inherit; font-style: inherit; line-height: inherit; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: inherit; text-decoration: none; vertical-align: 0px; white-space: nowrap;">Dan I Lubman</a></span><a class="xref-aff" href="http://anp.sagepub.com/content/46/3/279.2.full#aff-1" id="xref-aff-1-4" style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #305484; font-size: inherit; font-style: inherit; font-weight: normal; line-height: inherit; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: inherit; vertical-align: 0px;">1</a></li>
</ol><ol class="affiliation-list" style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-size: inherit; font-style: inherit; line-height: inherit; list-style-image: initial; list-style-position: initial; list-style-type: none; margin-bottom: 1em; margin-left: 5%; margin-right: 5%; margin-top: 1em; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: inherit; vertical-align: baseline;"><li class="aff" style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-size: inherit; font-style: inherit; line-height: inherit; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; vertical-align: baseline;"><a href="http://www.blogger.com/post-create.g?blogID=8681939617966339411" id="aff-1" name="aff-1" style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #7e0203; font-size: inherit; font-style: inherit; line-height: inherit; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: inherit; vertical-align: 0px;"></a><address style="border-bottom-width: 0px; border-color: initial; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-style: initial; border-top-width: 0px; display: inline; font-size: inherit; font-style: normal; line-height: inherit; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: inherit; vertical-align: baseline;"><sup style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-size: 0.85em; font-style: inherit; line-height: 0; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: inherit;">1</sup>Turning Point Alcohol and Drug Centre, Eastern Health and Monash University, Victoria, Australia</address></li>
<li class="aff" style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-size: inherit; font-style: inherit; line-height: inherit; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; vertical-align: baseline;"><a href="http://www.blogger.com/post-create.g?blogID=8681939617966339411" id="aff-2" name="aff-2" style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #7e0203; font-size: inherit; font-style: inherit; line-height: inherit; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: inherit; vertical-align: 0px;"></a><address style="border-bottom-width: 0px; border-color: initial; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-style: initial; border-top-width: 0px; display: inline; font-size: inherit; font-style: normal; line-height: inherit; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: inherit; vertical-align: baseline;"><sup style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-size: 0.85em; font-style: inherit; line-height: 0; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: inherit;">2</sup>Ambulance Victoria, Victoria, Australia</address></li>
</ol><ol class="corresp-list" style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-size: inherit; font-style: inherit; line-height: inherit; list-style-image: initial; list-style-position: initial; list-style-type: none; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: inherit; vertical-align: baseline;"><li class="corresp" id="corresp-1" style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-size: inherit; font-style: inherit; line-height: inherit; list-style-image: initial; list-style-position: initial; list-style-type: none; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; vertical-align: baseline;">Belinda Lloyd, Turning Point Alcohol and Drug Centre, 54−62 Gertrude Street, Fitzroy, VIC 3065, Australia. Email: <a href="mailto:belindal@turningpoint.org.au" style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #305484; font-size: inherit; font-style: inherit; line-height: inherit; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: inherit; vertical-align: 0em;">belindal@turningpoint.org.au</a></li>
</ol></div><div id="p-1" style="border-bottom-width: 0px; border-color: initial; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-style: initial; border-top-width: 0px; color: #403838; font-size: 13px; line-height: 1.5; margin-bottom: 5px; margin-top: 5px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: justify; vertical-align: baseline;">To the Editor</div><div id="p-2" style="border-bottom-width: 0px; border-color: initial; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-style: initial; border-top-width: 0px; color: #403838; font-size: 13px; line-height: 1.5; margin-bottom: 5px; margin-top: 5px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: justify; vertical-align: baseline;">In the December 2010 issue, <a class="xref-bibr" href="http://anp.sagepub.com/content/46/3/279.2.full#ref-2" id="xref-ref-2-1" style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #305484; font-size: inherit; font-style: inherit; line-height: inherit; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: inherit; vertical-align: baseline;">Hollingworth <em style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-size: inherit; line-height: inherit; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: inherit; vertical-align: baseline;">et al</em>. (2010)</a> detailed increased prescribing of atypical antipsychotic medications in Australia between 2002 and 2007. While olanzapine and risperidone remain the most commonly prescribed atypical antipsychotics, quetiapine prescribing is increasing, with PBS prescriptions rising by 27% between 2008/09 (431,096) and 2009/10 (545,410) (<a class="xref-bibr" href="http://anp.sagepub.com/content/46/3/279.2.full#ref-1" id="xref-ref-1-1" style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #305484; font-size: inherit; font-style: inherit; line-height: inherit; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: inherit; vertical-align: baseline;">Department of Health and Ageing, 2010</a>). Reasons for the growing use (including off-label prescribing) relate to its sedative properties and favourable extrapyramidal and metabolic profile, as well as emerging evidence of positive outcomes at low doses for a range of mental disorders (<a class="xref-bibr" href="http://anp.sagepub.com/content/46/3/279.2.full#ref-2" id="xref-ref-2-2" style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #305484; font-size: inherit; font-style: inherit; line-height: inherit; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: inherit; vertical-align: baseline;">Hollingworth et al., 2010</a>).</div><div id="p-3" style="border-bottom-width: 0px; border-color: initial; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-style: initial; border-top-width: 0px; color: #403838; font-size: 13px; line-height: 1.5; margin-bottom: 5px; margin-top: 5px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: justify; vertical-align: baseline;">While the toxicity profile of atypical antipsychotics is considered preferable to typical agents, particularly regarding overdose risk, recent literature has called the relative safety of quetiapine into question. In one study, quetiapine-related overdoses were more likely to result in hypotension, respiratory depression, coma, or death than all the other antipsychotics combined (<a class="xref-bibr" href="http://anp.sagepub.com/content/46/3/279.2.full#ref-4" id="xref-ref-4-1" style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #305484; font-size: inherit; font-style: inherit; line-height: inherit; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: inherit; vertical-align: baseline;">Ngo et al., 2008</a>). This is particularly concerning given the growing number of case reports citing quetiapine as a potential substance of misuse, a phenomenon unseen with other atypical antipsychotic preparations (<a class="xref-bibr" href="http://anp.sagepub.com/content/46/3/279.2.full#ref-5" id="xref-ref-5-1" style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #305484; font-size: inherit; font-style: inherit; line-height: inherit; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: inherit; vertical-align: baseline;">Sansone and Sansone, 2010</a>).</div><div id="p-4" style="border-bottom-width: 0px; border-color: initial; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-style: initial; border-top-width: 0px; color: #403838; font-size: 13px; line-height: 1.5; margin-bottom: 5px; margin-top: 5px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: justify; vertical-align: baseline;">A recent study (<a class="xref-bibr" href="http://anp.sagepub.com/content/46/3/279.2.full#ref-3" id="xref-ref-3-1" style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #305484; font-size: inherit; font-style: inherit; line-height: inherit; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: inherit; vertical-align: baseline;">Lloyd and McElwee, 2011</a>) identified a non-significant increase in antipsychotic-related ambulance attendances over 2000−2009 in metropolitan Melbourne. While demographic characteristics remained relatively consistent over the period, there was a significant increase in antipsychotic-related attendances where other drugs (both licit and illicit) were also implicated in presentations. However, differential harms across different antipsychotic preparations have not been adequately explored at a community level.</div><div id="p-5" style="border-bottom-width: 0px; border-color: initial; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-style: initial; border-top-width: 0px; color: #403838; font-size: 13px; line-height: 1.5; margin-bottom: 5px; margin-top: 5px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: justify; vertical-align: baseline;">To further our understanding of this emerging issue, we analysed ambulance attendance data from metropolitan Melbourne across different antipsychotic preparations to provide a preliminary quantification of quetiapine-related harms. Data were derived from the Ambo Project database (<a class="xref-bibr" href="http://anp.sagepub.com/content/46/3/279.2.full#ref-3" id="xref-ref-3-2" style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #305484; font-size: inherit; font-style: inherit; line-height: inherit; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: inherit; vertical-align: baseline;">Lloyd and McElwee, 2011</a>), utilizing data from patient care records completed by paramedics, with additional coding undertaken to identify involvement of alcohol or other drugs in ambulance presentations. While there was a small increase in antipsychotic-related ambulance attendances between 2000/01 and 2009/10 (from 783 to 1074 attendances), quetiapine-related attendances increased substantially over the same period (from 32 in 2000/01 to 598 in 2009/10). Similar increases were not found for other antipsychotic preparations.</div><div id="p-6" style="border-bottom-width: 0px; border-color: initial; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-style: initial; border-top-width: 0px; color: #403838; font-size: 13px; line-height: 1.5; margin-bottom: 5px; margin-top: 5px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: justify; vertical-align: baseline;">Anecdotal reports from Victorian alcohol and drug agencies participating in the Earlier Identification of Drug Harms Project (unpublished data) indicate that quetiapine demand, use, diversion, misuse, and harms are ongoing issues, particularly for clients with a history of illicit drug use. Over the course of this project involving bi-monthly data collection, quetiapine was the only antipsychotic consistently reported as being used in a problematic manner, regardless of source of supply.</div><div id="p-7" style="border-bottom-width: 0px; border-color: initial; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-style: initial; border-top-width: 0px; color: #403838; font-size: 13px; line-height: 1.5; margin-bottom: 5px; margin-top: 5px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: justify; vertical-align: baseline;">Such an increase in acute quetiapine-related harm represents a growing public health issue. Further exploration is required to identify the nature and magnitude of quetiapine-related harms, population groups at increased risk of harm, prescribing trends, and strategies to ensure benefits of quetiapine are balanced against potential risks to patients, and costs to the community. In the meantime, it is important that clinicians are aware of growing misuse and diversion of quetiapine, and adopt prescribing practices that minimize the risk of harms.</div><div class="section" id="sec-1" style="border-bottom-width: 0px; border-color: initial; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-style: initial; border-top-width: 0px; clear: both; color: #403838; font-size: 13px; line-height: 16px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: justify; vertical-align: baseline;"><div class="section-nav" style="background-color: white; border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; float: right; font-size: inherit; font-style: inherit; line-height: inherit; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 1em; padding-right: 0.5em; padding-top: 0px; text-align: inherit; vertical-align: baseline;"><div class="nav-placeholder" style="background-position: 0% 0%; background-repeat: no-repeat no-repeat; border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #aa0000; font-size: inherit; font-style: inherit; height: 15px; line-height: inherit; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: inherit; vertical-align: baseline; width: 9px;"></div><a class="next-section-link" href="http://anp.sagepub.com/content/46/3/279.2.full#ack-1" style="background-image: url(http://anp.sagepub.com/shared/img/content/down.gif); background-position: 0% 0%; background-repeat: no-repeat no-repeat; border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #305484; display: block; font-size: inherit; font-style: inherit; height: 15px; line-height: inherit; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: inherit; vertical-align: baseline; width: 9px;" title="Acknowledgments"><span style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-size: inherit; font-style: inherit; left: -9999px; line-height: inherit; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; position: absolute; text-align: inherit; vertical-align: baseline;">Next Section</span></a></div><h2 style="border-bottom-color: rgb(153, 153, 153); border-bottom-style: dotted; border-bottom-width: 2px; border-color: initial; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-style: initial; border-top-width: 0px; font-size: 16px; font-style: inherit; line-height: inherit; margin-bottom: 10px; margin-left: 0px; margin-right: 0px; margin-top: 10px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: left; vertical-align: baseline;">Funding</h2><div id="p-9" style="border-bottom-width: 0px; border-color: initial; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-style: initial; border-top-width: 0px; font-size: inherit; font-style: inherit; line-height: 1.5; margin-bottom: 5px; margin-top: 5px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: inherit; vertical-align: baseline;">This project is a collaborative project between Turning Point Alcohol and Drug Centre and Ambulance Victoria, and is funded by the Victorian Department of Health.</div></div><div class="section ack" id="ack-1" style="border-bottom-width: 0px; border-color: initial; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-style: initial; border-top-width: 0px; clear: both; color: #403838; font-size: 13px; line-height: 16px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: justify; vertical-align: baseline;"><div class="section-nav" style="background-color: white; border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; float: right; font-size: inherit; font-style: inherit; line-height: inherit; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 1em; padding-right: 0.5em; padding-top: 0px; text-align: inherit; vertical-align: baseline;"><a class="prev-section-link" href="http://anp.sagepub.com/content/46/3/279.2.full#sec-1" style="background-image: url(http://anp.sagepub.com/shared/img/content/up.gif); background-position: 0% 0%; background-repeat: no-repeat no-repeat; border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #305484; display: block; font-size: inherit; font-style: inherit; height: 15px; line-height: inherit; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: inherit; vertical-align: baseline; width: 9px;" title="Funding"><span style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-size: inherit; font-style: inherit; left: -9999px; line-height: inherit; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; position: absolute; text-align: inherit; vertical-align: baseline;">Previous Section</span></a><a class="next-section-link" href="http://anp.sagepub.com/content/46/3/279.2.full#ref-list-1" style="background-image: url(http://anp.sagepub.com/shared/img/content/down.gif); background-position: 0% 0%; background-repeat: no-repeat no-repeat; border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #305484; display: block; font-size: inherit; font-style: inherit; height: 15px; line-height: inherit; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: inherit; vertical-align: baseline; width: 9px;" title="References"><span style="border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-size: inherit; font-style: inherit; left: -9999px; line-height: inherit; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; position: absolute; text-align: inherit; vertical-align: baseline;">Next Section</span></a></div><h2 style="border-bottom-color: rgb(153, 153, 153); border-bottom-style: dotted; border-bottom-width: 2px; border-color: initial; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-style: initial; border-top-width: 0px; font-size: 16px; font-style: inherit; line-height: inherit; margin-bottom: 10px; margin-left: 0px; margin-right: 0px; margin-top: 10px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: left; vertical-align: baseline;">Acknowledgments</h2><div id="p-8" style="border-bottom-width: 0px; border-color: initial; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-style: initial; border-top-width: 0px; font-size: inherit; font-style: inherit; line-height: 1.5; margin-bottom: 5px; margin-top: 5px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: inherit; vertical-align: baseline;">The authors would like to acknowledge and kindly thank Ambulance Victoria and its paramedics for their entry of data used in this study and Annie Haines for coding cases.</div><div id="p-8" style="border-bottom-width: 0px; border-color: initial; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-style: initial; border-top-width: 0px; font-size: inherit; font-style: inherit; line-height: 1.5; margin-bottom: 5px; margin-top: 5px; outline-style: none; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: inherit; vertical-align: baseline;"><br />
<br />
</div></div></div>Seroquelhttp://www.blogger.com/profile/12012400050067849012noreply@blogger.com0tag:blogger.com,1999:blog-8681939617966339411.post-80187081023700854922012-02-25T12:30:00.011-08:002012-02-25T15:25:38.503-08:00AstraZeneca Seroquel - The Miller Firm LLC, Ennis and Ennis, P.A., Saiontz & Kirk, P.A."You Had a Lawyer" - blowing more ambulance chaser smoke without much substance - "selling a bad settlement for profit"<div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjeqVIzalEjnZY9hGBcDH_fCCPtkb_ylXQXAuZQrQCHKcBaCN0lDyqtTIjYarMIW-I3rrzLgjio7M1uCv_bUUO-dvM5564DXcPTelUZc5ghkKXli9quacJogJYg8GidT4VJuKwbPR6kypIW/s1600/smoke-gun.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="640" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjeqVIzalEjnZY9hGBcDH_fCCPtkb_ylXQXAuZQrQCHKcBaCN0lDyqtTIjYarMIW-I3rrzLgjio7M1uCv_bUUO-dvM5564DXcPTelUZc5ghkKXli9quacJogJYg8GidT4VJuKwbPR6kypIW/s640/smoke-gun.jpg" width="482" /></a></div><div style="text-align: center;"><span style="font-size: large;"><b>AstraZeneca Seroquel - The Miller Firm LLC, Ennis and Ennis, P.A., & Saiontz & Kirk, P.A."You Had a Lawyer" - blowing more ambulance chaser smoke without much substance - "selling a bad settlement for profit"</b></span></div><br />
I have become aware of this little gem of an interview at <a href="http://bipolarsoupkitchen-stephany.blogspot.com/2012/02/astrazeneca-seroquel-diabetes.html">Soulful Sepulcher Blog</a> this morning that is just begging for a proper response and some thoughtful critical commentary. It appears Ennis & Ennis PA is another Saiontz & Kirk, P.A. that trolls for & gathers up cases, that they then sell off to other firms for a nice tidy profit. So instead attempting to respond in a long winded diatribe in this opening salvo; I will just add my commentary and a response to Mr. Ennis in <span style="color: #cc0000;">RED font <span style="color: black;">after each of Attorney David Ennis answers below. </span></span><br />
<br />
_________________________________________________________________<br />
<h3 class="post-title entry-title"><a href="http://bipolarsoupkitchen-stephany.blogspot.com/2012/02/astrazeneca-seroquel-diabetes.html">The AstraZeneca Seroquel diabetes litigation lawsuit: Interview with Attorney David Ennis</a> </h3><div class="post-header"></div><div class="MsoNormal" style="font-family: Georgia, serif; font-style: normal; font-variant: normal; line-height: 200%; text-align: center;"><span style="font-family: 'Times New Roman',serif; line-height: 200%;"><b>The AstraZeneca Seroquel diabetes litigation lawsuit: Interview with Attorney David Ennis</b><span style="font-weight: normal;"></span></span></div><div class="MsoNormal" style="font-family: Georgia, serif; font-size: 100%; font-style: normal; font-variant: normal; line-height: 200%;"><span style="font-family: 'Times New Roman',serif; font-size: 12pt; font-weight: normal; line-height: 200%;">An interview with Attorney David Ennis from the law firm </span><a href="http://ennislaw.com/" style="font-weight: normal;"><b>http://ennislaw.com/</b></a><span style="font-family: 'Times New Roman',serif; font-size: 12pt; line-height: 200%;"> <span style="background-color: white;"><b>Ennis & Ennis</b>, P.A. a “plaintiff's national personal injury law firm concentrating on representing individuals who have been injured due to medication side effects, defective medical devices and defective products.</span>”</span></div><div class="MsoNormal" style="font-family: Georgia, serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%; text-align: center;"><span style="background-color: white; font-family: 'Times New Roman',serif; font-size: 12pt; line-height: 200%;">For the purpose of this interview I emailed Mr. Ennis questions, and I have copied them directly into this post. <i>My questions are italicized.</i></span><span style="font-family: "Times New Roman","serif"; font-size: 12pt; line-height: 200%;"></span></div><div class="MsoNormal" style="font-family: Georgia, serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><span style="background-color: white; font-family: 'Times New Roman',serif; font-size: 12pt; line-height: 200%;">Hi David, thanks for agreeing to answer some questions regarding the AstraZeneca Seroquel litigation. In the last several months news reports have announced a settlement in the Seroquel diabetes lawsuits. Plaintiffs were mailed information packets that they were to sign and mail back within a set time bracket. <i style="font-weight: normal;">The Seroquel Lawsuit blog </i><b> </b></span><a href="http://seroquellawsuitblog.blogspot.com/"><b>http://seroquellawsuitblog.blogspot.com/</b></a> <span style="background-color: white; font-family: 'Times New Roman',serif; font-size: 12pt; font-weight: normal; line-height: 200%;">has reported that the Miller Firm has not met the required percentage for the settlement offer, based on the numbers required by AstraZeneca. (This was stated on the Miller Firm’s recent information recorded update)With less than the 93% of the plaintiffs packets returned, this leaves many questions as to the future outcome of these cases.</span></div><div class="MsoNormal" style="font-family: Georgia,serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><br />
</div><div class="MsoNormal" style="font-family: Georgia, serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><i><span style="background-color: white; font-family: 'Times New Roman',serif; font-size: 12pt; line-height: 200%;"><b>1.Due to the deadline passing for the clients to return their settlement offer packets what are you and other law firms doing to move the lawsuit toward final settlement</b></span></i><span style="background-color: white; font-family: 'Times New Roman',serif; font-size: 12pt; line-height: 200%;"><b>?</b></span></div><div class="MsoNormal" style="font-family: Georgia,serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><br />
</div><div class="MsoNormal" style="font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"></div><div class="MsoNormal" style="background: none repeat scroll 0% 0% rgb(255, 255, 255); color: #0b5394; line-height: 19.5pt; margin-bottom: 0.0001pt;"><span style="font-family: 'Times New Roman',serif; font-size: 12pt;">Ennis: I cannot speak for other law firms. Ennis&Ennis is assisting the Miller Firm in trying to locate clients we represent together who have moved from their last known address.</span></div><div class="MsoNormal" style="background: none repeat scroll 0% 0% rgb(255, 255, 255); color: #0b5394; line-height: 19.5pt; margin-bottom: 0.0001pt;"><br />
</div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; line-height: 19.5pt; margin-bottom: 0.0001pt;"><span style="font-family: 'Times New Roman',serif; font-size: 12pt;"><span style="color: red;"><i>Commentary: I find it quite interesting, as well as more than a tad bit disturbing that now at this late juncture & over a year since The Miller Firm announced they had reached a settlement offer, (Dec. 2010). that both The Miller Firm and Ennis & Ennis PA are having such trouble tracking down these mysteriously missing clients only when it has become clear that the the settlement has not come anywhere close to meeting the 93% acceptance criteria agreed upon in the contractual stipulations of the AstraZeneca written settlement offer. </i></span></span><br />
<br />
<span style="font-family: 'Times New Roman',serif; font-size: 12pt;"><span style="color: red;"><i>In fact, it seems somewhat ludicrous that only now when this settlement is on the rocks, that these non-participating co-counsel case gathers and sellers are making any kind of effort to contact clients. Where were those efforts for the past few years? In Fact, if you had made any kind of genuine effort to keep in contact with your clients or to keep them regularly informed, there would be no need for this last minute & far to late desperate missing client search happening only when it appears your ambulance chaser "Pay Day" is going down in flames.</i></span> </span></div><div class="MsoNormal" style="font-family: Georgia, serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><span style="background-color: white; font-family: 'Times New Roman',serif; font-size: 12pt; line-height: 200%;"><b><br />
</b></span></div><div class="MsoNormal" style="font-family: Georgia, serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><i><span style="background-color: white; font-family: 'Times New Roman',serif; font-size: 12pt; line-height: 200%;"><b>2.Will AstraZeneca continue to negotiate and receive late packet agreements from clients who missed the deadline? Has the deadline been extended?</b></span></i></div><div class="MsoNormal" style="font-family: Georgia,serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><br />
</div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; color: #3d85c6; line-height: 19.5pt; margin-bottom: 0.0001pt;"><span style="font-family: 'Times New Roman',serif; font-size: 12pt;">Ennis: We are working with AZ to meet the terms of the settlement agreement.</span></div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; line-height: 19.5pt; margin-bottom: 0.0001pt;"><br />
</div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; line-height: 19.5pt; margin-bottom: 0.0001pt;"><span style="font-family: 'Times New Roman',serif; font-size: 12pt;"><span style="color: red;">Commentary: A lawyer speak answer for "This settlement is dead" and we have no intention of renegotiation or going to trial on our clients behalf. We are just desperately hoping AstraZeneca throws us a bone; since we have worked so hard selling this horribly unfair & insulting settlement for them & just maybe we can salvage our glorious pay day. </span></span><br />
<span style="font-family: 'Times New Roman',serif; font-size: 12pt;"><span style="color: red;"> </span> </span></div><div class="MsoNormal" style="font-family: Georgia, serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><i><span style="background-color: white; font-family: 'Times New Roman',serif; font-size: 12pt; line-height: 200%;"><b>3.How many clients did you represent in the litigation, and how many returned and accepted the settlement offer?</b></span></i></div><div class="MsoNormal" style="background: white; line-height: 19.5pt; margin-bottom: .0001pt; margin-bottom: 0in;"><span style="font-family: 'Times New Roman',serif; font-size: 12pt;"><span style="color: #3d85c6;">Ennis: Ennis&Ennis represents 187 clients. 122 have signed and accepted the terms. 5 others are sending in their packets. Very few have opted out. We located 5 more this week who are signing and sending their packets back to our office.</span> </span></div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; line-height: 19.5pt; margin-bottom: 0.0001pt;"><br />
</div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; line-height: 19.5pt; margin-bottom: 0.0001pt;"><span style="font-family: 'Times New Roman',serif; font-size: 12pt;"><span style="color: red;">Commentary: So Ennis is saying they have roughly a 65% approval <i>(Miller Firm stated in phone recordings that the over all approval was at around 60%, which makes a very large and astonishing 40% rejection of this settlement offer)</i> especially when it's clear that it takes a 93% approval to make this settlement to fly that by their own admission the plaintiff firms state will not be met. </span></span></div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; line-height: 19.5pt; margin-bottom: 0.0001pt;"><span style="font-family: 'Times New Roman',serif; font-size: 12pt;"><span style="color: red;">I hope everyone takes heed that Ennis will not even mention the numbers of those clients that have "REJECTED" the settlement outright! That is no simple mistake or omission unfortunately; because the Ennis firm has a rough estimate $350,000 pay day at stake...Client's be damned right...this is about seedy law firms selling a bad settlement to get their pay off money and move on to the next tort backroom deal...</span></span></div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; line-height: 19.5pt; margin-bottom: 0.0001pt;"><span style="font-family: 'Times New Roman',serif; font-size: 12pt;"><span style="color: red;"> </span> </span><span style="font-family: 'Times New Roman',serif; font-size: 12pt;"></span></div><div class="MsoNormal" style="font-family: Georgia, serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><i><span style="background-color: white; font-family: 'Times New Roman',serif; font-size: 12pt; line-height: 200%;"><b>4.Did you have clients appeal the settlement offer? Did clients have an opportunity to reject the offer?</b></span></i></div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; color: #3d85c6; line-height: 19.5pt; margin-bottom: 0.0001pt;"><span style="font-family: 'Times New Roman',serif; font-size: 12pt;">Ennis: Clients had an opportunity to reject the settlement offer.</span></div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; color: #3d85c6; line-height: 19.5pt; margin-bottom: 0.0001pt;"><br />
</div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; line-height: 19.5pt; margin-bottom: 0.0001pt;"><span style="font-family: 'Times New Roman',serif; font-size: 12pt;"><span style="color: #cc0000;">Commentary: OH REALLY! So even though the original offer paper work stated that clients would be given an opportunity to reject the settlement; there was never a single box to check or form to sign that would have given a injured party a clear choice to either accept or reject the settlement being offered to them.</span></span><br />
</div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; line-height: 19.5pt; margin-bottom: 0.0001pt;"><span style="font-family: 'Times New Roman',serif; font-size: 12pt;"><span style="color: #cc0000;">Mr. Ennis is being disingenuous at best here..we know that the only way a client could realistically reject this offer was to not sign on to the process, or not to return the original paper work. And now they are trying to sell "The Missing Ghost Client & Packet " theory!!</span></span><br />
</div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; line-height: 19.5pt; margin-bottom: 0.0001pt;"><span style="font-family: 'Times New Roman',serif; font-size: 12pt;"><span style="color: #cc0000;">Next thing we'll see; is Ennis and co-counsel will be actually starting to believe their own nonsensical advertising & corny promotion commercials...maybe they need an intervention & anti-psychotic medication? I'm quite sure their pals at AstraZeneca can help them out in negotiations on that front....</span> </span></div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; line-height: 19.5pt; margin-bottom: 0.0001pt;"><br />
</div><div class="MsoNormal" style="font-family: Georgia, serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><i><span style="background-color: white; font-family: 'Times New Roman',serif; font-size: 12pt; line-height: 200%;"><b><br />
</b></span></i></div><div class="MsoNormal" style="font-family: Georgia, serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><i><span style="background-color: white; font-family: 'Times New Roman',serif; font-size: 12pt; line-height: 200%;"><b>5.Does the lack of percentage of clients returning the packets indicate the client discontent with what was offered to them for a settlement in monetary terms?</b></span></i></div><div class="MsoNormal" style="font-family: Georgia,serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><br />
</div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; line-height: 19.5pt; margin-bottom: 0.0001pt;"><span style="font-family: 'Times New Roman',serif; font-size: 12pt;"><span style="color: #3d85c6;">Ennis: In a settlement neither party is happy with the terms. Every litigation is different. The defendant always feels they should not pay at all and the plaintiff always feel the settlement amount is too little. There is a risk for both sides. The lack of percentage of clients not returning packets has been the result of plaintiffs not being at their last known address</span>. <span style="color: red;"> </span></span></div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; line-height: 19.5pt; margin-bottom: 0.0001pt;"><br />
</div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; line-height: 19.5pt; margin-bottom: 0.0001pt;"><span style="font-family: 'Times New Roman',serif; font-size: 12pt;"><span style="color: red;">Commentary: I really need to get an industrial fan to clear all that smoke being blown here by Ennis: Neither party happy? I'm sure Ennis is fully aware that The Miller Firm (his co-counsel) has presented a settlement offer to their client's that has not only been called "very low considering similar prior settlements with like effect drugs" by many expert observers, but is also a mere faction of what other firms offered their clients with similar injuries in this very same litigation.</span></span></div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; line-height: 19.5pt; margin-bottom: 0.0001pt;"><br />
</div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; line-height: 19.5pt; margin-bottom: 0.0001pt;"><span style="font-family: 'Times New Roman',serif; font-size: 12pt;"><span style="color: red;"> Again, if Ennis or Miller had actually kept in contact & had any reasonable relationships developed with their clients while keeping them informed throughout this process; they would have no problem with this so called missing address and ghost client debacle. These facts clearly lead us to conclude that Ennis & co-counsel Miller could have cared less about injured parties concerns or questions until it was time to sign off on their "The Laws Firms" pay day. </span></span><br />
</div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; line-height: 19.5pt; margin-bottom: 0.0001pt;"><span style="font-family: 'Times New Roman',serif; font-size: 12pt;"><span style="color: red;"> In fact, if these ambulance chasers (being kind) had taken even the most elementary efforts at vetting or investigating the injured parties claims and cases; this would not be a problem...but when you use injured clients simple as cash cows for secret backroom quick pay day settlements...what do you expect to happen...same old song & dance...but your clients & I aren't buying it...either should the public...</span></span><br />
<br />
<span style="font-family: 'Times New Roman',serif; font-size: 12pt;"><span style="color: red;">If you haven't noticed a theme that permeates here, Ennis or co-counsel doesn't talk much about having compassion, empathy, or even attempting to try on those damaged shoes of the client's they are supposed to represent...the problem is that "they" (the lawyers) are focused only on receiving their own bounty money: Yet, truly respected attorney's believe in their clients, believe in the cases they accept, and they are willing to take the calculated risk of making the treasured investment of time, professional expertize, financial commitment, & with zealous ethically grounded steadfastness represent their client in seeking a just and right outcome/resolution/verdict in a court of law before a jury...</span> </span></div><div class="MsoNormal" style="font-family: Georgia, serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><i><span style="background-color: white; font-family: 'Times New Roman',serif; font-size: 12pt; line-height: 200%;"><b><br />
</b></span></i></div><div class="MsoNormal" style="font-family: Georgia, serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><i><span style="background-color: white; font-family: 'Times New Roman',serif; font-size: 12pt; line-height: 200%;"><b>6.How long will you continue to search for clients that may have changed addresses? On that note, weren’t the packets mailed via certified mail for a record of receipt? Therefore could lack of returns represent a client not wanting to participate in the settlement?</b></span></i></div><div class="MsoNormal" style="font-family: Georgia,serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><br />
</div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; color: #3d85c6; line-height: 19.5pt; margin-bottom: 0.0001pt;"><span style="font-family: 'Times New Roman',serif; font-size: 12pt;">Ennis: There is no set time limit. Our office personally called 65 clients this week and unfortunately were only able to locate 6. Many phones are out of service or have been disconnected. The Miller firm has hired outside companies who specialize in this to try to locate these clients.</span></div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; line-height: 19.5pt; margin-bottom: 0.0001pt;"><br />
</div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; line-height: 19.5pt; margin-bottom: 0.0001pt;"><span style="color: red; font-family: 'Times New Roman',serif; font-size: 12pt;">Commentary: No set time limit? I call out BULLSHIT!!! This was certainly not the case when Garretson Resolution Group and The Miller Firm gave injured clients a strict time limit (1 week) to return the offer packets or to appeal the offer ( <a href="http://seroquellawsuitblog.blogspot.com/2011/08/miller-firm-llc-you-have-lawyer-saiontz.html">refer to page 2 & 6 of the Miller/Garretson offer) </a>...So I gather what your saying...the only time rules happen to apply in this litigation are when you (the Lawyers) decide to create them for your own convenience...</span><br />
<br />
<span style="color: red; font-family: 'Times New Roman',serif; font-size: 12pt;">I find it quite insulting that your attempting to make excuses for a clear rejection of this poor & unjust settlement. I think it would have been really nice if The Miller Firm had actually invested a fraction of the time and energy they are putting forth trying to sell this settlement; into actual putting together a single formidable case to go to trial. Yet, we know now, that was never going to be the case. </span></div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; line-height: 19.5pt; margin-bottom: 0.0001pt;"><br />
</div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; line-height: 19.5pt; margin-bottom: 0.0001pt;"><span style="color: red; font-family: 'Times New Roman',serif; font-size: 12pt;">Law Firms like Miller and Ennis let other firms do the hard dirty work of trials and evidence collection; they pass up on that arduous work, and go directly past "GO", while collecting hefty piles of blood soaked client monopoly money. </span></div><div class="MsoNormal" style="font-family: Georgia, serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><i><span style="background-color: white; font-family: 'Times New Roman',serif; font-size: 12pt; line-height: 200%;"><b><br />
</b></span></i></div><div class="MsoNormal" style="font-family: Georgia, serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><i><span style="background-color: white; font-family: 'Times New Roman',serif; font-size: 12pt; line-height: 200%;"><b>7.Some readers, as well as myself have opined that the settlement was “low-ball”, for a life time body damage of diabetes as a result of taking Seroquel. Do you feel the settlement terms were fair to the injured clients? </b></span></i></div><div class="MsoNormal" style="color: #3d85c6; font-family: Georgia,serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><span style="font-family: 'Times New Roman',serif; font-size: 12pt; line-height: 115%;">Ennis: Again if you speak to most Plaintiff lawyers they are never happy with the settlement amount and if you speak to most Defense lawyers they feel they have paid too much. If you assume Seroquel was 100% responsible for someone's diabetes then one can argue no the settlement </span><span style="font-family: 'Times New Roman',serif; font-size: 12pt; line-height: 115%;">amount was low. But the evidence did not support that 100% was related to Seroquel. Both sides had qualified experts, but unfortunately the Florida Judge ruled 4 times against Seroquel plaintiff's and the Delaware judge ruled 3 times against Seroquel plaintiff's. Those 7 plaintiff's received no compensation. The parties were ordered to mediation which is very common and settlement agreements were reached. </span></div><div class="MsoNormal" style="font-family: Georgia,serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><br />
</div><div class="MsoNormal" style="font-family: Georgia,serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><span style="font-family: 'Times New Roman',serif; font-size: 12pt; line-height: 115%;"><span style="color: #cc0000;">Commentary: Is Ennis actually going to sit there playing apologist for AstraZeneca? </span></span><br />
<br />
<span style="font-family: 'Times New Roman',serif; font-size: 12pt; line-height: 115%;"><span style="color: #cc0000;">Evidence! You've got to be F-ing kidding! Quite obviously "the qualified experts" & "evidence" Ennis & co-counsel have not gathered to the point of these bad settlement offers didn't quite cut the mustard..</span></span><br />
<br />
<span style="font-family: 'Times New Roman',serif; font-size: 12pt; line-height: 115%;"><span style="color: #cc0000;">That's when true professionals and ethical counsel take the time to re-evaluate their strategy, come back with more convincing evidence, better & accepted experts, and keep bringing strong cases forward...this whole lose 1 of out of 30,000 or more and just lay down & quit routine being uttered is beyond absurd...it doesn't pass any smell test...and it's morally & ethically reprehensible..</span></span></div><div class="MsoNormal" style="font-family: Georgia,serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"></div><div class="MsoNormal" style="font-family: Georgia,serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><span style="font-family: 'Times New Roman',serif; font-size: 12pt; line-height: 115%;"><span style="color: #cc0000;">Ennis..you did happen to realize going into this litigation that it wasn't going to be easy...AstraZeneca decided to draw the line in the sand, play some serious legal hard ball, & spent upwards of a billion dollars to date in buying the best "experts", "legal counsel", and "who knows what else" on the planet. In fact, this blog is chalked full of convincing evidence & much more has been compiled since this seedy backroom settlement deal has been conspired. </span></span></div><div class="MsoNormal" style="font-family: Georgia,serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><br />
</div><div class="MsoNormal" style="font-family: Georgia,serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><span style="font-family: 'Times New Roman',serif; font-size: 12pt; line-height: 115%;"><span style="color: #cc0000;">No one with an ounce of common sense thought or would have imagined that plaintiff's would win each and every case. But, there are 30,000 plus cases (and more waiting in the wings) that could & should have been considered for and taken to jury presentation. </span></span></div><div class="MsoNormal" style="font-family: Georgia,serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><br />
</div><div class="MsoNormal" style="font-family: Georgia,serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><span style="font-family: 'Times New Roman',serif; font-size: 12pt; line-height: 115%;"><span style="color: #cc0000;">Just because parties are ordered by the court into a mediation process does not means that plaintiff attorney's are supposed to capitulate and accept settlements that add up to nothing more or less than the cost of continuing to litigate..this settlement has never been about injured parties...or the evidence...it's been about clearing the slate and profiteering off of those Ennis (and supposed co-counsel) have taken a solemn oath to serve in the client's best interest. </span></span></div><div class="MsoNormal" style="font-family: Georgia,serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><br />
</div><div class="MsoNormal" style="font-family: Georgia,serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><span style="font-family: 'Times New Roman',serif; font-size: 12pt; line-height: 115%;"><span style="color: #cc0000;">These kinds of glossed over answers and lawyer speak propaganda statements are just smoke blowing sessions that serve to further validate what this blog has been saying for some time now. </span></span></div><div class="MsoNormal" style="font-family: Georgia,serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><br />
</div><div class="MsoNormal" style="font-family: Georgia,serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><span style="font-family: 'Times New Roman',serif; font-size: 12pt; line-height: 115%;"><span style="color: #cc0000;">No one, including their supposed legal counsel has stood up for the injured parties best interest in this litigation. These kinds of poorly negotiated settlements by attorney's that win financially by losing: just continue to highlight the importance of getting cases before a jury of ours peers. Justice is absolutely being grossly subverted or forever corrupted here, and sadly by the very people sworn to serve this time honored promise & principle of our Republic.</span> </span></div><div class="MsoNormal" style="font-family: Georgia,serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><br />
</div><div class="MsoNormal" style="font-family: Georgia,serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><br />
</div><div class="MsoNormal" style="font-family: Georgia, serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><i><span style="background-color: white; font-family: 'Times New Roman',serif; font-size: 12pt; line-height: 200%;"><b><br />
</b></span></i></div><div class="MsoNormal" style="font-family: Georgia, serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><i><span style="background-color: white; font-family: 'Times New Roman',serif; font-size: 12pt; line-height: 200%;"><b>8.Were all of the clients with all law firms involved offered the same amount of monetary settlement? If not, this does not seem fair; can you explain why for example, one law firm can offer a higher amount for settlement than another to their clients?</b></span></i></div><div class="MsoNormal" style="font-family: Georgia,serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><br />
</div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; color: #3d85c6; line-height: 19.5pt; margin-bottom: 0.0001pt;"><span style="font-family: 'Times New Roman',serif; font-size: 12pt;">Ennis: The settlement negotiations are confidential. I am not aware nor would we be privy to what other firms settled their clients claims for. What I can say is that AZ felt they should not have to pay anything since they had won 7 cases and had many more cases dismissed and the plaintiffs were not happy because they felt the compensation was not enough. When both sides are unhappy that is the definition of a settlement. Nobody wins in a settlement. The only time you have a clear cut win or lose is if a jury decides the case. As of the date of the settlement the Judges hearing these cases had dismissed all of the cases before them. </span></div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; line-height: 19.5pt; margin-bottom: 0.0001pt;"><br />
</div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; line-height: 19.5pt; margin-bottom: 0.0001pt;"><span style="font-family: 'Times New Roman',serif; font-size: 12pt;"><span style="color: red;">Commentary: actually not so confidential after all correct! Ennis & Ennis has been to this blog in the past...I find it highly suspect that they would have not read the other settlement packets here...or that they are completely unaware of what other firms settlement offer averages are (<a href="http://seroquellawsuitblog.blogspot.com/2011/09/miller-firm-llc-astrazeneca.html">for your education: Miller Letter and settlement offer differences</a>)...Obviously no one except the lawyers (Ennis, Co-counsel, AstraZeneca) are winning in this settlement...certainly not the injured parties....In fact, how many cases do you think Ennis & co-counsel have actually brought to trial in this litigation...The Answer is ZERO...Of course Miller & Ennis; you can't win at trial, unless you actually take a case to trial...</span> </span></div><div class="MsoNormal" style="font-family: Georgia, serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><i><span style="background-color: white; font-family: 'Times New Roman',serif; font-size: 12pt; line-height: 200%;"><b><br />
</b></span></i></div><div class="MsoNormal" style="font-family: Georgia, serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><i><span style="background-color: white; font-family: 'Times New Roman',serif; font-size: 12pt; line-height: 200%;"><b><br />
</b></span></i></div><div class="MsoNormal" style="font-family: Georgia, serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><i><span style="background-color: white; font-family: 'Times New Roman',serif; font-size: 12pt; line-height: 200%;"><b>9.Do the attorneys representing the Seroquel victims get paid even though the required percentage was not met? If the required percentage of 93% is never met, will the attorneys be paid anything, or will they require payment from their clients?</b></span></i></div><div class="MsoNormal" style="font-family: Georgia,serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><br />
</div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; color: #3d85c6; line-height: 19.5pt; margin-bottom: 0.0001pt;"><span style="font-family: 'Times New Roman',serif; font-size: 12pt;">Ennis: We have not received any attorneys fees or reimbursement for costs. The lawyers do not get paid until the clients get paid. The clients who wish to opt out will not be responsible for attorneys fees or costs unless they agree to the settlement.</span></div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; line-height: 19.5pt; margin-bottom: 0.0001pt;"><br />
</div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; color: red; line-height: 19.5pt; margin-bottom: 0.0001pt;"><span style="font-family: 'Times New Roman',serif; font-size: 12pt;">Commentary: Did Ennis wear his dancing slippers while answering this one....</span></div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; color: red; line-height: 19.5pt; margin-bottom: 0.0001pt;"><span style="font-family: 'Times New Roman',serif; font-size: 12pt;">this is what is most likely going to happen:</span></div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; color: red; line-height: 19.5pt; margin-bottom: 0.0001pt;"><br />
</div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; color: red; line-height: 19.5pt; margin-bottom: 0.0001pt;"><span style="font-family: 'Times New Roman',serif; font-size: 12pt;"></span>The Miller Firm only has four options..<br />
<br />
1. renegotiate the settlement<i> ( they have stated on numerous occasions they will not do this)</i><br />
2. take cases to trial <i>( again, they have stated vehemently on numerous occasions they are not going to take a single case to trial)</i><br />
3. continue to sell the failed settlement as is <i>(this would mean them somehow magically meeting the 93% approval threshold or AstraZeneca simply walks away)</i><br />
4. walk away from the Seroquel litigation <i>( this means they will have no other recourse than drop all of their clients. which means The Millers Firm & co-counsel "other firms that sold their cases to The Miller Firm like Ennis&Ennis; will receive nothing, and will eat the cost invested thus far in this litigation **which appears to have been quite minimal by the way**)</i></div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; color: red; line-height: 19.5pt; margin-bottom: 0.0001pt;"><br />
</div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; line-height: 19.5pt; margin-bottom: 0.0001pt;"><i style="color: red;">Hope that clears some of the smoke being blown here! I certainly hope it's just not me seeing this dead whale being washed up on the beach...</i><span style="font-family: 'Times New Roman',serif; font-size: 12pt;"></span></div><div class="MsoNormal" style="font-family: Georgia, serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><i><span style="background-color: white; font-family: 'Times New Roman',serif; font-size: 12pt; line-height: 200%;"><b><br />
</b></span></i></div><div class="MsoNormal" style="font-family: Georgia, serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><i><span style="background-color: white; font-family: 'Times New Roman',serif; font-size: 12pt; line-height: 200%;"><b><br />
</b></span></i></div><div class="MsoNormal" style="font-family: Georgia, serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><i><span style="background-color: white; font-family: 'Times New Roman',serif; font-size: 12pt; line-height: 200%;"><b>10.I have noticed many of the drug injury law firm websites no longer host information on Seroquel, or Seroquel litigation updates. Was that part of the agreement required of law firms by AstraZeneca? </b></span></i></div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; color: #3d85c6; line-height: 19.5pt; margin-bottom: 0.0001pt;"><span style="font-family: 'Times New Roman',serif; font-size: 12pt;">Ennis: No. </span></div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; line-height: 19.5pt; margin-bottom: 0.0001pt;"><br />
</div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; line-height: 19.5pt; margin-bottom: 0.0001pt;"><span style="color: #cc0000; font-family: 'Times New Roman',serif; font-size: 12pt;">Commentary: out of sight, out of mind......these firms are busy selling other drug & device litigation...they certainly don't want their "Seroquel" dirty laundry being exposed out in public for all to see....that's not good PR for the legal case gathering and sell off business, especially don't want those next sucker potential clients to see how the dirty game is being played....</span><span style="font-family: 'Times New Roman',serif; font-size: 12pt;"></span></div><div class="MsoNormal" style="font-family: Georgia, serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><i><span style="background-color: white; font-family: 'Times New Roman',serif; font-size: 12pt; line-height: 200%;"><b><br />
</b></span></i></div><div class="MsoNormal" style="font-family: Georgia, serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><i><span style="background-color: white; font-family: 'Times New Roman',serif; font-size: 12pt; line-height: 200%;"><b>11.Have attorneys been threatened, or felt intimidated by the AstraZeneca legal teams?</b></span></i></div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; color: #3d85c6; line-height: 19.5pt; margin-bottom: 0.0001pt;"><span style="font-family: 'Times New Roman',serif; font-size: 12pt;">Ennis: No</span></div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; color: #3d85c6; line-height: 19.5pt; margin-bottom: 0.0001pt;"><br />
</div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; line-height: 19.5pt; margin-bottom: 0.0001pt;"><span style="color: #cc0000; font-family: 'Times New Roman',serif; font-size: 12pt;">Commentary: LMAO , How about injured clients being threatened & intimidated by the plaintiff attorney's? Expected answer: No Comment, cat has got their tongue...</span></div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; line-height: 19.5pt; margin-bottom: 0.0001pt;"><br />
</div><div class="MsoNormal" style="font-family: Georgia, serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><i><span style="background-color: white; font-family: 'Times New Roman',serif; font-size: 12pt; line-height: 200%;"><b>12.What happens next with your and Miller Firm clients? (How are you associated with the Miller Firm, if at all?)Will any law firms be taking individual cases to court after the time is up and the 93% has not been met? Will you be representing clients individually in court if the 93% is not met?</b></span></i></div><div class="MsoNormal" style="background: white; line-height: 19.5pt; margin-bottom: .0001pt; margin-bottom: 0in;"><span style="font-family: 'Times New Roman',serif; font-size: 12pt;">Will you be representing clients individually in court if the 93% is not met?<span style="color: #3d85c6;"> </span></span></div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; line-height: 19.5pt; margin-bottom: 0.0001pt;"><br />
</div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; line-height: 19.5pt; margin-bottom: 0.0001pt;"><span style="font-family: 'Times New Roman',serif; font-size: 12pt;"><span style="color: #3d85c6;">Ennis: We are co-counseling our Seroquel cases with the Miller firm. Both firms have extensive experience in</span><i style="color: #3d85c6;"> </i><span style="color: #3d85c6;">Mass Torts. As previously explained we are attempting to locate clients to communicate the settlement terms. </span></span></div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; line-height: 19.5pt; margin-bottom: 0.0001pt;"><br />
</div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; line-height: 19.5pt; margin-bottom: 0.0001pt;"><span style="color: red; font-family: 'Times New Roman',serif; font-size: 12pt;">Commentary: Ennis can't seem to get off his tap dancing sell the settlement band wagon here...what Ennis avoids telling us is that The Miller Firm has made it very clear on numerous occasions that they are not going to take a single case to trial going forward...so they are either lying...or clients will be dumped to the curb in mass...unless Ennis is stating that his firm will be taking Seroquel cases to trial? Is that what your saying Mr. Ennis? </span><br />
</div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; line-height: 19.5pt; margin-bottom: 0.0001pt;"><span style="color: red; font-family: 'Times New Roman',serif; font-size: 12pt;">I'll be awaiting your response with breathless & bated anticipation!</span></div><div class="MsoNormal" style="font-family: Georgia, serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><i><span style="background-color: white; font-family: 'Times New Roman',serif; font-size: 12pt; line-height: 200%;"><b><br />
</b></span></i></div><div class="MsoNormal" style="font-family: Georgia, serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><i><span style="background-color: white; font-family: 'Times New Roman',serif; font-size: 12pt; line-height: 200%;"><b>13.How many clients in the 26,000+ cases appealed or rejected the Seroquel settlement offer?</b></span></i></div><div class="MsoNormal" style="font-family: Georgia,serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><br />
</div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; color: #3d85c6; line-height: 19.5pt; margin-bottom: 0.0001pt;"><span style="font-family: 'Times New Roman',serif; font-size: 12pt;">Ennis: I do not know the answer to this question. I can only speak to the clients who retained our law firm as co-counsel with the Miller firm.</span></div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; color: #3d85c6; line-height: 19.5pt; margin-bottom: 0.0001pt;"><br />
</div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; line-height: 19.5pt; margin-bottom: 0.0001pt;"><span style="color: red; font-family: 'Times New Roman',serif; font-size: 12pt;">Commentary: But you haven't said or mentioned how many of the Ennis or Miller Firm clients have REJECTED the settlement offer (40%)...in fact, all you will talk about is tracking down these mysterious missing packets and ghost clients....SMOKE! Anyone? </span><span style="font-family: 'Times New Roman',serif; font-size: 12pt;"></span></div><div class="MsoNormal" style="font-family: Georgia, serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><i><span style="background-color: white; font-family: 'Times New Roman',serif; font-size: 12pt; line-height: 200%;"><b><br />
</b></span></i></div><div class="MsoNormal" style="font-family: Georgia, serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><i><span style="background-color: white; font-family: 'Times New Roman',serif; font-size: 12pt; line-height: 200%;"><b>14.In the next 30-90 days what do you think the news will be regarding the lack of 93% required packets? How long will AstraZeneca be willing to wait for law firms to gather missing client packets? Have you or have other law firms pressured clients to take the offer? </b></span></i></div><div class="MsoNormal" style="font-family: Georgia,serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><br />
</div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; color: #3d85c6; line-height: 19.5pt; margin-bottom: 0.0001pt;"><span style="font-family: 'Times New Roman',serif; font-size: 12pt;">Ennis: I do not have a crystal ball. I can only say based on the clients we have located I expect the response to be similar to what we have already reported. If 93% are not reached then AZ will have to make a determination do they want to pay the clients who have accepted the terms of do they want to go back to court to defend the claims and incur additional defense costs. We are not at that stage at this point. No one is at fault here it is just a matter of locating the clients. As previously discussed this is a very transient population. I think in the next 90 days a lot of these issues will be cleared up. It is not is anyone' s best interests to be adversarial toward one another. The parties are working to resolve the issues.</span></div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; color: #3d85c6; line-height: 19.5pt; margin-bottom: 0.0001pt;"><br />
</div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; line-height: 19.5pt; margin-bottom: 0.0001pt;"><span style="font-family: 'Times New Roman',serif; font-size: 12pt;"><span style="color: red;">Commentary:</span> </span><span style="font-family: 'Times New Roman',serif; font-size: 12pt;"><span style="color: red;"> The legal process by definition is an adversarial process; I find it unbelievable that an attorney of all people (using the term "people" loosely) would be lecturing anyone on process civility; especially in light of how badly clients have been treated, mislead, and left completely in the dark by The Miller Firm.</span></span><span style="font-family: 'Times New Roman',serif; font-size: 12pt;"> </span></div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; line-height: 19.5pt; margin-bottom: 0.0001pt;"><br />
</div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; line-height: 19.5pt; margin-bottom: 0.0001pt;"><span style="font-family: 'Times New Roman',serif; font-size: 12pt;"><span style="color: red;">Ennis states he doesn't expect the 93% threshold to be met even after concluding their suspicious ghost client hunt correct. On the Miller firm update recording this past week it stated that AstraZeneca is not releasing funds because the conditions of the agreement have not been met...</span></span><br />
<br />
<span style="font-family: 'Times New Roman',serif; font-size: 12pt;"><span style="color: red;">I would like you to clarify your position for everyone please....Is The Ennis & Ennis firm going to move forward representing their clients against AstraZeneca in court within the next 90 days if this settlement is not approved...? </span></span></div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; line-height: 19.5pt; margin-bottom: 0.0001pt;"><br />
</div><div class="MsoNormal" style="background: none repeat scroll 0% 0% white; line-height: 19.5pt; margin-bottom: 0.0001pt;"><span style="color: red; font-family: 'Times New Roman',serif; font-size: 12pt;">I'm sorry, but this shocking news, a giant unexpected revelation, & information that appears to fly in the face of everything your co-counsel (The Miller Firm) has been telling their clients...Talk about a confusing and baffling smoke-N-mirrors quandary...</span><span style="font-family: 'Times New Roman',serif; font-size: 12pt;"></span></div><div class="MsoNormal" style="font-family: Georgia, serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><i><span style="background-color: white; font-family: 'Times New Roman',serif; font-size: 12pt; line-height: 200%;"><b><br />
</b></span></i></div><div class="MsoNormal" style="font-family: Georgia, serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><i><span style="background-color: white; font-family: 'Times New Roman',serif; font-size: 12pt; line-height: 200%;"><b><br />
</b></span></i></div><div class="MsoNormal" style="font-family: Georgia, serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><i><span style="background-color: white; font-family: 'Times New Roman',serif; font-size: 12pt; line-height: 200%;"><b>15.What words of advice do you have for people injured by pharmaceuticals in the future? Will it be even more difficult to go up against “Big Pharma”? </b></span></i></div><div class="MsoNormal" style="font-family: Georgia,serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: 200%;"><br />
</div><div class="MsoNormal" style="font-size: 100%; font-variant: normal; font-weight: normal; line-height: 200%;"></div><div style="color: #3d85c6;"><span style="font-family: Arial,sans-serif; font-size: 10pt;">Ennis: People who have been injured by Big Pharma should not be discouraged by this outcome. We still live in a country where people who have been wronged have a right to hold the responsible party accountable. The problem is if you give away those rights you will be left with nothing. Big Pharma and other corporations always try to discourage litigation because it is in their best interest. Remember if the victim does nothing you get nothing and Big Pharma wins. As long as lawyers are willing to take the risk and we can get access to a jury we can equal the playing field. Over the last decade it has become more difficult due to political influences. We need major reform in this country against Medical Device manufacturers and generic drug makers. In the last 3 years patients have lost 2 major Supreme Court Decisions. One decision gave Medical Device manufacturers preemption for 360 device approvals. This must be changed in the legislature. Further this past summer the Supreme Court ruled Generic Drug Manufacturers Preemption if you took a Generic Drug. So if your neighbor took the Brand Drug and was injured he has a right to compensation, but if you took the same drug from a Generic Manufacturer you are barred from bringing a claim. This is a total injustice. Your readers need to call their Congressman and demand the Legislative Branch to overturn these terrible decisions. I recommend all of your readers to view the HBO documentary titled, "Hot Coffee" to really get a true understanding of what we are fighting against on a daily basis. It is a good fight and we will keep representing the victims unless our Political System shuts the door to the Court House's around our country. I hope this shed's some light to your readers on these issues. -David Ennis, Attorney</span></div><div style="color: #3d85c6;"><br />
</div><br />
<span style="font-family: Arial,sans-serif; font-size: 10pt;"><span style="color: red;">Commentary: Funny you would mention the "HOT COFFEE" documentary...that case actually went to trial...I don't see how firm's like Ennis & Ennis stock piling drug injury cases, and then selling them off to firms like Miller serves justice or clients. I certainly don't see how turning individual injury "TORT" claims/litigation into some kind of very profitable (for the lawyers) bastardized Class action system is serving injured parties or justice. </span></span><br />
<br />
<span style="font-family: Arial,sans-serif; font-size: 10pt;"><span style="color: red;">Though, I do encourage concerned parties to call or contact their congressman, department of justice, attorney bar associations in regards to holding plaintiff attorney firms accountable to their professional & ethical obligations, and to also open the courts once again to the constitutional promise of having our just day in court before a jury of our peers.</span></span><br />
<br />
<span style="font-family: Arial,sans-serif; font-size: 10pt;"><span style="color: red;">I guess that concludes this interesting question and answer session; really not much in the way of clear answers from Ennis...but you can't really judge someone to harshly for blowing a little smoke our way now & then... </span></span>Seroquelhttp://www.blogger.com/profile/12012400050067849012noreply@blogger.com1tag:blogger.com,1999:blog-8681939617966339411.post-32521362777440023632012-02-15T11:26:00.002-08:002012-02-21T12:59:08.912-08:00AstraZeneca Seroquel - The Miller Firm LLC & Saiontz & Kirk, P.A."You Had a Lawyer" more lies and deception related to the Seroquel Litigation - Feb. 2012 Update<div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg_3wPPHHkACaFXioDYQ_8vRBXHMvAtivjLuRr25JNmVsqG2ycrW3rbVuWsnkS_-HNU2DOfYlwM4p5SGDVy-K5ppcSQRdP0TYG5PFKLJOSQ8TgDQ9TbvtmYCIE99_dy8W4V_1XtqKrlzrc9/s1600/broken-liars-.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="388" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg_3wPPHHkACaFXioDYQ_8vRBXHMvAtivjLuRr25JNmVsqG2ycrW3rbVuWsnkS_-HNU2DOfYlwM4p5SGDVy-K5ppcSQRdP0TYG5PFKLJOSQ8TgDQ9TbvtmYCIE99_dy8W4V_1XtqKrlzrc9/s640/broken-liars-.jpg" width="640" /></a></div><h3 class="post-title entry-title" style="text-align: center;">AstraZeneca Seroquel - The Miller Firm LLC & Saiontz & Kirk, P.A."You Had a Lawyer" more lies and deception related to the Seroquel Litigation - Feb. 2012 Update</h3><h3 class="post-title entry-title"><span style="font-size: small;"><span style="font-weight: normal;"> </span></span></h3><h3 class="post-title entry-title"><span style="font-size: small;"><span style="font-weight: normal;"> </span></span></h3><h3 class="post-title entry-title"><span style="font-size: small;"><span style="font-weight: normal;">This blog has received some emails requesting updated information regarding The Miller Firm's Seroquel Litigation. In prior post <a href="http://seroquellawsuitblog.blogspot.com/2012/02/astrazeneca-seroquel-miller-firm-llc.html">here</a> & <a href="http://seroquellawsuitblog.blogspot.com/2012/02/astrazenecas-seroquel-diabetes-lawsuit.html">here</a>, information was given by The Miller Firm that roughly 40% of injured parties have rejected the low ball & insulting settlement offer that has been presented to them. Making it resoundingly clear that The Miller Firm LLC will not come anywhere close to reaching the 93% settlement approval threshold needed to make this insulting low ball offer fly. </span></span></h3><h3 class="post-title entry-title"><span style="font-size: small;"><span style="font-weight: normal;"> </span></span></h3><h3 class="post-title entry-title"><span style="font-size: small;"><span style="font-weight: normal;">Yet, as in their usual seedy </span><span style="font-weight: normal;">pattern of ignoring the clients they are supposedly representing; The Miller Firm is continuing to market this doomed settlement agreement in spite of the neon colored writing spray painted upon the wall <span style="color: #cc0000;"><span style="font-size: large;"><b>"REJECTED"</b></span>.</span> </span></span></h3><h3 class="post-title entry-title"><span style="font-size: small;"><span style="font-weight: normal;"> </span></span></h3><h3 class="post-title entry-title"><span style="font-size: small;"><span style="font-weight: normal;">So what is likely to happen going forward?</span></span></h3><h3 class="post-title entry-title"><span style="font-size: small;"><span style="font-weight: normal;"> </span></span></h3><h3 class="post-title entry-title" style="font-weight: normal;"><span style="font-size: small;"><span style="font-weight: normal;">The Miller Firm LLC and <i>(non-participating co-counsel </i></span><i>Saiontz & Kirk, P.A.) </i>have stated they have absolutely no intention of taking any cases to trial <i>(and it's seems pretty clear by now that they never have intended to take any cases to trial; just settle quick & cash in)</i>. </span></h3><h3 class="post-title entry-title" style="font-weight: normal;"><span style="font-size: small;"> </span></h3><h3 class="post-title entry-title" style="font-weight: normal;"><span style="font-size: small;">On The Miller Firm updated phone recording dated Feb. 13th 2012; they stated they are supposedly having a conference call this week with the AstraZeneca lawyers to grovel/beg freeing up "money" for those who have signed onto this insulting low ball settlement offer; even though this goes directly against the stated terms of the actual settlement agreement offer that was sent out to The Miller Firm clients. So it now seems that only two options appear to be on the table & available! and AstraZeneca is holding the all the cards with both! <i>(Who were injured parties taking to court to hold accountable for the injuries caused by AstraZeneca's direct unconscionable actions?)</i></span></h3><h3 class="post-title entry-title" style="font-weight: normal;"><span style="font-size: small;"><i> </i></span></h3><h3 class="post-title entry-title" style="font-weight: normal;"><span style="font-size: small;">1. AstraZeneca simply walks away from the settlement <i>(knowing all to well that The Miller Firm LLC is not prepared & is assuredly unmotivated/unlikely to take a single case to trial)</i> saving themselves approximating seven million dollars with little or no risk involved.</span></h3><h3 class="post-title entry-title" style="font-weight: normal;"><span style="font-size: small;"> </span></h3><h3 class="post-title entry-title" style="font-weight: normal;"><span style="font-size: small;">2. AstraZeneca decides to change the terms of the settlement & drop all approval percentage thresholds <i>(I'm thinking the court would have to approve this move?)</i> & clear the slate of potential future litigation with roughly 6 out of 10 Miller Firm Litigants. </span></h3><h3 class="post-title entry-title" style="font-weight: normal;"><span style="font-size: small;"> </span></h3><h3 class="post-title entry-title" style="font-weight: normal;"><span style="font-size: small;"><br />
</span></h3><h3 class="post-title entry-title"><span style="font-size: small;"><span style="font-weight: normal;"> </span></span></h3><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgv8tTSe66vQ6iEwjFMZUapIV8AjZKYCF1lNQS3fdta6d_ZXId0tm3bwhvFZeWSWoypFv2sQzCcxVOhyphenhyphenl_yuhhG1zhvVOsaLEpZQWzXTrwHZTtAu4juC7-6CmrcKqs01B_0UexPClDk23xo/s1600/seroquel+agreement.PNG" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="380" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgv8tTSe66vQ6iEwjFMZUapIV8AjZKYCF1lNQS3fdta6d_ZXId0tm3bwhvFZeWSWoypFv2sQzCcxVOhyphenhyphenl_yuhhG1zhvVOsaLEpZQWzXTrwHZTtAu4juC7-6CmrcKqs01B_0UexPClDk23xo/s640/seroquel+agreement.PNG" width="640" /></a></div><h3 class="post-title entry-title"><span style="font-size: small;"><span style="font-weight: normal;"> </span></span></h3><h3 class="post-title entry-title"><span style="font-size: small;"><span style="font-weight: normal;">It has become crystal clear that getting straight and honest answers from The Miller Firm LLC is pretty much impossible. They again have misrepresented themselves & have been shown to be liars by not following through on what they </span><a href="http://seroquellawsuitblog.blogspot.com/2012/02/astrazeneca-seroquel-miller-firm-llc.html" style="font-weight: normal;">told their client </a><span style="font-weight: normal;"> last week.</span></span></h3><h3 class="post-title entry-title"><span style="font-size: small;"><span style="font-weight: normal;"> </span></span></h3><h3 class="post-title entry-title"><span style="font-size: small;"><span style="font-weight: normal;">What we can be fairly certain about from these self serving & dishonest ambulance chasers at The Miller Firm LLC....is the client dump is surely coming. It is not a matter of "IF"...just a matter of when & how many <i>(it could be all of their Seroquel clients, or it could be 40%+, depending upon AstraZeneca & the courts).</i> </span></span></h3><h3 class="post-title entry-title"><span style="font-size: small;"><span style="font-weight: normal;"> </span></span></h3><h3 class="post-title entry-title"><span style="font-size: small;"><span style="font-weight: normal;"> </span></span></h3><h3 class="post-title entry-title" style="color: #cc0000;"><i><span style="font-size: small;"><span style="font-weight: normal;"><span style="font-size: large;"><b>Update Feb 21, 2012</b></span>: information provided on the Seroquel update phone recording at the Miller Firm LLC dated Feb. 20, 2012 stated that per phone conference on Feb 16, 2012 with representatives of AstraZeneca, that they are NOT releasing any funds to The Miller Firm LLC. The requirements of the settlement terms have not been met. </span></span></i></h3><h3 class="post-title entry-title" style="color: #cc0000;"><i><span style="font-size: small;"><span style="font-weight: normal;">What the Miller is not providing their clients: is what further demands is AstraZeneca asking for now. It has become beyond clear at the this juncture, that the 93% approval needed to make this settlement fly is not going to happen ever. </span></span></i></h3><h3 class="post-title entry-title"><span style="font-size: small;"><span style="font-weight: normal;"><i style="color: #cc0000;">Isn't it about time The Miller Firm LLC started being open & honest with those they are supposed to represent! This settlement as it stands is "DEAD & BURIED". The injured parties are once again asking for simple & straight forward answers from the Miller Firm. WHAT ARE YOU GOING TO DO? Move forward to court with Seroquel cases, or are you going to kick all of your clients to the curb...</i></span></span></h3><h3 class="post-title entry-title"><span style="font-size: small;"><span style="font-weight: normal;"><i style="color: #cc0000;"> </i></span></span></h3><h3 class="post-title entry-title"><span style="font-size: small;"><span style="font-weight: normal;"><i style="color: #cc0000;"> </i></span></span></h3><h3 class="post-title entry-title"><span style="font-size: small;"><span style="font-weight: normal;">If anyone reading would like to weigh in on this topic, or has pertinent information they would like to share, or has information about Law Firms that are interested in taking on & ethically representing discarded Seroquel injured parties cases; please leave a comment or send this blog an email. </span></span></h3><h3 class="post-title entry-title"><span style="font-size: small;"><span style="font-weight: normal;"> </span></span></h3><h3 class="post-title entry-title"><br />
</h3>Seroquelhttp://www.blogger.com/profile/12012400050067849012noreply@blogger.com1tag:blogger.com,1999:blog-8681939617966339411.post-43114689139325379522012-02-02T13:36:00.000-08:002012-02-02T13:59:22.568-08:00AstraZeneca Seroquel - The Miller Firm LLC & Saiontz & Kirk, P.A. "You Had a Lawyer" to begin mass client dump in Seroquel Litigation<div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj1KObG1NbGk2jfpPwQZVYlmzPIctUkOUn_i_KD5cYeem4nUDq2IfBZcUcde-zcgSAyr0rEQa556ghW5foJ4kvAqP4bdSj8chLGzWAtReArLejUOScaDNfJeqY6yoBtElcweo_s0q8dDAgg/s1600/horsey-bailout-4_t470.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="307" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj1KObG1NbGk2jfpPwQZVYlmzPIctUkOUn_i_KD5cYeem4nUDq2IfBZcUcde-zcgSAyr0rEQa556ghW5foJ4kvAqP4bdSj8chLGzWAtReArLejUOScaDNfJeqY6yoBtElcweo_s0q8dDAgg/s400/horsey-bailout-4_t470.jpg" width="400" /></a></div><div class="separator" style="clear: both; text-align: center;"></div><h3 class="post-title entry-title">AstraZeneca Seroquel - The Miller Firm LLC & Saiontz & Kirk, P.A."You Had a Lawyer" to begin mass client dump in Seroquel Litigation </h3><h3 class="post-title entry-title"> </h3><h3 class="post-title entry-title"><span style="font-size: small; font-weight: normal;">In Yesterdays posting here <a href="http://seroquellawsuitblog.blogspot.com/2012/02/astrazenecas-seroquel-diabetes-lawsuit.html">40% of Injured Seroquel Claimants Reject Settlement</a></span><span style="font-size: small; font-weight: normal;"> a regular anonymous source passed along new information that The Miller Firm had placed on their Seroquel update recording. It appears The Miller Firm is in the process of groveling & begging at AstraZeneca's criminal feet to <span style="font-size: large;"><i>"Show Them the Money"</i></span> even though a very large percentage <b><i>(40% or more, or an estimated 250+ of the 600+ injured parties)</i></b> of the clients they are supposedly representing have unequivocally rejected the token settlement offer <i>(that was a mere fraction of what other firms had offered in this same litigation for the same injuries)</i> that has been presented to them. </span></h3><h3 class="post-title entry-title"><span style="font-size: small; font-weight: normal;"> </span></h3><h3 class="post-title entry-title"><span style="font-size: small; font-weight: normal;">This morning I had continued correspondence with an anonymous source who stated after repeating attempts to contact </span><span style="font-size: small; font-weight: normal;">Saiontz & Kirk,P.A. to no avail <i>(which they had originally agreed to be their representation in the Seroquel Litigation)</i></span>, <span style="font-size: small; font-weight: normal;">they instead received a call from a representative of the The Miller Firm</span><span style="font-size: small;">. <span style="font-weight: normal;">My source stated that they were told that The Miller Firm</span><span style="font-weight: normal;"></span><b><span style="font-weight: normal;"> was in the process of working with AstraZeneca</span></b></span> <span style="font-size: small; font-weight: normal;">to hopefully finalize this token agreement with those who had signed onto the much ballyhooed & promoted settlement process even though they have fallen far short of the 93% approval threshold which was agreed upon in those now notorious secret settlement negotiations.</span><b><span style="font-size: small;"> </span></b></h3><h3 class="post-title entry-title"><b><span style="font-size: small;"> </span></b></h3><h3 class="post-title entry-title"><span style="font-size: small;"><span style="font-weight: normal;">The Miller Firm representative stated that there would be<span style="font-size: large;"><b> <i>"NO"</i> renegotiation of settlement terms or would any cases be further litigated or brought to trial</b></span>. The Miller Firm representative stated that those that had not signed onto the settlement would be sent letters stating they were no longer represented by The Miller Firm or co-counsel in this litigation some undetermined time down the road?</span></span></h3><h3 class="post-title entry-title"><span style="font-size: small;"><span style="font-weight: normal;"> </span></span></h3><h3 class="post-title entry-title"><span style="font-size: small;"><span style="font-weight: normal;"> Upon receiving this response; my source pressed further on this issue of The Miller Firm & non-participating co-counsel</span><span style="font-weight: normal;"> </span><b><span style="font-weight: normal;">Saiontz & Kirk</span></b></span><span style="font-size: small;"><i style="font-weight: normal;"> (While clarifying and reiterating that The Miller Firm had clearly stated that they were not renegotiating terms, not taking a single case any further in this litigation, were ignoring received appeals, and were well aware that this settlement has been without any doubt REJECTED by their client); </i><span style="font-weight: normal;">The Miller Firm representative then capitulated by stating that</span><i style="font-weight: normal;"> </i><span style="font-weight: normal;">a letter would be going out by mail within a week stating that The Miller Firm &</span></span> <span style="font-size: small;"><span style="font-weight: normal;">Saiontz & Kirk would be withdrawing from their legal representation in the Seroquel Litigation. </span></span></h3><h3 class="post-title entry-title"><span style="font-size: small;"><span style="font-weight: normal;"> </span></span></h3><h3 class="post-title entry-title"><span style="font-size: small;"><span style="font-weight: normal;">So after years of waiting patiently and much long suffering, this is what 250+ injured clients</span></span><span style="font-size: small;"><span style="font-weight: normal;"> (40%) will receive from these firms in return for innocently entrusting these<i><b> unethical, rude, secretive, shady, & solely self serving law firms</b></i> with their well evidenced injury cases. </span></span></h3><h3 class="post-title entry-title"><span style="font-size: small;"><span style="font-weight: normal;"> </span></span></h3><h3 class="post-title entry-title"><span style="font-size: small;"><span style="font-weight: normal;">One can only surmise that by using The Miller Firm rejection numbers as an example; there are quite possibly many thousands of injured Seroquel litigants seeking representation & their promised right of their day in court. The fact is that this litigation is far from over; it's only just beginning - even though AstraZeneca appears to be telling their share holders a very different story in a newly released quarterly report here --> <a href="http://pharmagossip.blogspot.com/2012/02/astrazeneca-seroquel-legal-update.html">PharmaGossip astrazeneca-seroquel-legal-update.</a></span></span></h3><h3 class="post-title entry-title"><span style="font-size: small;"><span style="font-weight: normal;"> </span></span></h3><h3 class="post-title entry-title"><span style="font-size: small;"><span style="font-weight: normal;">If there are any reputable law firms still remaining in America that wish too or are interested in representing the possibly thousands of injured Seroquel parties that have either been discarded or have not been able to find legal representation in either pertinent legal malpractice claims against these unscrupulous law firms and/or to proceed with the Seroquel injury litigation against AstraZeneca; please feel free to leave that information in the comment section here, or send along an email to the SeroquelLawSuitBlog@gmail.com.</span></span></h3><h3 class="post-title entry-title"><span style="font-size: small;"><span style="font-weight: normal;"> </span></span></h3><h3 class="post-title entry-title"><span style="font-size: small;"><span style="font-weight: normal;"><br />
</span></span> </h3><h3 class="post-title entry-title"></h3><h3 class="post-title entry-title"></h3><h3 class="post-title entry-title"><br />
</h3>Seroquelhttp://www.blogger.com/profile/12012400050067849012noreply@blogger.com2tag:blogger.com,1999:blog-8681939617966339411.post-53351537429287856852012-02-01T22:39:00.000-08:002012-02-01T22:39:08.755-08:00AstraZeneca's Seroquel diabetes lawsuit is not over: Miller Firm didn't make the 93% needed for settlement<b><span style="font-size: x-large;">If you thought the AstraZeneca diabetes lawsuit settlement was a done deal, think again.</span></b><br />
<div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiRj5VTZOqiIuU4NOfRtKugQNMnQIr5kD89uIgA5v-okupHRNQukxc9Fd5NRPhyphenhyphenoScGttrJ4ZFT0iNKA6vz0u_9wAZv5tDKyjbZoWsnDxJU_7wC8fG9EUQNfE1wu6-jtQfNC1sqVD3gTjZt/s1600/not+over.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="400" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiRj5VTZOqiIuU4NOfRtKugQNMnQIr5kD89uIgA5v-okupHRNQukxc9Fd5NRPhyphenhyphenoScGttrJ4ZFT0iNKA6vz0u_9wAZv5tDKyjbZoWsnDxJU_7wC8fG9EUQNfE1wu6-jtQfNC1sqVD3gTjZt/s400/not+over.jpg" width="388" /></a></div><br />
<br />
The<b> Miller Firm</b> has not met the required percentage of Claimants necessary to settle the lawsuits for the 623 clients represented by the Miller Firm, LLC<br />
<br />
<table align="center" cellpadding="0" cellspacing="0" class="tr-caption-container" style="margin-left: auto; margin-right: auto; text-align: center;"><tbody>
<tr><td style="text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhWtbG4q7CT2SqWqijzUbT94mPYyfU7X1IDHwzjyxMzkM9lMXxh6C9SxJbVmI8BnlSWwn8jGlN36IVxczQiPkkUUkWUfPt3rtpeIqoESfbbiuFaezVcI_TLORkk6hidQodohHepaQU6jgIz/s1600/Garretson+page+3+percentage+to+settle.JPG" imageanchor="1" style="margin-left: auto; margin-right: auto;"><img border="0" height="542" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhWtbG4q7CT2SqWqijzUbT94mPYyfU7X1IDHwzjyxMzkM9lMXxh6C9SxJbVmI8BnlSWwn8jGlN36IVxczQiPkkUUkWUfPt3rtpeIqoESfbbiuFaezVcI_TLORkk6hidQodohHepaQU6jgIz/s640/Garretson+page+3+percentage+to+settle.JPG" width="640" /></a></td></tr>
<tr><td class="tr-caption" style="text-align: center;">93% required for settlement<br />
</td></tr>
</tbody></table><span style="font-size: large;"><b>The Garretson Resolution</b> <b>Group</b> <i>page 3 </i>document shown above specifically states that if more than<b> 7%</b> of Miller Firm claimants DO NOT WANT TO SETTLE, THEN ASTRAZENECA HAS THE OPTION TO WITHDRAW THE ENTIRE SETTLEMENT AMOUNT OF: </span><span style="background-color: blue; color: white; font-size: x-large;">$ 6,986,913.73</span><br />
<span style="background-color: blue; color: white; font-size: x-large;"><br />
</span><br />
<table align="center" cellpadding="0" cellspacing="0" class="tr-caption-container" style="margin-left: auto; margin-right: auto; text-align: center;"><tbody>
<tr><td style="text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiBAny5IYiRFHtJrWppaJOx9J-dJcQqebdPJs3AKnkwq0tM3MmemzltZynQsWXuUAaP97eTKb0Dl7ybd4lT7wqi6DOUpkSSuke7kLt9_3dIsOJj74MH5pKzcALH2I96Eo0sYwQmFdgcG3fv/s1600/Garretson+firm+page+4.JPG" imageanchor="1" style="margin-left: auto; margin-right: auto;"><img border="0" height="592" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiBAny5IYiRFHtJrWppaJOx9J-dJcQqebdPJs3AKnkwq0tM3MmemzltZynQsWXuUAaP97eTKb0Dl7ybd4lT7wqi6DOUpkSSuke7kLt9_3dIsOJj74MH5pKzcALH2I96Eo0sYwQmFdgcG3fv/s640/Garretson+firm+page+4.JPG" width="640" /></a></td></tr>
<tr><td class="tr-caption" style="text-align: center;">Garretson Resolution Group, Inc.</td></tr>
</tbody></table>Page 3 shown above also states that if more than 7% of Miller Claimants do not want to settle, and AstraZeneca withdraws the $6 million dollar settlement offer, the attorneys can choose to proceed with litigation. That is what should have happened in the first place! Miller Firm and others representing over 26,000 clients who were injured by the antipsychotic Seroquel deserve more than a chump change settlement offer by a billion dollar pharmaceutical corporation that spent millions on defense. The evidence is stacked with proof that AstraZeneca hid and buried studies and data, illegally marketed the drug, was fined by the Dept of Justice--the list goes on and on--Study 15 was buried, in case you wondered why you got fat on Seroquel! the drug company knew this information and with intent to sell and profit, did so at the expense of innocent patients. These patients deserve their days in court!<br />
<br />
<br />
<br />
<b><span style="font-size: large;">February 2012</span></b><br />
<br />
The<b><span style="color: blue;"> <a href="http://www.millerfirmllc.com/"><span style="color: blue;">Miller Firm</span> </a>LLC</span></b> telephone recording states that they have received <b>60%</b> of their claimant percentage necessary to comply with the settlement terms; which means that<b> 40% of Miller Claimants DO NOT WANT TO SETTLE</b>, and the Miller Firm is no where near the 93% required by AstraZeneca for settlement, as a matter of fact, due to having over 7% of claimants NOT settling, AstraZeneca can now TAKE THEIR MONEY AND WALK AWAY.<br />
<br />
Where does this leave the claimants? Miller Firm states on the recording that they are attempting to negotiate settling the claims of those who agreed to settle, with AstraZeneca, and close the cases of those who did not want to settle.<br />
<br />
Will the Miller Firm walk away from their own clients? will the Miller Firm swiftly dump the clients that rejected the offer, or failed to send the packet back? There was no option to reject the offer, it was take it or leave it, appeal it or keep the settlement packet for bird cage liner.<br />
<br />
The Miller Firm is a case file gatherer, a law firm that takes large amounts of cases and settles for a quick buck, never really representing individual clients. The bell of justice won't ring for the 623 clients of the Miller Firm. It won't ring for the 26,000 injured people. AstraZeneca wins when they lose, and the patient loses over and over again. A life time disability is what they got from taking the antipsychotic Seroquel, along with a life time of angst and an ever-revolving merry-go-round of personal hell, without an end in sight. Insult to injury.<br />
<br />
When you read <a href="http://www.bloomberg.com/news/2010-08-09/astrazeneca-to-pay-nearly-200-million-to-settle-17-500-seroquel-lawsuits.html"><span style="color: blue;">Bloomberg</span></a> from <i>August 2010</i> <i>with a headline like this </i>:<br />
<br />
<br />
<h1 style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-repeat: no-repeat no-repeat; border-bottom-width: 0px; border-color: initial; border-image: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; clear: both; font-family: Arial, Helvetica, sans-serif; font-size: 30px; line-height: 1.3em; margin-bottom: 12px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; vertical-align: baseline;">"AstraZeneca to Pay $198 Million for Seroquel Lawsuits"</h1><br />
<i><span style="font-size: large;">Just remember, the Fat Lady hasn't sung yet.</span></i>Seroquelhttp://www.blogger.com/profile/12012400050067849012noreply@blogger.com0tag:blogger.com,1999:blog-8681939617966339411.post-25187883544249658702012-01-28T21:34:00.000-08:002012-01-28T22:37:41.455-08:00AstraZeneca Seroquel - a father's anguish - Government killed his son by way of prescription pad<div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh4afp7KUP0fMRe0GTCPawj4j6YzR4uTdCKH_HwWmCDmH73ncMWY3FvM7JHbQpe7TqOSp1tp3wo9QkqeHkx-f9FyudKOzyvFGnvMCXzU53fXxqouWVJHEmWcPpOX3XsH36j6dcfd1bOYySU/s1600/veterans+sleep+drug-1522506470_v2.grid-6x2.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="266" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh4afp7KUP0fMRe0GTCPawj4j6YzR4uTdCKH_HwWmCDmH73ncMWY3FvM7JHbQpe7TqOSp1tp3wo9QkqeHkx-f9FyudKOzyvFGnvMCXzU53fXxqouWVJHEmWcPpOX3XsH36j6dcfd1bOYySU/s400/veterans+sleep+drug-1522506470_v2.grid-6x2.jpg" width="400" /></a></div><h3 class="post-title entry-title"> </h3><h3 class="post-title entry-title"> <a href="http://pharmagossip.blogspot.com/2012/01/fathers-anguish-military-killed-my-son.html">Via PharmaGossip</a></h3><h3 class="post-title entry-title"> </h3><h3 class="post-title entry-title" style="text-align: center;"><span style="font-size: large;"><a href="http://pharmagossip.blogspot.com/2012/01/fathers-anguish-military-killed-my-son.html">A father’s anguish: Military killed my son with prescription pad | The Daily Caller</a></span></h3><h3 class="post-title entry-title" style="text-align: center;"><span style="font-size: large;"> </span></h3>A father who has lost two sons to war told The Daily Caller that the U.S. Central Command’s policy of allowing troops to deploy with a 180-day supply of the antipsychotic Seroquel has contributed to the deaths of troops and veterans. Seroquel, he said, has tragic side effects that military leaders have ignored in their quest to combat insomnia and post-traumatic stress disorder (PTSD) among fighting men and women.<br />
<br />
The father, West Virginia school principal Stan White, said there are better ways to treat troops and veterans who suffer from PTSD. But because the maker of Seroquel, London-based AstraZeneca, has so much influence over Congress and the military, he insisted, that peer counseling and other treatment options are being shoved aside in favor of low doses of the drug.<br />
<br />
White’s suspicions are slowly being validated by a series of studies, legal settlements, and military rulings — including a recommendation from the Department of Defense’s own advisory body on pharmaceuticals.<br />
<br />
“I think AstraZeneca is so strong and has so much power that no one can speak out,” said White, who has remained stoic despite his losses. “Money talks. I truly believe AstraZeneca and other big pharma companies have control over Congress.”<br />
<br />
His first son, Army Sgt. Robert White, died in combat in Iraq. When Robert’s younger brother Andrew returned from his own tour in the Middle Eastern country, a Veterans Administration doctor prescribed a combination of Seroquel and antidepressants for his PTSD.<br />
<br />
Andrew died at home, and the state of West Virginia ruled that an accidental medication overdose was to blame.<br />
<br />
But his father believes the “dangerous” pill cocktail killed him. And he told TheDC that he has identified 300 other soldiers and veterans who died from sudden cardiac arrest while taking Seroquel and antidepressants in combination.<br />
<br />
<div><div>Evidence supporting his theory has continued to accumulate, including a September 2011 <a href="http://eurheartj.oxfordjournals.org/content/early/2011/09/14/eurheartj.ehr368.abstract" target="_blank">study</a> from the European Society of Cardiology which linked the “combined use of antipsychotic and antidepressant drugs” with an increased risk of sudden heart attacks.</div><div></div></div>Seroquel has been on the market since 1997, and in that time doctors have widely experimented with prescribing it for “off-label” purposes that the FDA has not approved. The drug, a mood stabilizer, is approved to treat schizophrenia and bipolar disorder, but it has also been used to treat insomnia in Parkinson’s disease patients, dementia in adults of all ages, and a variety of disorders in children.<br />
<br />
Doctors have free rein to prescribe medications for off-label uses, and the FDA’s ever-growing avalanche of advisories sometimes makes it difficult for physicians to know what has been approved and what has not.<br />
<br />
A 2009 University of Chicago national <a href="http://www.physorg.com/news170052729.html" target="_blank">survey</a> of physicians, for instance, found that one in eight doctors thought Seroquel was approved for treating dementia, even though the FDA had issued a specific warning against it.<br />
<br />
Drug marketers, however, are forbidden to promote their products for any purpose not approved by the FDA.<br />
<br />
In April 2010 AstraZeneca conceded that it had crossed that line, agreeing to pay the U.S. government <a href="http://www.justice.gov/opa/pr/2010/April/10-civ-487.html" target="_blank">$520 million</a> to settle claims related to its illegal promotion of Seroquel for off-label uses.<br />
<br />
Read the rest of this disturbing & important article by clicking on links below<br />
<b><a href="http://dailycaller.com/2012/01/28/a-fathers-anguish-military-killed-my-son-with-prescription-pad/2/">NEXT: A massive increase in government spending on Seroquel</a> </b><br />
<b> </b><strong><a href="http://dailycaller.com/2012/01/28/a-fathers-anguish-military-killed-my-son-with-prescription-pad/3/">NEXT: AstraZeneca's $32.6 million lobby shop</a></strong>Seroquelhttp://www.blogger.com/profile/12012400050067849012noreply@blogger.com0tag:blogger.com,1999:blog-8681939617966339411.post-51014028911099408202012-01-28T20:57:00.000-08:002012-01-28T21:01:18.633-08:00Cash Rich AstraZeneca pacifying stock holders with 5bn dollar buy back, while continuing criminal business as usual<span class="storyTop "> </span><br />
<div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgYb4_lpFBYdCn7Lawp1zODLBQl_ACBr4Sp18gFtlOUundzm0ePPsPfEHndz_7lUu0HAzeWlvx4X8B_0Rn0QA7-AlLqTBzBSBxqd_p6aT4xWKy9GcpkQKt-e_uobIeLOqkZYGXMCVMNnLsA/s1600/drug-profits.JPG" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="306" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgYb4_lpFBYdCn7Lawp1zODLBQl_ACBr4Sp18gFtlOUundzm0ePPsPfEHndz_7lUu0HAzeWlvx4X8B_0Rn0QA7-AlLqTBzBSBxqd_p6aT4xWKy9GcpkQKt-e_uobIeLOqkZYGXMCVMNnLsA/s400/drug-profits.JPG" width="400" /></a></div><br />
Cash Rich AstraZeneca pacifying stock holders with 5 bn dollar buy back, while continuing their criminal business as usual model. If you haven't gotten the message by now, AstraZeneca has bought some powerful friends in very high places within our government. Especially when you look at the puny amounts they have paid in fines to walk away unscathed from a throng of unconscionable crimes without admitting any guilt or wrong doing; and then went on to pay even less to those persons health & lives they have destroyed or ended by their unsafe products and unscrupulous business practices. You only can just begin to fathom the depth of greed and conspired evil intent involved in this elitist masquerade that has been perpetrated against the citizens of America, and others from around the world.<br />
<br />
------------------------------------------------------------------------------------- <br />
From <a href="http://www.independent.co.uk/news/business/news/astrazeneca-to-return-billions-to-shareholders-6296106.html">The Independent</a><br />
<br />
<div class="widget storyContent article widget-editable viziwyg-section-1024 inpage-widget-6138696 title"><h1 class="title">AstraZeneca to return billions to shareholders </h1></div><div class="widget storyContent article widget-editable viziwyg-section-1024 inpage-widget-6138721"></div><div class="widget storyContent article widget-editable viziwyg-section-1024 inpage-widget-6138720"><h3 class="subtitle">Cash-rich drugs giant to keep investors happy with another huge buyback worth up to $5bn </h3><h3 class="subtitle"><span style="font-size: small; font-weight: normal;"><a href="http://www.independent.co.uk/search/simple.do?destinationSectionUniqueName=search&publicationName=ind&pageLength=5&startDay=1&startMonth=1&startYear=2010&useSectionFilter=true&useHideArticle=true&searchString=byline_text:%28%22Mark%20Leftly%20and%20Laura%20Chesters%22%29&displaySearchString=Mark%20Leftly%20and%20Laura%20Chesters"><span class="authorName">Mark Leftly and Laura Chesters</span></a></span><span class="authorName"><span style="font-size: small; font-weight: normal;"> Sunday January 29, 2012</span> </span> </h3><h3 class="subtitle" style="font-weight: normal;"><span style="font-size: small;">AstraZeneca, the FTSE 100 pharmaceuticals giant, will announce an estimated $3bn (£2bn) extension to its share buyback programme this week.</span></h3></div>A hugely cash generative business, AstraZeneca has been keeping investors happy over the past two years by purchasing $2.1bn of shares in 2010 and around $4bn in 2011. The group will confirm another round of share buybacks in its full-year results this week, with the consensus expectation $3bn and analysts at UBS expecting as much as $5bn.<br />
<br />
Savvas Neophytou, analyst at Panmure Gordon, said he had a "conservative" forecast – this still came to $1.5bn – as he felt that AstraZeneca might hold back some cash for acquisitions. He added: "The<br />
<br />
share buyback programme will be extended for sure. There are also a number of opportunities for the company to invest in."<br />
<br />
However, AstraZeneca, whose chief executive is David Brennan, right, has faced some disappointments recently in its drug pipeline. For example, its latest blockbuster drug (those likely to have sales of more than $1bn) is expected to be the diabetes treatment Dapagliflozin, but the US Food and Drug Administration has demanded more clinical trials before giving approval. The UBS analysts expect fourth-quarter sales to be fractionally down on the previous year at $8.611bn.<br />
<br />
Michael Mitchell, healthcare analyst at Seymour Pierce, said that there was a "question over whether a better use of money" would be investing in new drugs or buying companies with strong research and development records.Seroquelhttp://www.blogger.com/profile/12012400050067849012noreply@blogger.com0tag:blogger.com,1999:blog-8681939617966339411.post-58262443835803748082012-01-27T20:44:00.000-08:002012-01-27T20:44:42.039-08:00Ohio doctor wrote nine AstraZeneca Seroquel prescriptions per hour . Senator targeting big prescribers<div class="byline-block"> <div class="authors"> <div class="byline">Have you ever happened to wonder how a drug that was designed & originally approved to treat less than 1% of the population & was shown no better than drugs already in the market place becomes one of the most prescribed drugs on the planet. Or how a drug with hidden deadly side effects, that was marketed off label, and had damning clinical studies buried from the public & consumers becomes a multi-billion dollar a year blockbuster profit money tree for Big Pharma; while @ the same time defrauding American tax payers & our medicare/medicaid system of many billions of dollars. You don't need to look much further than this eye opening piece of the puzzle highlighted in the following report by ProPublica.</div><div class="byline"><br />
</div></div></div><div class="content-inset"><div class="article-inline-image Right demobbed" style="text-align: center;"> <img alt="." height="266" src="http://www.propublica.org/images/ngen/gypsy_image_lead_ngen/wdcpix_grassley_300x200_120124.jpg" width="400" /> </div><div class="article-inline-image Right demobbed" style="text-align: left;"><a href="http://www.propublica.org/article/senate-watchdog-targets-high-prescribing-medicaid-docs#comments">From Propublica</a></div><div class="article-inline-image Right demobbed" style="text-align: left;"><h1 class="article-title title-link">Senate Watchdog Targets High-Prescribing Medicaid Docs</h1>by <a href="http://www.propublica.org/site/author/charles_ornstein/" title="View Charles Ornstein's other articles">Charles Ornstein</a> and <a href="http://www.propublica.org/site/author/tracy_weber/" title="View Tracy Weber's other articles">Tracy Weber</a><br />
ProPublica, Jan. 24, 2012, 2:04 p.m.</div><div class="article-inline-image Right demobbed" style="text-align: left;"> </div><div class="article-inline-image Right demobbed" style="text-align: center;"> </div></div><div class="article"> An influential U.S. senator is grilling officials in nearly three-dozen states, demanding to know how they are cracking down on physicians who prescribe massive amounts of potentially dangerous prescription drugs.<br />
<br />
Iowa Republican Charles Grassley sent <a href="http://www.propublica.org/documents/item/286425-grassley-state-medicaid-letters">letters to 34 states</a> Monday asking what steps they had taken to investigate doctors whose prescribing of antipsychotics, anti-anxiety drugs and painkillers to Medicaid patients far exceeds that of their peers. <br />
</div><div class="sidebar-inject"><div class="content-left" style="display: block;"> <aside class="toggler"> <div class="related-sidebar-meat"> <div class="related-articles-module module"> <div class="module-title">Letters from Sen. Grassley</div><div class="module-title"> </div><div class="related-article"> <a class="title-link" href="http://www.propublica.org/documents/item/286425-grassley-state-medicaid-letters">Letters to States Who Responded to Initial Data Request</a><br />
</div><div class="related-article"> <a class="title-link" href="http://www.propublica.org/documents/item/286619-grassley-letters-to-states-who-did-not-respond">Letters to States Who Did Not Respond to Initial Data Request</a><br />
</div></div><div class="module"><br />
</div></div></aside> </div></div>The request is a follow-up to a 2010 letter Grassley sent all states that requested statistics on top prescribers of these drugs.<br />
<br />
“These types of drugs have addictive properties, and the potential for fraud and abuse by prescribers and patients is extremely high,” Grassley wrote in Monday’s letters. “When these drugs are prescribed to Medicaid patients, it is the American people who pay the price for over-prescription, abuse, and fraud.”<br />
<br />
ProPublica reported in November that Florida <a href="http://www.propublica.org/article/florida-sanctions-top-medicaid-prescribers-but-only-after-a-shove">allowed at least three physicians</a> to keep treating and prescribing drugs to the poor amid clear signs of possible misconduct. One doctor kept prescribing narcotic pain pills to Medicaid patients for more than a year after <a href="http://www.columbiasheriff.com/articles/72/1/Local-Doctor-Arrested-2152010/Page1.html">he was arrested and charged in 2010 with trafficking in them</a>.<br />
<br />
A number of the top-prescribing Medicaid doctors around the country are listed in our <a href="http://projects.propublica.org/docdollars">Dollars for Docs database</a> of payments made by 12 pharmaceutical companies to physicians for speaking and consulting Medicaid, jointly funded by the states and federal government, provides health care coverage to about 60 million low-income enrollees.<br />
<br />
Grassley, the senior Republican on the Senate Judiciary Committee, has long argued for greater transparency in health care. The painkillers and mental health drugs Grassley is inquiring about are among the top drivers of Medicaid drug spending.<br />
<br />
His letter to Ohio notes that the top prescriber of the anti-psychotic Abilify wrote 13,825 prescriptions in 2009 — about 54 prescriptions per weekday. Ohio paid $6.7 million for that those prescriptions, state officials reported to Grassley.<br />
<br />
The biggest prescriber of another anti-psychotic, Seroquel, wrote 18,890 scripts at a cost of $5.7 million. Grassley wrote the tally would amount to nine prescriptions per hour. When Ohio submitted the data to Grassley last year, it did not identify the doctors by name or license number.<br />
<br />
“After an extensive review of prescribing habits of the serial prescribers of pain and mental-health drugs in Ohio, I have concerns about the oversight and enforcement of Medicaid abuse in your state,” he wrote. “While I am sensitive to the concerns of misinterpretation of the data you provided, the numbers themselves are quite shocking.”<br />
<br />
Grassley’s letter to Maine cites a physician who wrote 1,867 prescriptions for the powerful painkiller OxyContin in 2009, nearly double the second-highest prescriber. The doctor also wrote 1,723 prescriptions for another painkiller, Roxicodone, nearly three times as many as the next highest prescriber.<br />
<br />
<br />
Calls to officials in Ohio and Maine have not been returned.<br />
<br />
In his letters to the 34 states, Grassley asked that officials tell him by Feb. 13 what action, if any, they have taken against top prescribers, whether those doctors are still eligible to bill Medicaid, whether any of the doctors were referred to their state medical boards for investigation, and what systems have been set up to track possibly excessive prescribing, among others.<br />
<br />
Grassley is sending letters to 12 other states that never provided him data, as requested, on their top Medicaid prescribers. Four other states will not receive follow-up letters because the senator felt their initial responses to his 2010 letter were adequate.<br />
<br />
<br />
ProPublica reported in November that since Grassley’s initial letter requesting the data in 2010, Louisiana, Arizona, Oklahoma and New York have kicked some high-prescribing physicians out of Medicaid. California has temporarily suspended or placed restrictions on 15 to 20 doctors in the past two years for prescribing disproportionately high volumes of painkillers and antipsychotics to Medicaid patients.<br />
<br />
But Grassley said more needs to be done.<br />
<br />
“When a doctor writes more prescriptions than seems humanly possible, it makes sense to ask questions,” he said in a statement to ProPublica. The statement noted that some states never responded to his original letter in 2010.<br />
<br />
“If state and federal taxpayers are being cheated because of inappropriate prescriptions,” Grassley said, “the state and federal governments have to get to the bottom of it and stop it.”Seroquelhttp://www.blogger.com/profile/12012400050067849012noreply@blogger.com1tag:blogger.com,1999:blog-8681939617966339411.post-64945385185365108642012-01-19T08:09:00.000-08:002012-01-19T18:16:34.377-08:00UPDATE: J&J Risperdal - TEXAS "TMAP" TRIAL "GUILTY" - Settles for Chump Change - AstraZeneca Seroquel Next?<div align="justify"><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhX8WHcwLUJpCzB2O1Sf1nQ-qYmiPcczbbQdEa4m7kbCid-I0Y0xefdHublk_coYtiY8nENLjH1VtXDxrI3mBJWwkt6kdSWlrcrEvgFTqNEBARzxxm-6e_Q64XahpL-6HwPj0AWnvtvY33Q/s1600/screwed1.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="400" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhX8WHcwLUJpCzB2O1Sf1nQ-qYmiPcczbbQdEa4m7kbCid-I0Y0xefdHublk_coYtiY8nENLjH1VtXDxrI3mBJWwkt6kdSWlrcrEvgFTqNEBARzxxm-6e_Q64XahpL-6HwPj0AWnvtvY33Q/s400/screwed1.jpg" width="320" /></a></div><div class="separator" style="clear: both; text-align: center;"></div><h3><span class="posted" style="font-size: large;">UPDATE: J&J Risperdal anti-psychotic drug - TEXAS TMAP TRIAL "GUILTY" then settles for chump change while </span><span style="font-size: large;"><b>admitting to no liability or fault<i> </i></b></span><span class="posted" style="font-size: large;"> - corporate crime pays very well - will AstraZeneca & Seroquel be next?</span></h3><h3><span class="posted"> </span></h3><h3><span class="posted"><span style="font-size: small; font-weight: normal;">Incredible & Shocking news out of Texas this morning, as a settlement is reached in the J&J TMAP Risperdal trial. J&J has made a estimated 28+ billion dollars on this drug and the energizer profit bunny is still going & going....J&J hid harmful side effects, buried damning studies, lied, lied some more, marketed the drug off label illegally to children, paid off government officials, and so much more.....& what happens....no one goes to prison, just some meaningless cost of doing business fines or settlements...and the crimes and corporate raping of America and society continues unabated....what went on in this backroom deal?...this goes way beyond not smelling right...why didn't the jury have an opportunity to make a rational judgement based on the evidence & reach a verdict? </span></span></h3>I sincerely hope people get angry, sick, & tired of these backroom deals, subversion of our justice system, and the elitist corporate power brokering when it comes to these crimes that have destroyed countless victims lives…where is their justice? The answer to that question; There is none<br />
<br />
SO WHAT HAS REALLY CHANGED? I suspect, very little….so very little indeed…<br />
<h3><span class="posted"><span style="font-size: small; font-weight: normal;">I invite you to read the real story & tragedy behind TMAP - this is what J&J, AstraZeneca, Lilly, & BMS actually did to countless thousands & thousands of children...the victims don't get to just walk away unscathed while profiteering beyond imagination...All of America should feel ashamed today...the Texas Attorney General </span></span>Gregg Abbott <span class="posted"><span style="font-size: small; font-weight: normal;"> should look in the mirror and see the people he is supposed to represent...he should go personally to witness the carnage...visit with the victims...instead of making amiable political backroom deals with criminal corporations...shameful doesn't begin to tell this story..</span></span></h3><h3><a href="http://motherjones.com/politics/2005/05/medicating-aliah"><span class="posted"><span style="font-size: small; font-weight: normal;">from motherjones.com - Medicating Aliah</span></span></a></h3><h3><span class="posted"><span style="font-size: small; font-weight: normal;">----------------------------------------------------------------- </span></span></h3><h3><span class="posted"><span style="font-size: small; font-weight: normal;"><br />
</span></span></h3><h3><span class="posted"><span style="font-size: small; font-weight: normal;">Latest Update <a href="http://www.washingtonpost.com/business/apnewsbreak-source-says-johnson-and-johnson-settles-with-texas-in-suit-that-sought-1-billion/2012/01/19/gIQAc1YmAQ_story.html?tid=sm_btn_tw">highlights from the Washingtonpost Thursday, January 19, 2:09 PM</a></span></span></h3><h3> </h3><div class="corrections "> </div><h1>Johnson & Johnson subsidiary settles Texas lawsuit over anti-psychotic drug for $158 million</h1><div class="module byline"> <h3> By Associated Press<span class="timestamp updated processed"></span><span class="timestamp updated processed"><span class="time special"></span></span> </h3></div><div class="article_body"> <article> AUSTIN, Texas — Texas and a subsidiary of health care giant Johnson & Johnson reached a $158 million settlement in a Medicaid fraud lawsuit Thursday, allowing the drugmaker to pay a fraction of the potential $1 billion in penalties and fines that state officials had initially sought.<br />
<br />
The lawsuit was one of dozens of state and federal cases alleging that the company committed fraud by making false or misleading statements about the safety, cost and effectiveness of the expensive anti-psychotic medication Risperdal, and improperly influencing officials and doctors to push the drug.<br />
</article> </div><div class="module article-side-rail left clearfix padding-right margin-top-7 margin-right-15" id="article-side-rail"> <div class="shareWrap"> <div class="network-news article left face-pile padding-bottom flipboard-remove"> <div style="margin-top: 0px;"><span class="left" style="margin-right: -1px;"><span></span></span></div></div><div class="left"> <div class="tweet flipboard-remove "> </div></div><div class="left"> <span class="IN-widget" style="display: inline-block; line-height: 1; text-align: center; vertical-align: baseline;"><span style="display: inline-block ! important; font-size: 1px ! important; margin: 0pt ! important; padding: 0pt ! important; text-indent: 0pt ! important; vertical-align: baseline ! important;"><span id="li_ui_li_gen_1327024797609_0"><a href="" id="li_ui_li_gen_1327024797609_0-link"><span id="li_ui_li_gen_1327024797609_0-logo">in</span><span id="li_ui_li_gen_1327024797609_0-title"><span id="li_ui_li_gen_1327024797609_0-mark"></span><span id="li_ui_li_gen_1327024797609_0-title-text">Share</span></span></a></span></span></span> </div></div><div class="left margin-right margin-bottom padding-top slug" id="slug_inline_bb" style="display: block;"> </div></div><b>Janssen Pharmaceuticals Inc., one of the J&J subsidiaries that had been sued, said in a statement it will pay the money to fully resolve all claims in Texas. <i><span style="font-size: large;">The company said it is not admitting any liability or fault with the settlement.</span></i></b><br />
<br />
<b> </b>But <b>analysts called the $158 million figure a victory for J&J, which made billions off Risperdal</b>, because the deal allowed the company to avoid a much larger verdict in a state with a reputation as an easy place to win big jury awards.<br />
<br />
The<b> settlement also is far less than the $327 million Johnson & Johnson recently was ordered to pay in South Carolina and the $258 million it was ordered to pay in Louisiana in Risperdal lawsuits</b>.<br />
<b><i><span style="font-size: large;">“For Johnson & Johnson, it’s a mighty easy result,”</span></i> said Eric Gordon, a clinical professor at the University of Michigan’s Ross School of Business.</b><span style="font-size: large;"><b> <i>“The legal team at Johnson & Johnson are doing high fives.”</i></b></span><br />
<br />
<span style="font-size: large;"><span style="font-size: small;">-------------------------------------------------</span><b> </b></span><br />
<h3 style="font-weight: normal;"><span class="posted" style="font-size: small;">UPDATE: </span></h3><h3 style="font-weight: normal;"><span class="posted" style="font-size: small;"><a href="http://www.marketwatch.com/story/jj-to-pay-158-million-to-settle-risperdal-case-2012-01-19?link=MW_latest_news">from marketwatch</a></span></h3><h1>J&J to pay $158 million to settle Risperdal case</h1><h3 style="font-weight: normal;"><span style="font-size: small;">CHICAGO (MarketWatch) -- Johnson & Johnson's Janssen Pharmaceuticals unit said Thursday it has reached a settlement with the State of Texas under which it will pay $158 million "in full resolution of all claims" in litigation over its antipsychotic drug Risperdal. The deal will cover claims brought by the state in 2004 for Medicaid overpayment from 1994 to 2008 "and will circumvent potentially lengthy and costly appellate activities," the company said. Sharing in the money will be the original plaintiff, his attorneys, the state of Texas and the federal government. Shares of Johnson & Johnson <span class="quotePeekContainer"> <span class="quotepeekbase bgQuote down" id="quote1643762236"> <a class="" href="http://www.marketwatch.com/investing/stock/JNJ?link=MW_story_quote"> <span class="symbol">JNJ</span> <span class="data bgPercentChange symbol">-0.32%</span> </a> </span> </span> were down about 1% in morning action.</span></h3><h3 style="font-weight: normal;"><span style="font-size: small;">------------------------------------------------- </span></h3><h3><span class="posted"> </span></h3><h1 id="blogtitle">from <a href="http://1boringoldman.com/">1 Boring Old Man</a> blog </h1><h1 id="blogtitle"><br />
</h1><h3><span class="posted"></span><a href="http://1boringoldman.com/index.php/2012/01/19/speaking-of-nails-in-the-coffin/" rel="bookmark">speaking of nails in the coffin… </a></h3><h3> </h3><div class="title" id="post-18343"></div><h3><span class="posted">Posted on </span> Thursday 19 January 2012 </h3></div><div align="justify"><b><u><span style="color: #200020;">Update</span></u> <span style="color: #200020;">10:20 AM</span></b>: I just got this email from Austin: "I wanted to let you know that a settlement is being announced this morning in Austin. I have no additional details right now, but should learn more later today."</div><hr size="1" /><div align="justify"><b><u><span style="color: #200020;">Update</span></u> <span style="color: #200020;">10:40 AM</span></b>: PHARMALOT TWITTER: Johnson & Johnson to settle charges brought by Texas AG of illegally promoting Risperdal: sources.. announcement due shortly…<br />
<br />
<div align="justify"><b><u><span style="color: #200020;">Update</span></u> :</b></div><blockquote><div align="center"><a href="http://www.businessweek.com/news/2012-01-19/j-j-said-to-settle-texas-risperdal-anti-psychotic-drug-case.html" target="_blank"><u><b><span style="color: #200020;">J&J Said to Settle Texas Risperdal Anti-Psychotic Drug Case</span></b></u></a><br />
<b><span style="color: #200020;">Bloomberg</span></b><br />
By Jef Feeley and Margaret Cronin Fisk<br />
January 19, 2012, 10:23 AM EST</div><br />
<div align="justify">Johnson & Johnson agreed to settle Texas officials’ claims that the drugmaker fraudulently marketed its Risperdal anti-psychotic drug and end a trial over the allegations, people familiar with the case said. The settlement will be announced in court today, the people said.</div></blockquote></div><div align="justify"></div><div align="justify">SIDE NOTE: The comment section should be buzzing with excellent feedback well worth reading...<br />
<br />
</div><div align="justify"></div><div align="justify"><span style="background-color: red;">**updates to this post will be done as information becomes available**</span></div>Seroquelhttp://www.blogger.com/profile/12012400050067849012noreply@blogger.com0